Community	Category	Resource	Identifier	Term	PValue	Bonferroni	Benjamini	FDR
Community00	gene oncology	GO(BP)	GO:0009891	positive regulation of biosynthetic process	4.33E-44	1.67E-40	8.34E-41	8.02E-41
Community00	gene oncology	GO(BP)	GO:0031328	positive regulation of cellular biosynthetic process	5.49E-44	2.11E-40	7.04E-41	1.02E-40
Community00	gene oncology	GO(BP)	GO:0010604	positive regulation of macromolecule metabolic process	5.39E-43	2.07E-39	5.19E-40	9.98E-40
Community00	gene oncology	GO(BP)	GO:0010557	positive regulation of macromolecule biosynthetic process	3.91E-39	1.50E-35	3.01E-36	7.24E-36
Community00	gene oncology	GO(BP)	GO:0051173	positive regulation of nitrogen compound metabolic process	5.00E-39	1.92E-35	3.21E-36	9.25E-36
Community00	gene oncology	GO(BP)	GO:0010628	positive regulation of gene expression	4.12E-37	1.59E-33	2.27E-34	7.63E-34
Community00	gene oncology	GO(BP)	GO:0045935	"positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process"	1.47E-36	5.65E-33	7.06E-34	2.72E-33
Community00	gene oncology	GO(BP)	GO:0045893	"positive regulation of transcription, DNA-dependent"	7.05E-36	2.71E-32	3.01E-33	1.30E-32
Community00	gene oncology	GO(BP)	GO:0010033	response to organic substance	8.70E-36	3.35E-32	3.35E-33	1.61E-32
Community00	gene oncology	GO(BP)	GO:0051254	positive regulation of RNA metabolic process	1.40E-35	5.39E-32	4.90E-33	2.59E-32
Community00	gene oncology	GO(BP)	GO:0006357	regulation of transcription from RNA polymerase II promoter	1.91E-35	7.36E-32	6.13E-33	3.54E-32
Community00	gene oncology	GO(BP)	GO:0043067	regulation of programmed cell death	5.87E-35	2.26E-31	1.74E-32	1.09E-31
Community00	gene oncology	GO(BP)	GO:0010941	regulation of cell death	8.43E-35	3.24E-31	2.32E-32	1.56E-31
Community00	gene oncology	GO(BP)	GO:0008285	negative regulation of cell proliferation	1.75E-34	6.72E-31	4.48E-32	3.23E-31
Community00	gene oncology	GO(BP)	GO:0045941	positive regulation of transcription	1.90E-34	7.29E-31	4.56E-32	3.51E-31
Community00	gene oncology	GO(BP)	GO:0042981	regulation of apoptosis	5.02E-34	1.93E-30	1.14E-31	9.29E-31
Community00	gene oncology	GO(BP)	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	6.04E-32	2.32E-28	1.29E-29	1.12E-28
Community00	gene oncology	GO(BP)	GO:0008284	positive regulation of cell proliferation	8.12E-32	3.13E-28	1.64E-29	1.50E-28
Community00	gene oncology	GO(CC)	GO:0005615	extracellular space	3.04E-31	1.35E-28	1.35E-28	4.31E-28
Community00	gene oncology	GO(MF)	GO:0043565	sequence-specific DNA binding	6.38E-30	5.88E-27	5.88E-27	9.97E-27
Community00	gene oncology	GO(MF)	GO:0003700	transcription factor activity	6.41E-30	5.91E-27	2.95E-27	1.00E-26
Community00	gene oncology	GO(CC)	GO:0044421	extracellular region part	6.04E-28	2.69E-25	1.34E-25	8.56E-25
Community00	gene oncology	GO(BP)	GO:0009611	response to wounding	7.82E-28	3.01E-24	1.50E-25	1.45E-24
Community00	gene oncology	GO(BP)	GO:0042592	homeostatic process	1.53E-27	5.89E-24	2.81E-25	2.84E-24
Community00	pathway	KEGG	hsa05200	Pathways in cancer	3.41E-26	5.05E-24	5.05E-24	4.06E-23
Community00	gene oncology	GO(BP)	GO:0048545	response to steroid hormone stimulus	7.08E-26	2.72E-22	1.24E-23	1.31E-22
Community00	gene oncology	GO(BP)	GO:0001775	cell activation	1.24E-25	4.78E-22	2.08E-23	2.30E-22
Community00	gene oncology	GO(BP)	GO:0009719	response to endogenous stimulus	1.61E-25	6.18E-22	2.58E-23	2.97E-22
Community00	gene oncology	GO(BP)	GO:0009991	response to extracellular stimulus	8.46E-25	3.26E-21	1.30E-22	1.57E-21
Community00	gene oncology	GO(BP)	GO:0009725	response to hormone stimulus	2.41E-24	9.26E-21	3.56E-22	4.46E-21
Community00	gene oncology	GO(MF)	GO:0016563	transcription activator activity	4.04E-24	3.73E-21	1.24E-21	6.32E-21
Community00	gene oncology	GO(MF)	GO:0030528	transcription regulator activity	4.74E-24	4.37E-21	1.09E-21	7.41E-21
Community00	gene oncology	GO(BP)	GO:0006355	"regulation of transcription, DNA-dependent"	5.49E-24	2.11E-20	7.82E-22	1.02E-20
Community00	gene oncology	GO(BP)	GO:0031667	response to nutrient levels	1.68E-23	6.47E-20	2.31E-21	3.11E-20
Community00	gene oncology	GO(BP)	GO:0051252	regulation of RNA metabolic process	2.10E-23	8.09E-20	2.79E-21	3.89E-20
Community00	gene oncology	GO(BP)	GO:0048534	hemopoietic or lymphoid organ development	6.27E-23	2.41E-19	8.04E-21	1.16E-19
Community00	gene oncology	GO(BP)	GO:0010605	negative regulation of macromolecule metabolic process	7.77E-23	2.99E-19	9.64E-21	1.44E-19
Community00	gene oncology	GO(BP)	GO:0002520	immune system development	1.85E-22	7.13E-19	2.23E-20	3.43E-19
Community00	gene oncology	GO(BP)	GO:0030097	hemopoiesis	1.23E-21	4.74E-18	1.44E-19	2.28E-18
Community00	gene oncology	GO(BP)	GO:0032583	regulation of gene-specific transcription	4.37E-21	1.68E-17	4.94E-19	8.09E-18
Community00	gene oncology	GO(BP)	GO:0009890	negative regulation of biosynthetic process	5.61E-21	2.16E-17	6.17E-19	1.04E-17
Community00	gene oncology	GO(BP)	GO:0042493	response to drug	7.54E-21	2.90E-17	8.05E-19	1.39E-17
Community00	gene oncology	GO(BP)	GO:0043065	positive regulation of apoptosis	1.67E-20	6.43E-17	1.74E-18	3.09E-17
Community00	gene oncology	GO(BP)	GO:0001944	vasculature development	2.00E-20	7.68E-17	2.02E-18	3.69E-17
Community00	gene oncology	GO(BP)	GO:0043068	positive regulation of programmed cell death	2.43E-20	9.35E-17	2.40E-18	4.50E-17
Community00	gene oncology	GO(MF)	GO:0046983	protein dimerization activity	3.06E-20	2.82E-17	5.64E-18	4.78E-17
Community00	gene oncology	GO(BP)	GO:0010942	positive regulation of cell death	3.12E-20	1.20E-16	3.00E-18	5.77E-17
Community00	gene oncology	GO(BP)	GO:0001568	blood vessel development	4.24E-20	1.63E-16	3.98E-18	7.85E-17
Community00	gene oncology	GO(MF)	GO:0010843	promoter binding	4.50E-20	4.15E-17	6.92E-18	7.04E-17
Community00	gene oncology	GO(BP)	GO:0051094	positive regulation of developmental process	5.62E-20	2.16E-16	5.15E-18	1.04E-16
Community00	gene oncology	GO(BP)	GO:0043069	negative regulation of programmed cell death	8.54E-20	3.29E-16	7.64E-18	1.58E-16
Community00	gene oncology	GO(BP)	GO:0045597	positive regulation of cell differentiation	9.17E-20	3.53E-16	8.02E-18	1.70E-16
Community00	gene oncology	GO(BP)	GO:0060548	negative regulation of cell death	9.80E-20	3.77E-16	8.38E-18	1.81E-16
Community00	gene oncology	GO(BP)	GO:0031327	negative regulation of cellular biosynthetic process	1.04E-19	4.01E-16	8.72E-18	1.93E-16
Community00	gene oncology	GO(BP)	GO:0045321	leukocyte activation	1.53E-19	5.90E-16	1.26E-17	2.84E-16
Community00	gene oncology	GO(BP)	GO:0048878	chemical homeostasis	1.54E-19	5.92E-16	1.23E-17	2.85E-16
Community00	gene oncology	GO(BP)	GO:0051270	regulation of cell motion	1.66E-19	6.40E-16	1.31E-17	3.08E-16
Community00	gene oncology	GO(BP)	GO:0043066	negative regulation of apoptosis	2.13E-19	8.19E-16	1.64E-17	3.94E-16
Community00	gene oncology	GO(BP)	GO:0051174	regulation of phosphorus metabolic process	5.66E-19	2.18E-15	4.27E-17	1.05E-15
Community00	gene oncology	GO(BP)	GO:0019220	regulation of phosphate metabolic process	5.66E-19	2.18E-15	4.27E-17	1.05E-15
Community00	gene oncology	GO(BP)	GO:0010629	negative regulation of gene expression	1.09E-18	4.18E-15	8.04E-17	2.01E-15
Community00	gene oncology	GO(BP)	GO:0042325	regulation of phosphorylation	1.20E-18	4.60E-15	8.68E-17	2.21E-15
Community00	gene oncology	GO(BP)	GO:0051240	positive regulation of multicellular organismal process	1.30E-18	5.02E-15	9.29E-17	2.41E-15
Community00	gene oncology	GO(BP)	GO:0051172	negative regulation of nitrogen compound metabolic process	1.32E-18	5.08E-15	9.23E-17	2.44E-15
Community00	gene oncology	GO(MF)	GO:0046906	tetrapyrrole binding	1.39E-18	1.28E-15	1.82E-16	2.17E-15
Community00	gene oncology	GO(MF)	GO:0020037	heme binding	1.44E-18	1.32E-15	1.66E-16	2.25E-15
Community00	gene oncology	GO(BP)	GO:0002521	leukocyte differentiation	1.50E-18	5.76E-15	1.03E-16	2.77E-15
Community00	gene oncology	GO(BP)	GO:0010558	negative regulation of macromolecule biosynthetic process	1.51E-18	5.83E-15	1.02E-16	2.80E-15
Community00	gene oncology	GO(BP)	GO:0070482	response to oxygen levels	2.19E-18	8.41E-15	1.45E-16	4.04E-15
Community00	gene oncology	GO(BP)	GO:0030334	regulation of cell migration	2.84E-18	1.09E-14	1.85E-16	5.25E-15
Community00	gene oncology	GO(CC)	GO:0005576	extracellular region	3.06E-18	1.36E-15	4.54E-16	4.34E-15
Community00	gene oncology	GO(BP)	GO:0006952	defense response	5.39E-18	2.07E-14	3.46E-16	9.97E-15
Community00	gene oncology	GO(BP)	GO:0040012	regulation of locomotion	6.36E-18	2.45E-14	4.01E-16	1.18E-14
Community00	gene oncology	GO(BP)	GO:0016481	negative regulation of transcription	9.51E-18	3.66E-14	5.90E-16	1.76E-14
Community00	gene oncology	GO(BP)	GO:0045934	"negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process"	9.97E-18	3.83E-14	6.09E-16	1.84E-14
Community00	gene oncology	GO(BP)	GO:0006928	cell motion	1.31E-17	5.05E-14	7.89E-16	2.43E-14
Community00	gene oncology	GO(MF)	GO:0003702	RNA polymerase II transcription factor activity	1.31E-17	1.20E-14	1.34E-15	2.04E-14
Community00	gene oncology	GO(BP)	GO:0007584	response to nutrient	1.40E-17	5.38E-14	8.28E-16	2.59E-14
Community00	gene oncology	GO(MF)	GO:0008134	transcription factor binding	2.25E-17	2.07E-14	2.07E-15	3.51E-14
Community00	gene oncology	GO(BP)	GO:0001666	response to hypoxia	2.69E-17	1.03E-13	1.57E-15	4.97E-14
Community00	gene oncology	GO(BP)	GO:0016477	cell migration	3.70E-17	1.42E-13	2.12E-15	6.84E-14
Community00	gene oncology	GO(BP)	GO:0051329	interphase of mitotic cell cycle	4.74E-17	1.82E-13	2.68E-15	8.77E-14
Community00	gene oncology	GO(BP)	GO:0010035	response to inorganic substance	7.07E-17	4.27E-13	6.22E-15	2.11E-13
Community00	gene oncology	GO(BP)	GO:0051272	positive regulation of cell motion	1.08E-16	4.27E-13	6.11E-15	2.11E-13
Community00	gene oncology	GO(BP)	GO:0051325	interphase	1.11E-16	4.27E-13	6.00E-15	2.11E-13
Community00	gene oncology	GO(BP)	GO:0051674	localization of cell	1.16E-16	4.27E-13	5.88E-15	2.11E-13
Community00	gene oncology	GO(BP)	GO:0048870	cell motility	1.16E-16	4.27E-13	5.88E-15	2.11E-13
Community00	gene oncology	GO(BP)	GO:0032101	regulation of response to external stimulus	1.27E-16	4.27E-13	5.88E-15	2.11E-13
Community00	gene oncology	GO(BP)	GO:0009628	response to abiotic stimulus	1.29E-16	4.27E-13	5.77E-15	2.11E-13
Community00	gene oncology	GO(BP)	GO:0045892	"negative regulation of transcription, DNA-dependent"	1.34E-16	4.27E-13	5.66E-15	2.11E-13
Community00	gene oncology	GO(BP)	GO:0046649	lymphocyte activation	1.49E-16	4.27E-13	5.66E-15	2.11E-13
Community00	gene oncology	GO(BP)	GO:0035295	tube development	1.57E-16	4.27E-13	5.55E-15	2.11E-13
Community00	gene oncology	GO(BP)	GO:0048514	blood vessel morphogenesis	2.01E-16	8.54E-13	1.10E-14	4.11E-13
Community00	gene oncology	GO(BP)	GO:0042060	wound healing	2.18E-16	8.54E-13	1.08E-14	4.11E-13
Community00	gene oncology	GO(BP)	GO:0051253	negative regulation of RNA metabolic process	3.88E-16	1.28E-12	1.60E-14	6.22E-13
Community00	gene oncology	GO(BP)	GO:0043193	positive regulation of gene-specific transcription	4.03E-16	1.71E-12	2.11E-14	8.22E-13
Community00	gene oncology	GO(BP)	GO:0051726	regulation of cell cycle	6.67E-16	2.56E-12	3.12E-14	1.23E-12
Community00	gene oncology	GO(BP)	GO:0030335	positive regulation of cell migration	8.57E-16	3.42E-12	4.12E-14	1.64E-12
Community00	gene oncology	GO(BP)	GO:0008283	cell proliferation	1.08E-15	4.27E-12	5.08E-14	2.05E-12
Community00	gene oncology	GO(BP)	GO:0040017	positive regulation of locomotion	1.16E-15	4.27E-12	5.03E-14	2.05E-12
Community00	gene oncology	GO(BP)	GO:0008219	cell death	1.32E-15	5.13E-12	5.96E-14	2.46E-12
Community00	gene oncology	GO(MF)	GO:0019825	oxygen binding	1.34E-15	1.23E-12	1.12E-13	2.09E-12
Community00	gene oncology	GO(BP)	GO:0006955	immune response	1.39E-15	5.13E-12	5.90E-14	2.46E-12
Community00	gene oncology	GO(BP)	GO:0006954	inflammatory response	1.52E-15	5.98E-12	6.79E-14	2.88E-12
Community00	gene oncology	GO(BP)	GO:0008202	steroid metabolic process	1.83E-15	6.83E-12	7.68E-14	3.29E-12
Community00	gene oncology	GO(BP)	GO:0016265	death	1.84E-15	7.26E-12	8.07E-14	3.50E-12
Community00	gene oncology	GO(BP)	GO:0001932	regulation of protein amino acid phosphorylation	2.32E-15	8.97E-12	9.86E-14	4.32E-12
Community00	gene oncology	GO(BP)	GO:0044093	positive regulation of molecular function	3.81E-15	1.45E-11	1.58E-13	6.98E-12
Community00	gene oncology	GO(BP)	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	7.18E-15	2.78E-11	2.99E-13	1.34E-11
Community00	gene oncology	GO(BP)	GO:0043627	response to estrogen stimulus	7.72E-15	2.95E-11	3.14E-13	1.42E-11
Community00	gene oncology	GO(BP)	GO:0032844	regulation of homeostatic process	8.63E-15	3.33E-11	3.51E-13	1.60E-11
Community00	gene oncology	GO(BP)	GO:0001890	placenta development	8.64E-15	3.33E-11	3.47E-13	1.60E-11
Community00	gene oncology	GO(BP)	GO:0012501	programmed cell death	9.27E-15	3.54E-11	3.65E-13	1.71E-11
Community00	gene oncology	GO(BP)	GO:0001817	regulation of cytokine production	1.01E-14	3.89E-11	3.97E-13	1.87E-11
Community00	gene oncology	GO(BP)	GO:0040008	regulation of growth	1.04E-14	4.01E-11	4.06E-13	1.93E-11
Community00	gene oncology	GO(BP)	GO:0010647	positive regulation of cell communication	1.10E-14	4.23E-11	4.23E-13	2.03E-11
Community00	gene oncology	GO(BP)	GO:0001501	skeletal system development	1.45E-14	5.55E-11	5.50E-13	2.67E-11
Community00	gene oncology	GO(BP)	GO:0031399	regulation of protein modification process	1.48E-14	5.68E-11	5.57E-13	2.73E-11
Community00	gene oncology	GO(BP)	GO:0009967	positive regulation of signal transduction	1.48E-14	5.68E-11	5.57E-13	2.73E-11
Community00	gene oncology	GO(BP)	GO:0010627	regulation of protein kinase cascade	1.64E-14	6.28E-11	6.10E-13	3.02E-11
Community00	gene oncology	GO(BP)	GO:0030099	myeloid cell differentiation	2.53E-14	9.74E-11	9.36E-13	4.68E-11
Community00	gene oncology	GO(BP)	GO:0002237	response to molecule of bacterial origin	3.36E-14	1.29E-10	1.23E-12	6.23E-11
Community00	gene oncology	GO(BP)	GO:0055088	lipid homeostasis	4.38E-14	1.69E-10	1.59E-12	8.12E-11
Community00	gene oncology	GO(BP)	GO:0014070	response to organic cyclic substance	4.42E-14	1.70E-10	1.59E-12	8.20E-11
Community00	gene oncology	GO(BP)	GO:0006915	apoptosis	4.80E-14	1.85E-10	1.71E-12	8.88E-11
Community00	gene oncology	GO(BP)	GO:0032268	regulation of cellular protein metabolic process	4.83E-14	1.86E-10	1.70E-12	8.94E-11
Community00	gene oncology	GO(MF)	GO:0042802	identical protein binding	5.84E-14	5.38E-11	4.49E-12	9.13E-11
Community00	gene oncology	GO(BP)	GO:0060348	bone development	6.88E-14	2.65E-10	2.41E-12	1.27E-10
Community00	gene oncology	GO(BP)	GO:0033273	response to vitamin	7.62E-14	2.93E-10	2.64E-12	1.41E-10
Community00	gene oncology	GO(BP)	GO:0001503	ossification	8.66E-14	3.33E-10	2.97E-12	1.60E-10
Community00	gene oncology	GO(CC)	GO:0005667	transcription factor complex	9.11E-14	4.06E-11	1.01E-11	1.29E-10
Community00	gene oncology	GO(BP)	GO:0045596	negative regulation of cell differentiation	9.21E-14	3.54E-10	3.14E-12	1.71E-10
Community00	gene oncology	GO(BP)	GO:0006979	response to oxidative stress	1.10E-13	4.25E-10	3.72E-12	2.04E-10
Community00	gene oncology	GO(BP)	GO:0051241	negative regulation of multicellular organismal process	1.10E-13	4.25E-10	3.72E-12	2.04E-10
Community00	gene oncology	GO(BP)	GO:0048732	gland development	1.21E-13	4.66E-10	4.05E-12	2.24E-10
Community00	gene oncology	GO(BP)	GO:0007565	female pregnancy	2.12E-13	8.16E-10	7.03E-12	3.92E-10
Community00	gene oncology	GO(BP)	GO:0031960	response to corticosteroid stimulus	2.39E-13	9.19E-10	7.86E-12	4.42E-10
Community00	gene oncology	GO(BP)	GO:0010551	regulation of specific transcription from RNA polymerase II promoter	2.91E-13	1.12E-09	9.50E-12	5.39E-10
Community00	gene oncology	GO(BP)	GO:0051384	response to glucocorticoid stimulus	3.13E-13	1.20E-09	1.01E-11	5.79E-10
Community00	gene oncology	GO(BP)	GO:0052547	regulation of peptidase activity	3.14E-13	1.21E-09	1.01E-11	5.81E-10
Community00	gene oncology	GO(BP)	GO:0050865	regulation of cell activation	7.19E-13	2.76E-09	2.28E-11	1.33E-09
Community00	gene oncology	GO(BP)	GO:0045449	regulation of transcription	7.82E-13	3.01E-09	2.46E-11	1.45E-09
Community00	gene oncology	GO(BP)	GO:0052548	regulation of endopeptidase activity	9.64E-13	3.71E-09	3.01E-11	1.78E-09
Community00	gene oncology	GO(BP)	GO:0045859	regulation of protein kinase activity	1.12E-12	4.32E-09	3.49E-11	2.08E-09
Community00	gene oncology	GO(BP)	GO:0009314	response to radiation	1.20E-12	4.60E-09	3.68E-11	2.21E-09
Community00	gene oncology	GO(BP)	GO:0051338	regulation of transferase activity	1.22E-12	4.68E-09	3.72E-11	2.25E-09
Community00	gene oncology	GO(BP)	GO:0007610	behavior	1.32E-12	5.07E-09	3.99E-11	2.44E-09
Community00	gene oncology	GO(BP)	GO:0007568	aging	1.60E-12	6.14E-09	4.80E-11	2.95E-09
Community00	gene oncology	GO(BP)	GO:0009617	response to bacterium	2.19E-12	8.43E-09	6.54E-11	4.06E-09
Community00	gene oncology	GO(BP)	GO:0032496	response to lipopolysaccharide	2.24E-12	8.64E-09	6.64E-11	4.15E-09
Community00	gene oncology	GO(BP)	GO:0019216	regulation of lipid metabolic process	2.46E-12	9.45E-09	7.21E-11	4.54E-09
Community00	gene oncology	GO(BP)	GO:0043085	positive regulation of catalytic activity	2.55E-12	9.81E-09	7.43E-11	4.72E-09
Community00	gene oncology	GO(BP)	GO:0006916	anti-apoptosis	2.85E-12	1.10E-08	8.24E-11	5.27E-09
Community00	gene oncology	GO(BP)	GO:0043549	regulation of kinase activity	3.83E-12	1.47E-08	1.10E-10	7.09E-09
Community00	gene oncology	GO(BP)	GO:0034097	response to cytokine stimulus	3.88E-12	1.49E-08	1.10E-10	7.17E-09
Community00	gene oncology	GO(BP)	GO:0043281	regulation of caspase activity	3.88E-12	1.49E-08	1.10E-10	7.17E-09
Community00	gene oncology	GO(BP)	GO:0043434	response to peptide hormone stimulus	4.08E-12	1.57E-08	1.16E-10	7.56E-09
Community00	gene oncology	GO(CC)	GO:0009986	cell surface	5.43E-12	2.42E-09	4.83E-10	7.69E-09
Community00	pathway	KEGG	hsa05215	Prostate cancer	5.89E-12	8.72E-10	4.36E-10	7.02E-09
Community00	gene oncology	GO(MF)	GO:0003690	double-stranded DNA binding	6.63E-12	6.11E-09	4.70E-10	1.04E-08
Community00	gene oncology	GO(BP)	GO:0035239	tube morphogenesis	7.37E-12	2.84E-08	2.07E-10	1.36E-08
Community00	gene oncology	GO(BP)	GO:0003006	reproductive developmental process	8.60E-12	3.31E-08	2.40E-10	1.59E-08
Community00	gene oncology	GO(MF)	GO:0042803	protein homodimerization activity	8.78E-12	8.10E-09	5.78E-10	1.37E-08
Community00	gene oncology	GO(BP)	GO:0045937	positive regulation of phosphate metabolic process	9.66E-12	3.71E-08	2.67E-10	1.79E-08
Community00	gene oncology	GO(BP)	GO:0048872	homeostasis of number of cells	9.66E-12	3.71E-08	2.67E-10	1.79E-08
Community00	gene oncology	GO(BP)	GO:0010562	positive regulation of phosphorus metabolic process	9.66E-12	3.71E-08	2.67E-10	1.79E-08
Community00	gene oncology	GO(BP)	GO:0046890	regulation of lipid biosynthetic process	1.06E-11	4.06E-08	2.90E-10	1.95E-08
Community00	pathway	KEGG	hsa05219	Bladder cancer	1.07E-11	1.59E-09	5.29E-10	1.28E-08
Community00	gene oncology	GO(BP)	GO:0000302	response to reactive oxygen species	1.19E-11	4.58E-08	3.25E-10	2.20E-08
Community00	gene oncology	GO(BP)	GO:0043009	chordate embryonic development	1.52E-11	5.85E-08	4.12E-10	2.81E-08
Community00	gene oncology	GO(BP)	GO:0048660	regulation of smooth muscle cell proliferation	1.56E-11	6.00E-08	4.19E-10	2.88E-08
Community00	gene oncology	GO(BP)	GO:0030098	lymphocyte differentiation	1.85E-11	7.13E-08	4.95E-10	3.43E-08
Community00	gene oncology	GO(BP)	GO:0051098	regulation of binding	1.97E-11	7.59E-08	5.24E-10	3.65E-08
Community00	gene oncology	GO(BP)	GO:0009792	embryonic development ending in birth or egg hatching	2.05E-11	7.90E-08	5.41E-10	3.80E-08
Community00	gene oncology	GO(BP)	GO:0002694	regulation of leukocyte activation	2.82E-11	1.09E-07	7.38E-10	5.22E-08
Community00	gene oncology	GO(BP)	GO:0010740	positive regulation of protein kinase cascade	3.29E-11	1.26E-07	8.54E-10	6.08E-08
Community00	gene oncology	GO(BP)	GO:0042327	positive regulation of phosphorylation	3.68E-11	1.42E-07	9.51E-10	6.81E-08
Community00	gene oncology	GO(BP)	GO:0042110	T cell activation	3.86E-11	1.48E-07	9.89E-10	7.14E-08
Community00	gene oncology	GO(BP)	GO:0009612	response to mechanical stimulus	4.33E-11	1.67E-07	1.10E-09	8.02E-08
Community00	gene oncology	GO(BP)	GO:0050863	regulation of T cell activation	4.56E-11	1.76E-07	1.15E-09	8.44E-08
Community00	gene oncology	GO(BP)	GO:0001934	positive regulation of protein amino acid phosphorylation	4.62E-11	1.78E-07	1.16E-09	8.55E-08
Community00	gene oncology	GO(BP)	GO:0051249	regulation of lymphocyte activation	4.89E-11	1.88E-07	1.22E-09	9.06E-08
Community00	pathway	KEGG	hsa05222	Small cell lung cancer	5.25E-11	7.77E-09	1.94E-09	6.25E-08
Community00	gene oncology	GO(BP)	GO:0048568	embryonic organ development	6.91E-11	2.66E-07	1.72E-09	1.28E-07
Community00	gene oncology	GO(BP)	GO:0051247	positive regulation of protein metabolic process	7.17E-11	2.76E-07	1.77E-09	1.33E-07
Community00	gene oncology	GO(MF)	GO:0003704	specific RNA polymerase II transcription factor activity	8.00E-11	7.37E-08	4.91E-09	1.25E-07
Community00	gene oncology	GO(BP)	GO:0050878	regulation of body fluid levels	8.75E-11	3.37E-07	2.14E-09	1.62E-07
Community00	gene oncology	GO(BP)	GO:0050670	regulation of lymphocyte proliferation	8.92E-11	3.43E-07	2.17E-09	1.65E-07
Community00	gene oncology	GO(BP)	GO:0044057	regulation of system process	8.94E-11	3.44E-07	2.16E-09	1.65E-07
Community00	gene oncology	GO(BP)	GO:0008203	cholesterol metabolic process	9.06E-11	3.48E-07	2.18E-09	1.68E-07
Community00	pathway	KEGG	hsa04115	p53 signaling pathway	9.38E-11	1.39E-08	2.78E-09	1.12E-07
Community00	gene oncology	GO(MF)	GO:0004879	ligand-dependent nuclear receptor activity	1.02E-10	9.43E-08	5.89E-09	1.60E-07
Community00	gene oncology	GO(MF)	GO:0005125	cytokine activity	1.03E-10	9.52E-08	5.60E-09	1.62E-07
Community00	gene oncology	GO(BP)	GO:0032944	regulation of mononuclear cell proliferation	1.13E-10	4.34E-07	2.69E-09	2.09E-07
Community00	gene oncology	GO(BP)	GO:0070663	regulation of leukocyte proliferation	1.13E-10	4.34E-07	2.69E-09	2.09E-07
Community00	gene oncology	GO(MF)	GO:0003677	DNA binding	1.13E-10	1.04E-07	5.80E-09	1.77E-07
Community00	gene oncology	GO(MF)	GO:0005506	iron ion binding	1.26E-10	1.16E-07	6.10E-09	1.96E-07
Community00	gene oncology	GO(BP)	GO:0060429	epithelium development	1.99E-10	7.64E-07	4.72E-09	3.68E-07
Community00	gene oncology	GO(BP)	GO:0048608	reproductive structure development	2.32E-10	8.94E-07	5.48E-09	4.30E-07
Community00	gene oncology	GO(BP)	GO:0060249	anatomical structure homeostasis	2.33E-10	8.95E-07	5.46E-09	4.31E-07
Community00	gene oncology	GO(BP)	GO:0006919	activation of caspase activity	2.45E-10	9.41E-07	5.70E-09	4.53E-07
Community00	gene oncology	GO(BP)	GO:0045637	regulation of myeloid cell differentiation	2.47E-10	9.51E-07	5.73E-09	4.58E-07
Community00	gene oncology	GO(BP)	GO:0006917	induction of apoptosis	2.63E-10	1.01E-06	6.05E-09	4.86E-07
Community00	gene oncology	GO(BP)	GO:0045137	development of primary sexual characteristics	2.76E-10	1.06E-06	6.31E-09	5.10E-07
Community00	gene oncology	GO(BP)	GO:0012502	induction of programmed cell death	2.87E-10	1.10E-06	6.54E-09	5.31E-07
Community00	gene oncology	GO(BP)	GO:0008361	regulation of cell size	2.96E-10	1.14E-06	6.71E-09	5.49E-07
Community00	gene oncology	GO(CC)	GO:0031974	membrane-enclosed lumen	3.16E-10	1.41E-07	2.35E-08	4.48E-07
Community00	gene oncology	GO(BP)	GO:0002573	myeloid leukocyte differentiation	3.26E-10	1.25E-06	7.34E-09	6.03E-07
Community00	gene oncology	GO(BP)	GO:0060541	respiratory system development	3.41E-10	1.31E-06	7.62E-09	6.31E-07
Community00	gene oncology	GO(BP)	GO:0045165	cell fate commitment	3.52E-10	1.35E-06	7.83E-09	6.51E-07
Community00	gene oncology	GO(BP)	GO:0008544	epidermis development	3.67E-10	1.41E-06	8.10E-09	6.78E-07
Community00	gene oncology	GO(BP)	GO:0032270	positive regulation of cellular protein metabolic process	3.99E-10	1.53E-06	8.77E-09	7.38E-07
Community00	gene oncology	GO(BP)	GO:0007548	sex differentiation	4.21E-10	1.62E-06	9.20E-09	7.79E-07
Community00	gene oncology	GO(BP)	GO:0043523	regulation of neuron apoptosis	4.26E-10	1.64E-06	9.25E-09	7.87E-07
Community00	gene oncology	GO(BP)	GO:0042542	response to hydrogen peroxide	4.48E-10	1.72E-06	9.67E-09	8.28E-07
Community00	gene oncology	GO(BP)	GO:0048771	tissue remodeling	4.48E-10	1.72E-06	9.67E-09	8.28E-07
Community00	gene oncology	GO(BP)	GO:0031668	cellular response to extracellular stimulus	4.50E-10	1.73E-06	9.67E-09	8.33E-07
Community00	gene oncology	GO(MF)	GO:0019899	enzyme binding	4.89E-10	4.51E-07	2.26E-08	7.65E-07
Community00	gene oncology	GO(BP)	GO:0045926	negative regulation of growth	4.94E-10	1.90E-06	1.06E-08	9.15E-07
Community00	gene oncology	GO(MF)	GO:0046982	protein heterodimerization activity	5.44E-10	5.01E-07	2.39E-08	8.50E-07
Community00	gene oncology	GO(BP)	GO:0007398	ectoderm development	5.52E-10	2.12E-06	1.17E-08	1.02E-06
Community00	gene oncology	GO(BP)	GO:0001649	osteoblast differentiation	5.68E-10	2.18E-06	1.20E-08	1.05E-06
Community00	gene oncology	GO(BP)	GO:0051101	regulation of DNA binding	5.77E-10	2.22E-06	1.21E-08	1.07E-06
Community00	gene oncology	GO(BP)	GO:0016125	sterol metabolic process	5.78E-10	2.22E-06	1.21E-08	1.07E-06
Community00	gene oncology	GO(BP)	GO:0010552	positive regulation of specific transcription from RNA polymerase II promoter	5.99E-10	2.30E-06	1.25E-08	1.11E-06
Community00	gene oncology	GO(MF)	GO:0003707	steroid hormone receptor activity	6.60E-10	6.08E-07	2.77E-08	1.03E-06
Community00	gene oncology	GO(CC)	GO:0005654	nucleoplasm	6.99E-10	3.11E-07	4.44E-08	9.90E-07
Community00	gene oncology	GO(BP)	GO:0007050	cell cycle arrest	8.47E-10	3.26E-06	1.75E-08	1.57E-06
Community00	gene oncology	GO(BP)	GO:0044092	negative regulation of molecular function	9.49E-10	3.65E-06	1.95E-08	1.76E-06
Community00	gene oncology	GO(BP)	GO:0051052	regulation of DNA metabolic process	1.01E-09	3.90E-06	2.07E-08	1.87E-06
Community00	gene oncology	GO(BP)	GO:0010952	positive regulation of peptidase activity	1.05E-09	4.05E-06	2.14E-08	1.95E-06
Community00	gene oncology	GO(BP)	GO:0043280	positive regulation of caspase activity	1.05E-09	4.05E-06	2.14E-08	1.95E-06
Community00	gene oncology	GO(MF)	GO:0043566	structure-specific DNA binding	1.21E-09	1.11E-06	4.84E-08	1.89E-06
Community00	gene oncology	GO(BP)	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	1.26E-09	4.84E-06	2.55E-08	2.33E-06
Community00	gene oncology	GO(BP)	GO:0001558	regulation of cell growth	1.32E-09	5.06E-06	2.65E-08	2.43E-06
Community00	gene oncology	GO(BP)	GO:0042326	negative regulation of phosphorylation	1.60E-09	6.16E-06	3.21E-08	2.96E-06
Community00	gene oncology	GO(BP)	GO:0001889	liver development	1.83E-09	7.03E-06	3.64E-08	3.38E-06
Community00	gene oncology	GO(BP)	GO:0007599	hemostasis	2.11E-09	8.12E-06	4.18E-08	3.90E-06
Community00	gene oncology	GO(BP)	GO:0042129	regulation of T cell proliferation	2.34E-09	9.00E-06	4.61E-08	4.33E-06
Community00	gene oncology	GO(BP)	GO:0000079	regulation of cyclin-dependent protein kinase activity	2.44E-09	9.37E-06	4.78E-08	4.51E-06
Community00	gene oncology	GO(BP)	GO:0032355	response to estradiol stimulus	2.44E-09	9.37E-06	4.78E-08	4.51E-06
Community00	gene oncology	GO(BP)	GO:0031401	positive regulation of protein modification process	2.45E-09	9.41E-06	4.78E-08	4.53E-06
Community00	gene oncology	GO(BP)	GO:0007346	regulation of mitotic cell cycle	2.46E-09	9.47E-06	4.78E-08	4.56E-06
Community00	gene oncology	GO(BP)	GO:0030324	lung development	2.54E-09	9.76E-06	4.91E-08	4.70E-06
Community00	gene oncology	GO(BP)	GO:0001836	release of cytochrome c from mitochondria	2.82E-09	1.09E-05	5.43E-08	5.22E-06
Community00	gene oncology	GO(MF)	GO:0003705	"RNA polymerase II transcription factor activity, enhancer binding"	2.84E-09	2.62E-06	1.09E-07	4.44E-06
Community00	gene oncology	GO(BP)	GO:0001655	urogenital system development	2.99E-09	1.15E-05	5.73E-08	5.54E-06
Community00	gene oncology	GO(BP)	GO:0001894	tissue homeostasis	3.02E-09	1.16E-05	5.75E-08	5.59E-06
Community00	gene oncology	GO(BP)	GO:0006351	"transcription, DNA-dependent"	3.07E-09	1.18E-05	5.82E-08	5.68E-06
Community00	gene oncology	GO(CC)	GO:0043233	organelle lumen	3.29E-09	1.46E-06	1.83E-07	4.66E-06
Community00	gene oncology	GO(MF)	GO:0016564	transcription repressor activity	3.39E-09	3.12E-06	1.25E-07	5.30E-06
Community00	gene oncology	GO(BP)	GO:0048598	embryonic morphogenesis	3.46E-09	1.33E-05	6.53E-08	6.40E-06
Community00	gene oncology	GO(BP)	GO:0045471	response to ethanol	3.87E-09	1.49E-05	7.27E-08	7.17E-06
Community00	gene oncology	GO(BP)	GO:0051345	positive regulation of hydrolase activity	4.02E-09	1.55E-05	7.50E-08	7.43E-06
Community00	gene oncology	GO(BP)	GO:0045936	negative regulation of phosphate metabolic process	4.13E-09	1.59E-05	7.68E-08	7.64E-06
Community00	gene oncology	GO(BP)	GO:0010563	negative regulation of phosphorus metabolic process	4.13E-09	1.59E-05	7.68E-08	7.64E-06
Community00	gene oncology	GO(BP)	GO:0007423	sensory organ development	4.18E-09	1.61E-05	7.73E-08	7.74E-06
Community00	gene oncology	GO(BP)	GO:0008406	gonad development	4.21E-09	1.62E-05	7.74E-08	7.79E-06
Community00	gene oncology	GO(BP)	GO:0000082	G1/S transition of mitotic cell cycle	4.24E-09	1.63E-05	7.77E-08	7.85E-06
Community00	gene oncology	GO(BP)	GO:0007596	blood coagulation	4.39E-09	1.69E-05	8.00E-08	8.12E-06
Community00	gene oncology	GO(BP)	GO:0030323	respiratory tube development	4.39E-09	1.69E-05	8.00E-08	8.12E-06
Community00	gene oncology	GO(BP)	GO:0050817	coagulation	4.39E-09	1.69E-05	8.00E-08	8.12E-06
Community00	gene oncology	GO(BP)	GO:0032774	RNA biosynthetic process	4.44E-09	1.71E-05	8.05E-08	8.21E-06
Community00	gene oncology	GO(BP)	GO:0048729	tissue morphogenesis	4.55E-09	1.75E-05	8.22E-08	8.42E-06
Community00	gene oncology	GO(BP)	GO:0022402	cell cycle process	4.69E-09	1.80E-05	8.43E-08	8.68E-06
Community00	pathway	KEGG	hsa04060	Cytokine-cytokine receptor interaction	5.13E-09	7.59E-07	1.26E-07	6.11E-06
Community00	gene oncology	GO(BP)	GO:0051090	regulation of transcription factor activity	5.24E-09	2.02E-05	9.38E-08	9.70E-06
Community00	gene oncology	GO(BP)	GO:0051051	negative regulation of transport	5.36E-09	2.06E-05	9.54E-08	9.91E-06
Community00	gene oncology	GO(BP)	GO:0045787	positive regulation of cell cycle	5.54E-09	2.13E-05	9.82E-08	1.03E-05
Community00	gene oncology	GO(BP)	GO:0009896	positive regulation of catabolic process	5.57E-09	2.14E-05	9.83E-08	1.03E-05
Community00	gene oncology	GO(CC)	GO:0000267	cell fraction	6.57E-09	2.93E-06	3.25E-07	9.31E-06
Community00	gene oncology	GO(BP)	GO:0051591	response to cAMP	6.63E-09	2.55E-05	1.17E-07	1.23E-05
Community00	gene oncology	GO(BP)	GO:0001525	angiogenesis	6.88E-09	2.65E-05	1.20E-07	1.27E-05
Community00	gene oncology	GO(BP)	GO:0006366	transcription from RNA polymerase II promoter	7.11E-09	2.73E-05	1.24E-07	1.32E-05
Community00	gene oncology	GO(BP)	GO:0048871	multicellular organismal homeostasis	7.26E-09	2.79E-05	1.26E-07	1.34E-05
Community00	gene oncology	GO(BP)	GO:0009416	response to light stimulus	8.29E-09	3.19E-05	1.43E-07	1.53E-05
Community00	gene oncology	GO(BP)	GO:0048511	rhythmic process	9.75E-09	3.75E-05	1.67E-07	1.80E-05
Community00	gene oncology	GO(BP)	GO:0019218	regulation of steroid metabolic process	9.86E-09	3.79E-05	1.69E-07	1.82E-05
Community00	gene oncology	GO(BP)	GO:0031331	positive regulation of cellular catabolic process	9.86E-09	3.79E-05	1.69E-07	1.82E-05
Community00	gene oncology	GO(BP)	GO:0002684	positive regulation of immune system process	1.06E-08	4.09E-05	1.81E-07	1.97E-05
Community00	gene oncology	GO(BP)	GO:0010038	response to metal ion	1.13E-08	4.35E-05	1.92E-07	2.09E-05
Community00	gene oncology	GO(BP)	GO:0001701	in utero embryonic development	1.22E-08	4.70E-05	2.06E-07	2.26E-05
Community00	gene oncology	GO(BP)	GO:0031669	cellular response to nutrient levels	1.25E-08	4.82E-05	2.10E-07	2.32E-05
Community00	gene oncology	GO(BP)	GO:0030301	cholesterol transport	1.40E-08	5.40E-05	2.35E-07	2.60E-05
Community00	gene oncology	GO(BP)	GO:0015918	sterol transport	1.40E-08	5.40E-05	2.35E-07	2.60E-05
Community00	gene oncology	GO(BP)	GO:0007507	heart development	1.45E-08	5.58E-05	2.42E-07	2.69E-05
Community00	gene oncology	GO(BP)	GO:0031329	regulation of cellular catabolic process	1.52E-08	5.86E-05	2.53E-07	2.82E-05
Community00	gene oncology	GO(BP)	GO:0006350	transcription	1.91E-08	7.36E-05	3.16E-07	3.54E-05
Community00	gene oncology	GO(BP)	GO:0006275	regulation of DNA replication	1.93E-08	7.44E-05	3.18E-07	3.58E-05
Community00	gene oncology	GO(BP)	GO:0008637	apoptotic mitochondrial changes	1.94E-08	7.46E-05	3.18E-07	3.59E-05
Community00	gene oncology	GO(BP)	GO:0050678	regulation of epithelial cell proliferation	1.95E-08	7.49E-05	3.17E-07	3.60E-05
Community00	gene oncology	GO(BP)	GO:0042632	cholesterol homeostasis	1.98E-08	7.61E-05	3.21E-07	3.66E-05
Community00	gene oncology	GO(BP)	GO:0055092	sterol homeostasis	1.98E-08	7.61E-05	3.21E-07	3.66E-05
Community00	gene oncology	GO(BP)	GO:0007167	enzyme linked receptor protein signaling pathway	2.01E-08	7.74E-05	3.25E-07	3.72E-05
Community00	gene oncology	GO(MF)	GO:0019900	kinase binding	2.36E-08	2.18E-05	8.37E-07	3.69E-05
Community00	gene oncology	GO(BP)	GO:0030879	mammary gland development	2.44E-08	9.40E-05	3.93E-07	4.52E-05
Community00	gene oncology	GO(BP)	GO:0030308	negative regulation of cell growth	2.71E-08	1.04E-04	4.34E-07	5.01E-05
Community00	gene oncology	GO(BP)	GO:0048584	positive regulation of response to stimulus	3.23E-08	1.24E-04	5.16E-07	5.98E-05
Community00	gene oncology	GO(BP)	GO:0032570	response to progesterone stimulus	3.35E-08	1.29E-04	5.33E-07	6.20E-05
Community00	gene oncology	GO(BP)	GO:0034369	plasma lipoprotein particle remodeling	3.35E-08	1.29E-04	5.33E-07	6.20E-05
Community00	gene oncology	GO(BP)	GO:0034368	protein-lipid complex remodeling	3.35E-08	1.29E-04	5.33E-07	6.20E-05
Community00	gene oncology	GO(BP)	GO:0034367	macromolecular complex remodeling	3.35E-08	1.29E-04	5.33E-07	6.20E-05
Community00	gene oncology	GO(CC)	GO:0031981	nuclear lumen	3.53E-08	1.57E-05	1.57E-06	5.00E-05
Community00	gene oncology	GO(BP)	GO:0051054	positive regulation of DNA metabolic process	3.67E-08	1.41E-04	5.82E-07	6.80E-05
Community00	gene oncology	GO(MF)	GO:0019901	protein kinase binding	3.74E-08	3.45E-05	1.28E-06	5.85E-05
Community00	gene oncology	GO(MF)	GO:0005496	steroid binding	3.75E-08	3.46E-05	1.24E-06	5.87E-05
Community00	gene oncology	GO(BP)	GO:0051336	regulation of hydrolase activity	4.27E-08	1.64E-04	6.74E-07	7.91E-05
Community00	pathway	BIOCARTA	h_p53Pathway	p53 Signaling Pathway	4.37E-08	1.09E-05	1.09E-05	5.68E-05
Community00	gene oncology	GO(BP)	GO:0045428	regulation of nitric oxide biosynthetic process	5.41E-08	2.08E-04	8.49E-07	1.00E-04
Community00	gene oncology	GO(BP)	GO:0009894	regulation of catabolic process	5.41E-08	2.08E-04	8.47E-07	1.00E-04
Community00	gene oncology	GO(BP)	GO:0042698	ovulation cycle	5.95E-08	2.29E-04	9.26E-07	1.10E-04
Community00	gene oncology	GO(BP)	GO:0045792	negative regulation of cell size	8.88E-08	3.42E-04	1.38E-06	1.64E-04
Community00	gene oncology	GO(BP)	GO:0033554	cellular response to stress	8.91E-08	3.43E-04	1.38E-06	1.65E-04
Community00	gene oncology	GO(BP)	GO:0046660	female sex differentiation	9.04E-08	3.48E-04	1.39E-06	1.67E-04
Community00	gene oncology	GO(BP)	GO:0031099	regeneration	9.04E-08	3.48E-04	1.39E-06	1.67E-04
Community00	gene oncology	GO(BP)	GO:0046545	development of primary female sexual characteristics	9.04E-08	3.48E-04	1.39E-06	1.67E-04
Community00	gene oncology	GO(BP)	GO:0007267	cell-cell signaling	9.31E-08	3.58E-04	1.43E-06	1.72E-04
Community00	gene oncology	GO(CC)	GO:0009897	external side of plasma membrane	1.01E-07	4.51E-05	4.10E-06	1.44E-04
Community00	gene oncology	GO(BP)	GO:0032868	response to insulin stimulus	1.04E-07	4.01E-04	1.59E-06	1.93E-04
Community00	gene oncology	GO(BP)	GO:0001819	positive regulation of cytokine production	1.13E-07	4.36E-04	1.72E-06	2.10E-04
Community00	gene oncology	GO(BP)	GO:0046425	regulation of JAK-STAT cascade	1.14E-07	4.39E-04	1.73E-06	2.11E-04
Community00	gene oncology	GO(BP)	GO:0001776	leukocyte homeostasis	1.14E-07	4.39E-04	1.73E-06	2.11E-04
Community00	gene oncology	GO(BP)	GO:0021700	developmental maturation	1.22E-07	4.70E-04	1.84E-06	2.26E-04
Community00	gene oncology	GO(BP)	GO:0002697	regulation of immune effector process	1.22E-07	4.70E-04	1.84E-06	2.26E-04
Community00	pathway	KEGG	hsa04110	Cell cycle	1.28E-07	1.89E-05	2.70E-06	1.52E-04
Community00	gene oncology	GO(MF)	GO:0003712	transcription cofactor activity	1.44E-07	1.33E-04	4.58E-06	2.25E-04
Community00	gene oncology	GO(BP)	GO:0022602	ovulation cycle process	1.47E-07	5.65E-04	2.21E-06	2.72E-04
Community00	pathway	BIOCARTA	h_g1Pathway	Cell Cycle;  G1/S Check Point 	1.48E-07	3.68E-05	1.84E-05	1.92E-04
Community00	pathway	KEGG	hsa05220	Chronic myeloid leukemia	1.54E-07	2.29E-05	2.86E-06	1.84E-04
Community00	gene oncology	GO(BP)	GO:0003013	circulatory system process	1.55E-07	5.97E-04	2.33E-06	2.87E-04
Community00	gene oncology	GO(BP)	GO:0008015	blood circulation	1.55E-07	5.97E-04	2.33E-06	2.87E-04
Community00	gene oncology	GO(BP)	GO:0007243	protein kinase cascade	1.62E-07	6.22E-04	2.41E-06	2.99E-04
Community00	gene oncology	GO(BP)	GO:0030855	epithelial cell differentiation	1.64E-07	6.30E-04	2.43E-06	3.03E-04
Community00	gene oncology	GO(BP)	GO:0030155	regulation of cell adhesion	1.64E-07	6.30E-04	2.43E-06	3.03E-04
Community00	gene oncology	GO(CC)	GO:0005829	cytosol	1.66E-07	7.38E-05	6.15E-06	2.35E-04
Community00	gene oncology	GO(BP)	GO:0032880	regulation of protein localization	1.86E-07	7.15E-04	2.75E-06	3.44E-04
Community00	gene oncology	GO(MF)	GO:0008083	growth factor activity	2.08E-07	1.92E-04	6.39E-06	3.25E-04
Community00	gene oncology	GO(BP)	GO:0045834	positive regulation of lipid metabolic process	2.11E-07	8.10E-04	3.11E-06	3.90E-04
Community00	gene oncology	GO(BP)	GO:0032535	regulation of cellular component size	2.18E-07	8.37E-04	3.19E-06	4.03E-04
Community00	gene oncology	GO(BP)	GO:0001892	embryonic placenta development	2.25E-07	8.67E-04	3.30E-06	4.17E-04
Community00	gene oncology	GO(BP)	GO:0055080	cation homeostasis	2.30E-07	8.86E-04	3.36E-06	4.26E-04
Community00	gene oncology	GO(BP)	GO:0030900	forebrain development	2.35E-07	9.03E-04	3.41E-06	4.34E-04
Community00	gene oncology	GO(BP)	GO:0001763	morphogenesis of a branching structure	2.41E-07	9.26E-04	3.48E-06	4.46E-04
Community00	gene oncology	GO(BP)	GO:0042035	regulation of cytokine biosynthetic process	2.41E-07	9.26E-04	3.48E-06	4.46E-04
Community00	gene oncology	GO(BP)	GO:0042509	regulation of tyrosine phosphorylation of STAT protein	2.45E-07	9.42E-04	3.53E-06	4.54E-04
Community00	gene oncology	GO(BP)	GO:0048661	positive regulation of smooth muscle cell proliferation	2.45E-07	9.42E-04	3.53E-06	4.54E-04
Community00	gene oncology	GO(BP)	GO:0032504	multicellular organism reproduction	2.57E-07	9.87E-04	3.68E-06	4.75E-04
Community00	gene oncology	GO(BP)	GO:0048609	reproductive process in a multicellular organism	2.57E-07	9.87E-04	3.68E-06	4.75E-04
Community00	gene oncology	GO(BP)	GO:0048754	branching morphogenesis of a tube	2.75E-07	0.001057253	3.93E-06	5.09E-04
Community00	gene oncology	GO(BP)	GO:0006694	steroid biosynthetic process	2.81E-07	0.001081662	4.01E-06	5.21E-04
Community00	gene oncology	GO(BP)	GO:0060284	regulation of cell development	2.82E-07	0.001085977	4.01E-06	5.23E-04
Community00	gene oncology	GO(CC)	GO:0031012	extracellular matrix	2.93E-07	1.30E-04	1.00E-05	4.15E-04
Community00	gene oncology	GO(BP)	GO:0001822	kidney development	3.01E-07	0.001157544	4.26E-06	5.57E-04
Community00	gene oncology	GO(BP)	GO:0060341	regulation of cellular localization	3.37E-07	0.001296193	4.75E-06	6.24E-04
Community00	gene oncology	GO(BP)	GO:0032768	regulation of monooxygenase activity	3.39E-07	0.00130489	4.77E-06	6.28E-04
Community00	gene oncology	GO(CC)	GO:0070013	intracellular organelle lumen	3.45E-07	1.54E-04	1.10E-05	4.89E-04
Community00	gene oncology	GO(BP)	GO:0050727	regulation of inflammatory response	3.48E-07	0.001336728	4.86E-06	6.43E-04
Community00	gene oncology	GO(BP)	GO:0043086	negative regulation of catalytic activity	3.54E-07	0.001362689	4.94E-06	6.56E-04
Community00	gene oncology	GO(BP)	GO:0050900	leukocyte migration	3.62E-07	0.001392051	5.03E-06	6.70E-04
Community00	gene oncology	GO(BP)	GO:0051341	regulation of oxidoreductase activity	3.79E-07	0.001456253	5.24E-06	7.01E-04
Community00	pathway	KEGG	hsa05212	Pancreatic cancer	3.80E-07	5.63E-05	6.26E-06	4.53E-04
Community00	gene oncology	GO(BP)	GO:0051050	positive regulation of transport	4.28E-07	0.001645702	5.90E-06	7.92E-04
Community00	gene oncology	GO(BP)	GO:0042593	glucose homeostasis	4.47E-07	0.001716244	6.13E-06	8.26E-04
Community00	gene oncology	GO(BP)	GO:0033500	carbohydrate homeostasis	4.47E-07	0.001716244	6.13E-06	8.26E-04
Community00	gene oncology	GO(BP)	GO:0000278	mitotic cell cycle	4.59E-07	0.001765486	6.29E-06	8.50E-04
Community00	gene oncology	GO(BP)	GO:0050818	regulation of coagulation	4.99E-07	0.001917083	6.80E-06	9.23E-04
Community00	gene oncology	GO(CC)	GO:0005626	insoluble fraction	5.03E-07	2.24E-04	1.49E-05	7.12E-04
Community00	gene oncology	GO(BP)	GO:0055066	"di-, tri-valent inorganic cation homeostasis"	5.18E-07	0.001989013	7.04E-06	9.58E-04
Community00	gene oncology	GO(BP)	GO:0007242	intracellular signaling cascade	5.48E-07	0.002104029	7.42E-06	0.001013165
Community00	gene oncology	GO(BP)	GO:0008217	regulation of blood pressure	5.52E-07	0.00212105	7.45E-06	0.001021371
Community00	gene oncology	GO(BP)	GO:0009411	response to UV	5.55E-07	0.002133976	7.47E-06	0.001027602
Community00	gene oncology	GO(BP)	GO:0048592	eye morphogenesis	5.99E-07	0.002303514	8.04E-06	0.001109335
Community00	gene oncology	GO(BP)	GO:0033189	response to vitamin A	6.51E-07	0.002501769	8.70E-06	0.001204931
Community00	gene oncology	GO(BP)	GO:0051248	negative regulation of protein metabolic process	6.52E-07	0.002503205	8.67E-06	0.001205623
Community00	gene oncology	GO(BP)	GO:0050864	regulation of B cell activation	7.13E-07	0.002738901	9.46E-06	0.001319297
Community00	gene oncology	GO(BP)	GO:0050801	ion homeostasis	7.57E-07	0.002908079	1.00E-05	0.001400906
Community00	gene oncology	GO(BP)	GO:0051223	regulation of protein transport	8.00E-07	0.003071477	1.05E-05	0.00147974
Community00	gene oncology	GO(BP)	GO:0050866	negative regulation of cell activation	8.36E-07	0.003209928	1.10E-05	0.001546549
Community00	gene oncology	GO(BP)	GO:0045429	positive regulation of nitric oxide biosynthetic process	9.41E-07	0.003615122	1.23E-05	0.001742124
Community00	gene oncology	GO(BP)	GO:0051318	G1 phase	9.41E-07	0.003615122	1.23E-05	0.001742124
Community00	gene oncology	GO(BP)	GO:0043029	T cell homeostasis	9.41E-07	0.003615122	1.23E-05	0.001742124
Community00	gene oncology	GO(CC)	GO:0005792	microsome	1.01E-06	4.51E-04	2.82E-05	0.001434516
Community00	gene oncology	GO(BP)	GO:0045833	negative regulation of lipid metabolic process	1.03E-06	0.003946702	1.34E-05	0.001902227
Community00	gene oncology	GO(BP)	GO:0045740	positive regulation of DNA replication	1.03E-06	0.003946702	1.34E-05	0.001902227
Community00	gene oncology	GO(BP)	GO:0031644	regulation of neurological system process	1.08E-06	0.004144652	1.40E-05	0.001997832
Community00	gene oncology	GO(CC)	GO:0000307	cyclin-dependent protein kinase holoenzyme complex	1.10E-06	4.88E-04	2.87E-05	0.001552668
Community00	pathway	KEGG	hsa04630	Jak-STAT signaling pathway	1.10E-06	1.62E-04	1.62E-05	0.001307425
Community00	gene oncology	GO(BP)	GO:0030193	regulation of blood coagulation	1.17E-06	0.004481966	1.51E-05	0.00216079
Community00	gene oncology	GO(BP)	GO:0032269	negative regulation of cellular protein metabolic process	1.20E-06	0.004619371	1.55E-05	0.002227187
Community00	gene oncology	GO(BP)	GO:0051271	negative regulation of cell motion	1.24E-06	0.004743918	1.59E-05	0.002287379
Community00	gene oncology	GO(BP)	GO:0019725	cellular homeostasis	1.26E-06	0.004840672	1.62E-05	0.002334143
Community00	gene oncology	GO(MF)	GO:0019838	growth factor binding	1.38E-06	0.001274522	4.11E-05	0.002162808
Community00	pathway	KEGG	hsa04510	Focal adhesion	1.47E-06	2.18E-04	1.98E-05	0.001754094
Community00	pathway	KEGG	hsa05218	Melanoma	1.47E-06	2.18E-04	1.82E-05	0.001755811
Community00	gene oncology	GO(BP)	GO:0001829	trophectodermal cell differentiation	1.52E-06	0.005841555	1.95E-05	0.002818173
Community00	gene oncology	GO(BP)	GO:0043691	reverse cholesterol transport	1.52E-06	0.005841555	1.95E-05	0.002818173
Community00	gene oncology	GO(BP)	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	1.56E-06	0.005999364	1.99E-05	0.002894534
Community00	gene oncology	GO(MF)	GO:0009055	electron carrier activity	1.61E-06	0.001486032	4.65E-05	0.002521993
Community00	gene oncology	GO(BP)	GO:0050671	positive regulation of lymphocyte proliferation	1.70E-06	0.00650619	2.15E-05	0.00313986
Community00	gene oncology	GO(BP)	GO:0048469	cell maturation	1.73E-06	0.006649892	2.19E-05	0.00320944
Community00	gene oncology	GO(CC)	GO:0045121	membrane raft	1.74E-06	7.73E-04	4.30E-05	0.002461672
Community00	gene oncology	GO(CC)	GO:0042598	vesicular fraction	1.76E-06	7.84E-04	4.13E-05	0.002495135
Community00	gene oncology	GO(BP)	GO:0030217	T cell differentiation	1.80E-06	0.006896195	2.27E-05	0.003328724
Community00	gene oncology	GO(BP)	GO:0051251	positive regulation of lymphocyte activation	1.80E-06	0.006901179	2.26E-05	0.003331138
Community00	gene oncology	GO(BP)	GO:0009615	response to virus	1.93E-06	0.007378926	2.41E-05	0.003562594
Community00	gene oncology	GO(BP)	GO:0070201	regulation of establishment of protein localization	1.95E-06	0.007485383	2.44E-05	0.003614185
Community00	gene oncology	GO(BP)	GO:0032368	regulation of lipid transport	1.98E-06	0.007583737	2.46E-05	0.003661854
Community00	gene oncology	GO(BP)	GO:0006940	regulation of smooth muscle contraction	2.02E-06	0.007729455	2.50E-05	0.003732487
Community00	gene oncology	GO(BP)	GO:0032946	positive regulation of mononuclear cell proliferation	2.08E-06	0.00797123	2.57E-05	0.003849704
Community00	gene oncology	GO(BP)	GO:0070665	positive regulation of leukocyte proliferation	2.08E-06	0.00797123	2.57E-05	0.003849704
Community00	pathway	KEGG	hsa00140	Steroid hormone biosynthesis	2.10E-06	3.11E-04	2.39E-05	0.002500778
Community00	gene oncology	GO(BP)	GO:0034372	very-low-density lipoprotein particle remodeling	2.20E-06	0.008425302	2.71E-05	0.004069924
Community00	gene oncology	GO(BP)	GO:0042330	taxis	2.26E-06	0.008652502	2.78E-05	0.004180151
Community00	gene oncology	GO(BP)	GO:0006935	chemotaxis	2.26E-06	0.008652502	2.78E-05	0.004180151
Community00	gene oncology	GO(CC)	GO:0044451	nucleoplasm part	2.43E-06	0.001080035	5.40E-05	0.003439542
Community00	gene oncology	GO(BP)	GO:0050867	positive regulation of cell activation	2.49E-06	0.009543216	3.05E-05	0.004612528
Community00	gene oncology	GO(BP)	GO:0007611	learning or memory	2.49E-06	0.009543216	3.05E-05	0.004612528
Community00	gene oncology	GO(BP)	GO:0030336	negative regulation of cell migration	2.54E-06	0.009718347	3.10E-05	0.004697586
Community00	gene oncology	GO(BP)	GO:0051222	positive regulation of protein transport	2.58E-06	0.009870583	3.14E-05	0.004771538
Community00	gene oncology	GO(BP)	GO:0006800	oxygen and reactive oxygen species metabolic process	2.58E-06	0.009870583	3.14E-05	0.004771538
Community00	gene oncology	GO(BP)	GO:0007626	locomotory behavior	2.65E-06	0.010142702	3.22E-05	0.004903752
Community00	gene oncology	GO(BP)	GO:0007049	cell cycle	2.67E-06	0.010224117	3.23E-05	0.004943316
Community00	gene oncology	GO(BP)	GO:0048585	negative regulation of response to stimulus	2.73E-06	0.010436425	3.29E-05	0.005046504
Community00	gene oncology	GO(BP)	GO:0030183	B cell differentiation	2.75E-06	0.010523813	3.31E-05	0.005088983
Community00	gene oncology	GO(BP)	GO:0043062	extracellular structure organization	3.06E-06	0.011686516	3.66E-05	0.005654531
Community00	gene oncology	GO(BP)	GO:0060537	muscle tissue development	3.15E-06	0.012048277	3.76E-05	0.005830629
Community00	gene oncology	GO(CC)	GO:0031226	intrinsic to plasma membrane	3.28E-06	0.001457763	6.95E-05	0.004643326
Community00	gene oncology	GO(BP)	GO:0046006	regulation of activated T cell proliferation	3.40E-06	0.012994984	4.05E-05	0.006291772
Community00	gene oncology	GO(BP)	GO:0007166	cell surface receptor linked signal transduction	3.41E-06	0.013019496	4.04E-05	0.006303718
Community00	gene oncology	GO(BP)	GO:0010817	regulation of hormone levels	3.41E-06	0.01302335	4.03E-05	0.006305596
Community00	gene oncology	GO(BP)	GO:0055114	oxidation reduction	3.51E-06	0.013414582	4.14E-05	0.0064963
Community00	gene oncology	GO(BP)	GO:0070664	negative regulation of leukocyte proliferation	3.61E-06	0.013774764	4.24E-05	0.006671935
Community00	gene oncology	GO(BP)	GO:0001933	negative regulation of protein amino acid phosphorylation	3.61E-06	0.013774764	4.24E-05	0.006671935
Community00	gene oncology	GO(BP)	GO:0032945	negative regulation of mononuclear cell proliferation	3.61E-06	0.013774764	4.24E-05	0.006671935
Community00	gene oncology	GO(BP)	GO:0050672	negative regulation of lymphocyte proliferation	3.61E-06	0.013774764	4.24E-05	0.006671935
Community00	gene oncology	GO(BP)	GO:0035270	endocrine system development	3.64E-06	0.013922226	4.27E-05	0.00674386
Community00	gene oncology	GO(BP)	GO:0034754	cellular hormone metabolic process	3.73E-06	0.014243248	4.36E-05	0.006900477
Community00	gene oncology	GO(BP)	GO:0045927	positive regulation of growth	3.87E-06	0.014760454	4.51E-05	0.007152912
Community00	gene oncology	GO(BP)	GO:0000080	G1 phase of mitotic cell cycle	3.94E-06	0.015057536	4.58E-05	0.007297971
Community00	gene oncology	GO(CC)	GO:0032994	protein-lipid complex	4.21E-06	0.00187118	8.51E-05	0.005961354
Community00	gene oncology	GO(CC)	GO:0034358	plasma lipoprotein particle	4.21E-06	0.00187118	8.51E-05	0.005961354
Community00	pathway	BIOCARTA	h_cellcyclePathway	Cyclins and Cell Cycle Regulation	4.28E-06	0.00106623	3.56E-04	0.005562095
Community00	gene oncology	GO(BP)	GO:0002700	regulation of production of molecular mediator of immune response	4.28E-06	0.016338557	4.96E-05	0.007923962
Community00	gene oncology	GO(BP)	GO:0006873	cellular ion homeostasis	4.30E-06	0.016396411	4.96E-05	0.007952253
Community00	gene oncology	GO(BP)	GO:0043388	positive regulation of DNA binding	4.31E-06	0.016447686	4.97E-05	0.007977328
Community00	gene oncology	GO(BP)	GO:0006801	superoxide metabolic process	4.33E-06	0.016512622	4.97E-05	0.008009085
Community00	gene oncology	GO(BP)	GO:0050810	regulation of steroid biosynthetic process	4.33E-06	0.016512622	4.97E-05	0.008009085
Community00	gene oncology	GO(BP)	GO:0007179	transforming growth factor beta receptor signaling pathway	4.49E-06	0.017127046	5.14E-05	0.008309674
Community00	gene oncology	GO(BP)	GO:0043405	regulation of MAP kinase activity	4.62E-06	0.017599189	5.27E-05	0.008540783
Community00	gene oncology	GO(BP)	GO:0045860	positive regulation of protein kinase activity	4.69E-06	0.017862895	5.33E-05	0.008669913
Community00	gene oncology	GO(BP)	GO:0032526	response to retinoic acid	4.78E-06	0.018218639	5.42E-05	0.008844166
Community00	gene oncology	GO(BP)	GO:0045639	positive regulation of myeloid cell differentiation	4.78E-06	0.018218639	5.42E-05	0.008844166
Community00	gene oncology	GO(BP)	GO:0050871	positive regulation of B cell activation	4.78E-06	0.018218639	5.42E-05	0.008844166
Community00	gene oncology	GO(BP)	GO:0007569	cell aging	4.78E-06	0.018218639	5.42E-05	0.008844166
Community00	gene oncology	GO(CC)	GO:0005887	integral to plasma membrane	5.12E-06	0.002276726	9.91E-05	0.007254802
Community00	gene oncology	GO(BP)	GO:0045580	regulation of T cell differentiation	5.19E-06	0.019751939	5.87E-05	0.009595936
Community00	gene oncology	GO(BP)	GO:0043524	negative regulation of neuron apoptosis	5.19E-06	0.019751939	5.87E-05	0.009595936
Community00	gene oncology	GO(BP)	GO:0040014	regulation of multicellular organism growth	5.39E-06	0.020505603	6.08E-05	0.009965884
Community00	gene oncology	GO(BP)	GO:0040013	negative regulation of locomotion	5.39E-06	0.020505603	6.08E-05	0.009965884
Community00	gene oncology	GO(BP)	GO:0030003	cellular cation homeostasis	5.40E-06	0.020543106	6.07E-05	0.0099843
Community00	gene oncology	GO(CC)	GO:0044459	plasma membrane part	5.56E-06	0.002469158	1.03E-04	0.007868722
Community00	gene oncology	GO(BP)	GO:0010224	response to UV-B	5.67E-06	0.021566242	6.36E-05	0.010486994
Community00	gene oncology	GO(BP)	GO:0051347	positive regulation of transferase activity	5.70E-06	0.021682293	6.37E-05	0.010544047
Community00	gene oncology	GO(BP)	GO:0002696	positive regulation of leukocyte activation	5.96E-06	0.022650526	6.64E-05	0.011020304
Community00	gene oncology	GO(BP)	GO:0051353	positive regulation of oxidoreductase activity	6.03E-06	0.022928176	6.70E-05	0.011156962
Community00	gene oncology	GO(BP)	GO:0046427	positive regulation of JAK-STAT cascade	6.03E-06	0.022928176	6.70E-05	0.011156962
Community00	gene oncology	GO(BP)	GO:0018149	peptide cross-linking	6.03E-06	0.022928176	6.70E-05	0.011156962
Community00	gene oncology	GO(BP)	GO:0002683	negative regulation of immune system process	6.06E-06	0.023027286	6.71E-05	0.011205753
Community00	gene oncology	GO(BP)	GO:0015671	oxygen transport	6.10E-06	0.023180109	6.74E-05	0.011280995
Community00	gene oncology	GO(BP)	GO:0055082	cellular chemical homeostasis	6.13E-06	0.02332415	6.76E-05	0.011351925
Community00	gene oncology	GO(BP)	GO:0010876	lipid localization	6.23E-06	0.023683722	6.85E-05	0.011529034
Community00	gene oncology	GO(CC)	GO:0031983	vesicle lumen	6.36E-06	0.002825985	1.13E-04	0.009007419
Community00	gene oncology	GO(BP)	GO:0030005	"cellular di-, tri-valent inorganic cation homeostasis"	6.43E-06	0.024436415	7.05E-05	0.011899986
Community00	gene oncology	GO(BP)	GO:0022403	cell cycle phase	6.64E-06	0.025227063	7.26E-05	0.01228995
Community00	gene oncology	GO(MF)	GO:0005344	oxygen transporter activity	6.66E-06	0.00612142	1.86E-04	0.010412634
Community00	gene oncology	GO(BP)	GO:0034599	cellular response to oxidative stress	6.80E-06	0.025831233	7.41E-05	0.012588151
Community00	gene oncology	GO(CC)	GO:0005624	membrane fraction	6.87E-06	0.003052217	1.18E-04	0.009729567
Community00	gene oncology	GO(BP)	GO:0001654	eye development	6.92E-06	0.026265814	7.52E-05	0.012802762
Community00	gene oncology	GO(BP)	GO:0031349	positive regulation of defense response	7.00E-06	0.026579784	7.59E-05	0.012957871
Community00	gene oncology	GO(BP)	GO:0046661	male sex differentiation	7.00E-06	0.026579784	7.59E-05	0.012957871
Community00	gene oncology	GO(BP)	GO:0045619	regulation of lymphocyte differentiation	7.66E-06	0.029026185	8.27E-05	0.014168158
Community00	gene oncology	GO(BP)	GO:0048562	embryonic organ morphogenesis	7.70E-06	0.029202108	8.30E-05	0.014255308
Community00	gene oncology	GO(BP)	GO:0048145	regulation of fibroblast proliferation	8.13E-06	0.030802945	8.74E-05	0.015049063
Community00	gene oncology	GO(BP)	GO:0042130	negative regulation of T cell proliferation	8.26E-06	0.031289486	8.85E-05	0.015290567
Community00	gene oncology	GO(BP)	GO:0042692	muscle cell differentiation	8.27E-06	0.031323083	8.84E-05	0.015307248
Community00	gene oncology	GO(BP)	GO:0048593	camera-type eye morphogenesis	8.49E-06	0.032115604	9.04E-05	0.015700903
Community00	gene oncology	GO(BP)	GO:0042306	regulation of protein import into nucleus	8.49E-06	0.032115604	9.04E-05	0.015700903
Community00	gene oncology	GO(BP)	GO:0051969	regulation of transmission of nerve impulse	8.56E-06	0.032401899	9.10E-05	0.015843188
Community00	gene oncology	GO(BP)	GO:0043408	regulation of MAPKKK cascade	8.60E-06	0.032551364	9.12E-05	0.015917487
Community00	pathway	KEGG	hsa05221	Acute myeloid leukemia	8.61E-06	0.001273732	9.10E-05	0.010259489
Community00	gene oncology	GO(BP)	GO:0033674	positive regulation of kinase activity	8.76E-06	0.033124516	9.25E-05	0.016202506
Community00	gene oncology	GO(BP)	GO:0032374	regulation of cholesterol transport	8.94E-06	0.033822415	9.43E-05	0.016549787
Community00	gene oncology	GO(BP)	GO:0032371	regulation of sterol transport	8.94E-06	0.033822415	9.43E-05	0.016549787
Community00	gene oncology	GO(BP)	GO:0001825	blastocyst formation	8.94E-06	0.033822415	9.43E-05	0.016549787
Community00	gene oncology	GO(BP)	GO:0048678	response to axon injury	8.94E-06	0.033822415	9.43E-05	0.016549787
Community00	gene oncology	GO(BP)	GO:0008585	female gonad development	9.08E-06	0.034324006	9.54E-05	0.016799538
Community00	gene oncology	GO(BP)	GO:0032103	positive regulation of response to external stimulus	9.08E-06	0.034324006	9.54E-05	0.016799538
Community00	gene oncology	GO(BP)	GO:0030522	intracellular receptor-mediated signaling pathway	9.54E-06	0.036016779	9.99E-05	0.017643353
Community00	gene oncology	GO(BP)	GO:0030182	neuron differentiation	9.89E-06	0.037342358	1.03E-04	0.018305159
Community00	gene oncology	GO(BP)	GO:0033135	regulation of peptidyl-serine phosphorylation	1.03E-05	0.038851821	1.07E-04	0.019059875
Community00	gene oncology	GO(BP)	GO:0048589	developmental growth	1.07E-05	0.040166263	1.11E-04	0.019718044
Community00	gene oncology	GO(BP)	GO:0046546	development of primary male sexual characteristics	1.07E-05	0.040428173	1.11E-04	0.019849295
Community00	gene oncology	GO(MF)	GO:0008289	lipid binding	1.10E-05	0.010122788	2.99E-04	0.017253156
Community00	gene oncology	GO(BP)	GO:0042113	B cell activation	1.11E-05	0.041729565	1.15E-04	0.020501992
Community00	gene oncology	GO(BP)	GO:0050870	positive regulation of T cell activation	1.11E-05	0.041729565	1.15E-04	0.020501992
Community00	gene oncology	GO(BP)	GO:0002260	lymphocyte homeostasis	1.12E-05	0.042015321	1.15E-04	0.020645428
Community00	gene oncology	GO(CC)	GO:0005578	proteinaceous extracellular matrix	1.15E-05	0.005121974	1.90E-04	0.016343766
Community00	gene oncology	GO(BP)	GO:0048705	skeletal system morphogenesis	1.23E-05	0.046040657	1.26E-04	0.022670484
Community00	gene oncology	GO(BP)	GO:0051960	regulation of nervous system development	1.23E-05	0.046212354	1.26E-04	0.02275705
Community00	gene oncology	GO(BP)	GO:0034370	triglyceride-rich lipoprotein particle remodeling	1.23E-05	0.04629722	1.26E-04	0.022799844
Community00	gene oncology	GO(BP)	GO:0030101	natural killer cell activation	1.29E-05	0.048580972	1.32E-04	0.023952841
Community00	gene oncology	GO(BP)	GO:0002246	healing during inflammatory response	1.34E-05	0.050127303	1.36E-04	0.024735102
Community00	gene oncology	GO(BP)	GO:0051099	positive regulation of binding	1.48E-05	0.055504013	1.51E-04	0.027464982
Community00	gene oncology	GO(BP)	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	1.59E-05	0.05917276	1.61E-04	0.029336581
Community00	gene oncology	GO(BP)	GO:0051130	positive regulation of cellular component organization	1.60E-05	0.059553202	1.61E-04	0.029531078
Community00	gene oncology	GO(BP)	GO:0010565	regulation of cellular ketone metabolic process	1.61E-05	0.05999804	1.62E-04	0.029758596
Community00	gene oncology	GO(BP)	GO:0002695	negative regulation of leukocyte activation	1.61E-05	0.05999804	1.62E-04	0.029758596
Community00	gene oncology	GO(BP)	GO:0001893	maternal placenta development	1.66E-05	0.061776933	1.66E-04	0.030669504
Community00	gene oncology	GO(BP)	GO:0051055	negative regulation of lipid biosynthetic process	1.66E-05	0.061776933	1.66E-04	0.030669504
Community00	pathway	KEGG	hsa05223	Non-small cell lung cancer	1.67E-05	0.002472608	1.65E-04	0.019927033
Community00	gene oncology	GO(BP)	GO:0045767	regulation of anti-apoptosis	1.68E-05	0.062683151	1.69E-04	0.031134208
Community00	gene oncology	GO(BP)	GO:0001818	negative regulation of cytokine production	1.68E-05	0.062683151	1.69E-04	0.031134208
Community00	pathway	KEGG	hsa05216	Thyroid cancer	1.82E-05	0.002695711	1.69E-04	0.021727278
Community00	gene oncology	GO(BP)	GO:0043525	positive regulation of neuron apoptosis	1.83E-05	0.068053576	1.83E-04	0.03389734
Community00	pathway	KEGG	hsa05210	Colorectal cancer	1.90E-05	0.002802055	1.65E-04	0.022585512
Community00	gene oncology	GO(BP)	GO:0046822	regulation of nucleocytoplasmic transport	1.91E-05	0.070936416	1.91E-04	0.035387132
Community00	gene oncology	GO(BP)	GO:0032582	negative regulation of gene-specific transcription	1.93E-05	0.071572766	1.92E-04	0.035716604
Community00	gene oncology	GO(BP)	GO:0042108	positive regulation of cytokine biosynthetic process	1.93E-05	0.071572766	1.92E-04	0.035716604
Community00	gene oncology	GO(BP)	GO:0046620	regulation of organ growth	1.95E-05	0.072433216	1.94E-04	0.036162461
Community00	gene oncology	GO(BP)	GO:0030198	extracellular matrix organization	2.03E-05	0.075160482	2.01E-04	0.03757837
Community00	gene oncology	GO(CC)	GO:0044432	endoplasmic reticulum part	2.05E-05	0.009086629	3.26E-04	0.029050661
Community00	gene oncology	GO(BP)	GO:0007259	JAK-STAT cascade	2.11E-05	0.077932748	2.08E-04	0.039021905
Community00	gene oncology	GO(BP)	GO:0051781	positive regulation of cell division	2.11E-05	0.077932748	2.08E-04	0.039021905
Community00	gene oncology	GO(BP)	GO:0045786	negative regulation of cell cycle	2.26E-05	0.08323223	2.22E-04	0.041793438
Community00	gene oncology	GO(BP)	GO:0019217	regulation of fatty acid metabolic process	2.34E-05	0.086009238	2.29E-04	0.043252136
Community00	gene oncology	GO(BP)	GO:0019221	cytokine-mediated signaling pathway	2.35E-05	0.086513645	2.30E-04	0.043517562
Community00	gene oncology	GO(BP)	GO:0033138	positive regulation of peptidyl-serine phosphorylation	2.38E-05	0.087545891	2.33E-04	0.044061201
Community00	gene oncology	GO(BP)	GO:0022604	regulation of cell morphogenesis	2.40E-05	0.088237298	2.34E-04	0.044425676
Community00	gene oncology	GO(BP)	GO:0042531	positive regulation of tyrosine phosphorylation of STAT protein	2.54E-05	0.093137657	2.47E-04	0.047016816
Community00	gene oncology	GO(BP)	GO:0042445	hormone metabolic process	2.56E-05	0.093790888	2.48E-04	0.047363274
Community00	gene oncology	GO(BP)	GO:0034381	lipoprotein particle clearance	2.56E-05	0.093816344	2.47E-04	0.04737678
Community00	gene oncology	GO(BP)	GO:0051412	response to corticosterone stimulus	2.56E-05	0.093816344	2.47E-04	0.04737678
Community00	gene oncology	GO(BP)	GO:0006869	lipid transport	2.57E-05	0.094069499	2.48E-04	0.047511118
Community00	gene oncology	GO(BP)	GO:0031400	negative regulation of protein modification process	2.66E-05	0.097258567	2.56E-04	0.049206619
Community00	gene oncology	GO(BP)	GO:0014706	striated muscle tissue development	2.66E-05	0.097258567	2.56E-04	0.049206619
Community00	gene oncology	GO(BP)	GO:0051091	positive regulation of transcription factor activity	2.67E-05	0.097727916	2.56E-04	0.049456656
Community00	gene oncology	GO(BP)	GO:0032386	regulation of intracellular transport	2.73E-05	0.099597836	2.61E-04	0.05045411
Community00	gene oncology	GO(BP)	GO:0032102	negative regulation of response to external stimulus	2.82E-05	0.10269474	2.69E-04	0.052110604
Community00	gene oncology	GO(MF)	GO:0003713	transcription coactivator activity	2.83E-05	0.025774809	7.46E-04	0.044274705
Community00	gene oncology	GO(CC)	GO:0060205	cytoplasmic membrane-bounded vesicle lumen	3.12E-05	0.013804417	4.79E-04	0.044235673
Community00	gene oncology	GO(BP)	GO:0009636	response to toxin	3.14E-05	0.113882644	2.99E-04	0.058142646
Community00	gene oncology	GO(BP)	GO:0006937	regulation of muscle contraction	3.15E-05	0.114231253	2.99E-04	0.058331817
Community00	gene oncology	GO(BP)	GO:0010553	negative regulation of specific transcription from RNA polymerase II promoter	3.24E-05	0.117236684	3.07E-04	0.059965775
Community00	gene oncology	GO(BP)	GO:0002761	regulation of myeloid leukocyte differentiation	3.24E-05	0.117236684	3.07E-04	0.059965775
Community00	gene oncology	GO(BP)	GO:0009267	cellular response to starvation	3.27E-05	0.118126154	3.09E-04	0.060450413
Community00	gene oncology	GO(BP)	GO:0051348	negative regulation of transferase activity	3.36E-05	0.121370872	3.17E-04	0.062222471
Community00	gene oncology	GO(BP)	GO:0019932	second-messenger-mediated signaling	3.45E-05	0.124385738	3.25E-04	0.063874845
Community00	gene oncology	GO(BP)	GO:0044246	regulation of multicellular organismal metabolic process	3.82E-05	0.136712155	3.58E-04	0.070690072
Community00	gene oncology	GO(BP)	GO:0032655	regulation of interleukin-12 production	3.82E-05	0.136712155	3.58E-04	0.070690072
Community00	gene oncology	GO(BP)	GO:0008584	male gonad development	4.03E-05	0.143629631	3.77E-04	0.074557267
Community00	gene oncology	GO(MF)	GO:0015485	cholesterol binding	4.17E-05	0.03767622	0.001066218	0.065108397
Community00	gene oncology	GO(BP)	GO:0032965	regulation of collagen biosynthetic process	4.22E-05	0.149832341	3.94E-04	0.0780514
Community00	gene oncology	GO(BP)	GO:0045765	regulation of angiogenesis	4.30E-05	0.152427052	4.00E-04	0.079520595
Community00	gene oncology	GO(BP)	GO:0010243	response to organic nitrogen	4.30E-05	0.152427052	4.00E-04	0.079520595
Community00	gene oncology	GO(BP)	GO:0010743	regulation of foam cell differentiation	4.64E-05	0.163482403	4.31E-04	0.085831008
Community00	gene oncology	GO(CC)	GO:0005833	hemoglobin complex	4.75E-05	0.020904045	7.04E-04	0.067220121
Community00	gene oncology	GO(CC)	GO:0042627	chylomicron	4.75E-05	0.020904045	7.04E-04	0.067220121
Community00	gene oncology	GO(BP)	GO:0033157	regulation of intracellular protein transport	4.79E-05	0.168244914	4.44E-04	0.088575076
Community00	gene oncology	GO(BP)	GO:0006641	triglyceride metabolic process	4.85E-05	0.170227283	4.48E-04	0.089721891
Community00	pathway	BIOCARTA	h_inflamPathway	Cytokines and Inflammatory Response	4.86E-05	0.012019854	0.003018604	0.063030886
Community00	gene oncology	GO(BP)	GO:0006469	negative regulation of protein kinase activity	4.92E-05	0.172482364	4.54E-04	0.091029792
Community00	pathway	KEGG	hsa05213	Endometrial cancer	5.10E-05	0.007519453	4.19E-04	0.060741491
Community00	gene oncology	GO(BP)	GO:0000060	"protein import into nucleus, translocation"	5.25E-05	0.182805636	4.83E-04	0.097062721
Community00	gene oncology	GO(BP)	GO:0007517	muscle organ development	5.34E-05	0.185768787	4.90E-04	0.098808403
Community00	gene oncology	GO(BP)	GO:0015669	gas transport	5.53E-05	0.191784318	5.07E-04	0.102371864
Community00	gene oncology	GO(BP)	GO:0045646	regulation of erythrocyte differentiation	5.53E-05	0.191784318	5.07E-04	0.102371864
Community00	gene oncology	GO(BP)	GO:0010464	regulation of mesenchymal cell proliferation	5.53E-05	0.191784318	5.07E-04	0.102371864
Community00	gene oncology	GO(BP)	GO:0051146	striated muscle cell differentiation	5.56E-05	0.192654002	5.08E-04	0.102889227
Community00	gene oncology	GO(BP)	GO:0051250	negative regulation of lymphocyte activation	5.66E-05	0.195820164	5.16E-04	0.104777431
Community00	gene oncology	GO(BP)	GO:0042063	gliogenesis	5.80E-05	0.200086402	5.28E-04	0.107333422
Community00	gene oncology	GO(BP)	GO:0070661	leukocyte proliferation	5.88E-05	0.202436939	5.33E-04	0.108747479
Community00	gene oncology	GO(BP)	GO:0032943	mononuclear cell proliferation	5.88E-05	0.202436939	5.33E-04	0.108747479
Community00	gene oncology	GO(BP)	GO:0002009	morphogenesis of an epithelium	5.98E-05	0.205453864	5.41E-04	0.110568519
Community00	gene oncology	GO(BP)	GO:0031100	organ regeneration	6.13E-05	0.21000585	5.53E-04	0.113329198
Community00	gene oncology	GO(BP)	GO:0002637	regulation of immunoglobulin production	6.13E-05	0.21000585	5.53E-04	0.113329198
Community00	gene oncology	GO(BP)	GO:0008610	lipid biosynthetic process	6.14E-05	0.210291312	5.53E-04	0.113502852
Community00	gene oncology	GO(BP)	GO:0002822	regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	6.67E-05	0.226446463	6.00E-04	0.123433635
Community00	gene oncology	GO(MF)	GO:0005539	glycosaminoglycan binding	6.85E-05	0.061216401	0.001705848	0.107072667
Community00	gene oncology	GO(CC)	GO:0034385	triglyceride-rich lipoprotein particle	6.88E-05	0.030147757	9.87E-04	0.097388879
Community00	gene oncology	GO(CC)	GO:0034361	very-low-density lipoprotein particle	6.88E-05	0.030147757	9.87E-04	0.097388879
Community00	gene oncology	GO(BP)	GO:0010712	regulation of collagen metabolic process	6.99E-05	0.235800464	6.27E-04	0.129278449
Community00	gene oncology	GO(BP)	GO:0065005	protein-lipid complex assembly	6.99E-05	0.235800464	6.27E-04	0.129278449
Community00	gene oncology	GO(BP)	GO:0034377	plasma lipoprotein particle assembly	6.99E-05	0.235800464	6.27E-04	0.129278449
Community00	gene oncology	GO(BP)	GO:0070228	regulation of lymphocyte apoptosis	6.99E-05	0.235800464	6.27E-04	0.129278449
Community00	gene oncology	GO(BP)	GO:0033673	negative regulation of kinase activity	7.07E-05	0.238036904	6.32E-04	0.130686426
Community00	gene oncology	GO(BP)	GO:0043433	negative regulation of transcription factor activity	7.09E-05	0.238626767	6.32E-04	0.131058467
Community00	gene oncology	GO(BP)	GO:0030278	regulation of ossification	7.13E-05	0.239946644	6.35E-04	0.131891984
Community00	gene oncology	GO(CC)	GO:0042175	nuclear envelope-endoplasmic reticulum network	7.44E-05	0.032563623	0.001034016	0.105319444
Community00	gene oncology	GO(MF)	GO:0017127	cholesterol transporter activity	7.52E-05	0.066998635	0.001823299	0.117538686
Community00	gene oncology	GO(CC)	GO:0042995	cell projection	7.55E-05	0.03301923	0.001016957	0.106817214
Community00	pathway	KEGG	hsa04620	Toll-like receptor signaling pathway	7.61E-05	0.011193077	5.92E-04	0.090570724
Community00	gene oncology	GO(BP)	GO:0033344	cholesterol efflux	7.81E-05	0.259556047	6.94E-04	0.14444815
Community00	gene oncology	GO(BP)	GO:0002819	regulation of adaptive immune response	7.83E-05	0.260155063	6.94E-04	0.144836897
Community00	gene oncology	GO(CC)	GO:0008305	integrin complex	7.87E-05	0.034403952	0.001029167	0.111373568
Community00	gene oncology	GO(CC)	GO:0005789	endoplasmic reticulum membrane	8.37E-05	0.036580737	0.001064193	0.11854897
Community00	gene oncology	GO(BP)	GO:0018108	peptidyl-tyrosine phosphorylation	8.50E-05	0.278794589	7.51E-04	0.157092672
Community00	gene oncology	GO(MF)	GO:0032934	sterol binding	8.51E-05	0.075423511	0.002008736	0.132902664
Community00	gene oncology	GO(BP)	GO:0055074	calcium ion homeostasis	8.75E-05	0.285699156	7.71E-04	0.161712709
Community00	gene oncology	GO(BP)	GO:0060558	regulation of calcidiol 1-monooxygenase activity	8.76E-05	0.286124694	7.71E-04	0.161998901
Community00	gene oncology	GO(BP)	GO:0045084	positive regulation of interleukin-12 biosynthetic process	8.76E-05	0.286124694	7.71E-04	0.161998901
Community00	gene oncology	GO(MF)	GO:0033764	"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor"	8.79E-05	0.077850655	0.002024151	0.137354453
Community00	gene oncology	GO(MF)	GO:0005518	collagen binding	9.06E-05	0.080104383	0.002034393	0.141498493
Community00	gene oncology	GO(BP)	GO:0044236	multicellular organismal metabolic process	1.00E-04	0.319744252	8.79E-04	0.185163337
Community00	gene oncology	GO(BP)	GO:0021536	diencephalon development	1.00E-04	0.319744252	8.79E-04	0.185163337
Community00	gene oncology	GO(BP)	GO:0055065	metal ion homeostasis	1.01E-04	0.322771171	8.87E-04	0.187304555
Community00	gene oncology	GO(BP)	GO:0051302	regulation of cell division	1.01E-04	0.322804331	8.86E-04	0.187328064
Community00	gene oncology	GO(BP)	GO:0006690	icosanoid metabolic process	1.01E-04	0.322804331	8.86E-04	0.187328064
Community00	gene oncology	GO(BP)	GO:0032963	collagen metabolic process	1.03E-04	0.326439901	8.96E-04	0.189912588
Community00	gene oncology	GO(BP)	GO:0021983	pituitary gland development	1.03E-04	0.326439901	8.96E-04	0.189912588
Community00	gene oncology	GO(BP)	GO:0030888	regulation of B cell proliferation	1.03E-04	0.326439901	8.96E-04	0.189912588
Community00	gene oncology	GO(CC)	GO:0030424	axon	1.04E-04	0.045327204	0.001287687	0.147539335
Community00	gene oncology	GO(BP)	GO:0003018	vascular process in circulatory system	1.07E-04	0.336564167	9.28E-04	0.197183753
Community00	gene oncology	GO(BP)	GO:0051385	response to mineralocorticoid stimulus	1.08E-04	0.33936438	9.35E-04	0.199214343
Community00	gene oncology	GO(BP)	GO:0045913	positive regulation of carbohydrate metabolic process	1.08E-04	0.33936438	9.35E-04	0.199214343
Community00	gene oncology	GO(BP)	GO:0010676	positive regulation of cellular carbohydrate metabolic process	1.08E-04	0.33936438	9.35E-04	0.199214343
Community00	gene oncology	GO(BP)	GO:0060349	bone morphogenesis	1.08E-04	0.33936438	9.35E-04	0.199214343
Community00	gene oncology	GO(BP)	GO:0032770	positive regulation of monooxygenase activity	1.10E-04	0.344498806	9.51E-04	0.202959953
Community00	gene oncology	GO(BP)	GO:0046697	decidualization	1.10E-04	0.344498806	9.51E-04	0.202959953
Community00	gene oncology	GO(BP)	GO:0042522	regulation of tyrosine phosphorylation of Stat5 protein	1.10E-04	0.344498806	9.51E-04	0.202959953
Community00	gene oncology	GO(BP)	GO:0043010	camera-type eye development	1.13E-04	0.353122225	9.78E-04	0.209317007
Community00	gene oncology	GO(MF)	GO:0016209	antioxidant activity	1.14E-04	0.099621414	0.002495451	0.177808642
Community00	gene oncology	GO(CC)	GO:0043235	receptor complex	1.16E-04	0.050331498	0.001394764	0.164242055
Community00	gene oncology	GO(BP)	GO:0018212	peptidyl-tyrosine modification	1.20E-04	0.370364199	0.001036713	0.222284421
Community00	gene oncology	GO(BP)	GO:0010675	regulation of cellular carbohydrate metabolic process	1.22E-04	0.375479824	0.001052626	0.226199841
Community00	gene oncology	GO(CC)	GO:0005901	caveola	1.24E-04	0.053696748	0.001451372	0.17552216
Community00	gene oncology	GO(BP)	GO:0043588	skin development	1.31E-04	0.395124377	0.001121541	0.241538033
Community00	gene oncology	GO(BP)	GO:0050804	regulation of synaptic transmission	1.36E-04	0.407856445	0.001166371	0.251746144
Community00	gene oncology	GO(BP)	GO:0034101	erythrocyte homeostasis	1.42E-04	0.421010797	0.001213644	0.262524861
Community00	gene oncology	GO(BP)	GO:0006639	acylglycerol metabolic process	1.42E-04	0.421010797	0.001213644	0.262524861
Community00	gene oncology	GO(BP)	GO:0006974	response to DNA damage stimulus	1.43E-04	0.423231821	0.001219466	0.264368794
Community00	gene oncology	GO(BP)	GO:0045785	positive regulation of cell adhesion	1.43E-04	0.423610806	0.001218222	0.264684139
Community00	gene oncology	GO(BP)	GO:0045923	positive regulation of fatty acid metabolic process	1.46E-04	0.429055568	0.001236461	0.269237533
Community00	gene oncology	GO(BP)	GO:0046889	positive regulation of lipid biosynthetic process	1.46E-04	0.429055568	0.001236461	0.269237533
Community00	gene oncology	GO(BP)	GO:0050792	regulation of viral reproduction	1.46E-04	0.429055568	0.001236461	0.269237533
Community00	pathway	KEGG	hsa05330	Allograft rejection	1.47E-04	0.021524029	0.001087361	0.175005929
Community00	gene oncology	GO(BP)	GO:0042102	positive regulation of T cell proliferation	1.49E-04	0.435225586	0.001257642	0.274449975
Community00	gene oncology	GO(BP)	GO:0006109	regulation of carbohydrate metabolic process	1.49E-04	0.435225586	0.001257642	0.274449975
Community00	gene oncology	GO(BP)	GO:0050767	regulation of neurogenesis	1.53E-04	0.44480285	0.001292421	0.282654194
Community00	gene oncology	GO(BP)	GO:0006575	cellular amino acid derivative metabolic process	1.53E-04	0.44480285	0.001292421	0.282654194
Community00	gene oncology	GO(BP)	GO:0006875	cellular metal ion homeostasis	1.55E-04	0.449791199	0.001309356	0.286983347
Community00	gene oncology	GO(BP)	GO:0007155	cell adhesion	1.62E-04	0.462919517	0.001359266	0.298566195
Community00	gene oncology	GO(BP)	GO:0022610	biological adhesion	1.62E-04	0.463470871	0.00135854	0.299058788
Community00	gene oncology	GO(BP)	GO:0045768	positive regulation of anti-apoptosis	1.64E-04	0.468930997	0.001377837	0.303964374
Community00	gene oncology	GO(BP)	GO:0045069	regulation of viral genome replication	1.65E-04	0.470063735	0.001379479	0.304988354
Community00	gene oncology	GO(BP)	GO:0032330	regulation of chondrocyte differentiation	1.65E-04	0.470063735	0.001379479	0.304988354
Community00	gene oncology	GO(BP)	GO:0048662	negative regulation of smooth muscle cell proliferation	1.65E-04	0.470063735	0.001379479	0.304988354
Community00	gene oncology	GO(BP)	GO:0045940	positive regulation of steroid metabolic process	1.65E-04	0.470063735	0.001379479	0.304988354
Community00	gene oncology	GO(BP)	GO:0002703	regulation of leukocyte mediated immunity	1.65E-04	0.470225864	0.001377152	0.305135095
Community00	gene oncology	GO(BP)	GO:0006638	neutral lipid metabolic process	1.67E-04	0.474102587	0.001390048	0.308657235
Community00	gene oncology	GO(BP)	GO:0016202	regulation of striated muscle tissue development	1.67E-04	0.474102587	0.001390048	0.308657235
Community00	gene oncology	GO(BP)	GO:0031670	cellular response to nutrient	1.70E-04	0.47916271	0.001407901	0.313293613
Community00	gene oncology	GO(BP)	GO:0002902	regulation of B cell apoptosis	1.70E-04	0.47916271	0.001407901	0.313293613
Community00	gene oncology	GO(BP)	GO:0045075	regulation of interleukin-12 biosynthetic process	1.70E-04	0.47916271	0.001407901	0.313293613
Community00	gene oncology	GO(BP)	GO:0003007	heart morphogenesis	1.72E-04	0.483489389	0.001422822	0.317293659
Community00	gene oncology	GO(MF)	GO:0015248	sterol transporter activity	1.77E-04	0.150897716	0.003796858	0.277022304
Community00	gene oncology	GO(BP)	GO:0006953	acute-phase response	1.79E-04	0.497889362	0.001480483	0.330850915
Community00	gene oncology	GO(BP)	GO:0006874	cellular calcium ion homeostasis	1.80E-04	0.499246611	0.001483108	0.33214863
Community00	gene oncology	GO(BP)	GO:0040007	growth	1.80E-04	0.499246611	0.001483108	0.33214863
Community00	gene oncology	GO(MF)	GO:0016712	"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen"	1.81E-04	0.153582316	0.003782427	0.282377668
Community00	gene oncology	GO(BP)	GO:0043269	regulation of ion transport	1.90E-04	0.518952947	0.001565775	0.351395398
Community00	gene oncology	GO(BP)	GO:0045670	regulation of osteoclast differentiation	1.93E-04	0.524896818	0.001588957	0.357354909
Community00	gene oncology	GO(BP)	GO:0048286	lung alveolus development	1.93E-04	0.524896818	0.001588957	0.357354909
Community00	gene oncology	GO(BP)	GO:0043542	endothelial cell migration	1.93E-04	0.524896818	0.001588957	0.357354909
Community00	gene oncology	GO(BP)	GO:0008633	activation of pro-apoptotic gene products	1.93E-04	0.524896818	0.001588957	0.357354909
Community00	gene oncology	GO(BP)	GO:0006662	glycerol ether metabolic process	1.96E-04	0.528826053	0.001603251	0.361335361
Community00	gene oncology	GO(BP)	GO:0033559	unsaturated fatty acid metabolic process	1.96E-04	0.528826053	0.001603251	0.361335361
Community00	gene oncology	GO(BP)	GO:0043392	negative regulation of DNA binding	1.96E-04	0.528826053	0.001603251	0.361335361
Community00	gene oncology	GO(BP)	GO:0048634	regulation of muscle development	1.96E-04	0.528826053	0.001603251	0.361335361
Community00	gene oncology	GO(BP)	GO:0044259	multicellular organismal macromolecule metabolic process	2.05E-04	0.545679746	0.001677215	0.378792091
Community00	gene oncology	GO(BP)	GO:0050728	negative regulation of inflammatory response	2.05E-04	0.545679746	0.001677215	0.378792091
Community00	gene oncology	GO(CC)	GO:0034363	intermediate-density lipoprotein particle	2.07E-04	0.088094469	0.002361793	0.293101656
Community00	gene oncology	GO(BP)	GO:0051092	positive regulation of NF-kappaB transcription factor activity	2.15E-04	0.56208563	0.00175161	0.396415363
Community00	gene oncology	GO(BP)	GO:0001541	ovarian follicle development	2.15E-04	0.56208563	0.00175161	0.396415363
Community00	gene oncology	GO(BP)	GO:0001570	vasculogenesis	2.15E-04	0.56208563	0.00175161	0.396415363
Community00	gene oncology	GO(BP)	GO:0006259	DNA metabolic process	2.20E-04	0.571361062	0.001793179	0.406672159
Community00	gene oncology	GO(MF)	GO:0030247	polysaccharide binding	2.23E-04	0.185767221	0.004556454	0.347914575
Community00	gene oncology	GO(MF)	GO:0001871	pattern binding	2.23E-04	0.185767221	0.004556454	0.347914575
Community00	gene oncology	GO(BP)	GO:0032147	activation of protein kinase activity	2.24E-04	0.577651801	0.001820593	0.41375496
Community00	gene oncology	GO(MF)	GO:0016229	steroid dehydrogenase activity	2.25E-04	0.187593722	0.004506223	0.351709781
Community00	gene oncology	GO(BP)	GO:0042304	regulation of fatty acid biosynthetic process	2.39E-04	0.601738254	0.001940406	0.441880606
Community00	gene oncology	GO(BP)	GO:0032642	regulation of chemokine production	2.39E-04	0.601738254	0.001940406	0.441880606
Community00	gene oncology	GO(CC)	GO:0043005	neuron projection	2.40E-04	0.101412729	0.002669716	0.339783469
Community00	pathway	KEGG	hsa04512	ECM-receptor interaction	2.41E-04	0.035011908	0.001695681	0.286485161
Community00	gene oncology	GO(BP)	GO:0043271	negative regulation of ion transport	2.53E-04	0.621829865	0.002045087	0.466668214
Community00	gene oncology	GO(BP)	GO:0001936	regulation of endothelial cell proliferation	2.53E-04	0.622687862	0.002045557	0.46775572
Community00	gene oncology	GO(BP)	GO:0022405	hair cycle process	2.56E-04	0.62619956	0.002060836	0.472232574
Community00	gene oncology	GO(BP)	GO:0001942	hair follicle development	2.56E-04	0.62619956	0.002060836	0.472232574
Community00	gene oncology	GO(BP)	GO:0050868	negative regulation of T cell activation	2.56E-04	0.62619956	0.002060836	0.472232574
Community00	gene oncology	GO(BP)	GO:0022404	molting cycle process	2.56E-04	0.62619956	0.002060836	0.472232574
Community00	gene oncology	GO(BP)	GO:0042594	response to starvation	2.56E-04	0.62619956	0.002060836	0.472232574
Community00	gene oncology	GO(BP)	GO:0046651	lymphocyte proliferation	2.56E-04	0.62619956	0.002060836	0.472232574
Community00	gene oncology	GO(BP)	GO:0043406	positive regulation of MAP kinase activity	2.57E-04	0.62826281	0.002068085	0.474882449
Community00	gene oncology	GO(MF)	GO:0008395	steroid hydroxylase activity	2.57E-04	0.211035385	0.005030577	0.40117705
Community00	gene oncology	GO(BP)	GO:0007160	cell-matrix adhesion	2.59E-04	0.631144627	0.002079986	0.478608231
Community00	gene oncology	GO(BP)	GO:0030656	regulation of vitamin metabolic process	2.64E-04	0.637201971	0.002110081	0.486534879
Community00	gene oncology	GO(BP)	GO:0060556	regulation of vitamin D biosynthetic process	2.64E-04	0.637201971	0.002110081	0.486534879
Community00	gene oncology	GO(BP)	GO:0035150	regulation of tube size	2.65E-04	0.639201236	0.002117163	0.489180056
Community00	gene oncology	GO(BP)	GO:0010001	glial cell differentiation	2.65E-04	0.639201236	0.002117163	0.489180056
Community00	gene oncology	GO(BP)	GO:0018904	organic ether metabolic process	2.65E-04	0.639201236	0.002117163	0.489180056
Community00	gene oncology	GO(BP)	GO:0050880	regulation of blood vessel size	2.65E-04	0.639201236	0.002117163	0.489180056
Community00	gene oncology	GO(CC)	GO:0034364	high-density lipoprotein particle	2.68E-04	0.112310977	0.002901485	0.378483971
Community00	gene oncology	GO(BP)	GO:0060173	limb development	2.84E-04	0.66417663	0.002261278	0.523512148
Community00	gene oncology	GO(BP)	GO:0048736	appendage development	2.84E-04	0.66417663	0.002261278	0.523512148
Community00	pathway	KEGG	hsa04520	Adherens junction	2.90E-04	0.042087345	0.001952577	0.345538827
Community00	gene oncology	GO(BP)	GO:0006260	DNA replication	2.92E-04	0.674922398	0.002323779	0.539072861
Community00	gene oncology	GO(BP)	GO:0052200	response to host defenses	2.95E-04	0.679001102	0.00234501	0.545113557
Community00	gene oncology	GO(BP)	GO:0075136	response to host	2.95E-04	0.679001102	0.00234501	0.545113557
Community00	gene oncology	GO(BP)	GO:0002262	myeloid cell homeostasis	2.95E-04	0.679001102	0.00234501	0.545113557
Community00	gene oncology	GO(BP)	GO:0042104	positive regulation of activated T cell proliferation	2.95E-04	0.679001102	0.00234501	0.545113557
Community00	gene oncology	GO(BP)	GO:0052173	response to defenses of other organism during symbiotic interaction	2.95E-04	0.679001102	0.00234501	0.545113557
Community00	gene oncology	GO(BP)	GO:0042633	hair cycle	3.03E-04	0.688490697	0.002401907	0.559468866
Community00	gene oncology	GO(BP)	GO:0042303	molting cycle	3.03E-04	0.688490697	0.002401907	0.559468866
Community00	gene oncology	GO(BP)	GO:0030218	erythrocyte differentiation	3.03E-04	0.688490697	0.002401907	0.559468866
Community00	gene oncology	GO(BP)	GO:0001824	blastocyst development	3.03E-04	0.688490697	0.002401907	0.559468866
Community00	gene oncology	GO(BP)	GO:0008629	induction of apoptosis by intracellular signals	3.07E-04	0.692646113	0.002424536	0.565892479
Community00	gene oncology	GO(BP)	GO:0042476	odontogenesis	3.07E-04	0.692646113	0.002424536	0.565892479
Community00	gene oncology	GO(BP)	GO:0002706	regulation of lymphocyte mediated immunity	3.07E-04	0.692646113	0.002424536	0.565892479
Community00	pathway	KEGG	hsa04640	Hematopoietic cell lineage	3.19E-04	0.046155452	0.002052437	0.379674293
Community00	gene oncology	GO(BP)	GO:0007586	digestion	3.20E-04	0.708008516	0.002524592	0.590414859
Community00	gene oncology	GO(BP)	GO:0048666	neuron development	3.30E-04	0.718680085	0.002595525	0.608217354
Community00	gene oncology	GO(BP)	GO:0022612	gland morphogenesis	3.36E-04	0.725937896	0.002643536	0.620713193
Community00	gene oncology	GO(BP)	GO:0033280	response to vitamin D	3.36E-04	0.725937896	0.002643536	0.620713193
Community00	gene oncology	GO(BP)	GO:0045446	endothelial cell differentiation	3.36E-04	0.725937896	0.002643536	0.620713193
Community00	gene oncology	GO(BP)	GO:0060350	endochondral bone morphogenesis	3.36E-04	0.725937896	0.002643536	0.620713193
Community00	gene oncology	GO(MF)	GO:0003714	transcription corepressor activity	3.40E-04	0.269030505	0.006507558	0.530055127
Community00	gene oncology	GO(BP)	GO:0032870	cellular response to hormone stimulus	3.48E-04	0.737817021	0.002728338	0.641894141
Community00	gene oncology	GO(BP)	GO:0001656	metanephros development	3.57E-04	0.747230036	0.002797049	0.659367579
Community00	gene oncology	GO(BP)	GO:0060562	epithelial tube morphogenesis	3.65E-04	0.754112792	0.002847326	0.67255894
Community00	gene oncology	GO(BP)	GO:0019229	regulation of vasoconstriction	3.77E-04	0.765735447	0.002939493	0.695692047
Community00	pathway	KEGG	hsa05214	Glioma	4.08E-04	0.058643389	0.002514884	0.48530311
Community00	gene oncology	GO(MF)	GO:0004714	transmembrane receptor protein tyrosine kinase activity	4.11E-04	0.315662529	0.007711016	0.641194614
Community00	gene oncology	GO(BP)	GO:0050680	negative regulation of epithelial cell proliferation	4.14E-04	0.796342163	0.003216101	0.762550098
Community00	gene oncology	GO(BP)	GO:0010594	regulation of endothelial cell migration	4.14E-04	0.796342163	0.003216101	0.762550098
Community00	gene oncology	GO(BP)	GO:0043122	regulation of I-kappaB kinase/NF-kappaB cascade	4.14E-04	0.796388605	0.003210073	0.76265897
Community00	gene oncology	GO(BP)	GO:0010959	regulation of metal ion transport	4.36E-04	0.813035257	0.003375008	0.803366432
Community00	gene oncology	GO(BP)	GO:0010906	regulation of glucose metabolic process	4.55E-04	0.826414042	0.003517105	0.83878841
Community00	pathway	BIOCARTA	h_eponfkbPathway	Erythropoietin mediated neuroprotection through NF-kB	4.58E-04	0.107760842	0.022546163	0.592737887
Community00	pathway	BIOCARTA	h_fibrinolysisPathway	Fibrinolysis Pathway	4.58E-04	0.107760842	0.022546163	0.592737887
Community00	gene oncology	GO(BP)	GO:0051896	regulation of protein kinase B signaling cascade	4.61E-04	0.830106271	0.003553075	0.849043214
Community00	gene oncology	GO(BP)	GO:0002053	positive regulation of mesenchymal cell proliferation	4.61E-04	0.830106271	0.003553075	0.849043214
Community00	gene oncology	GO(BP)	GO:0051924	regulation of calcium ion transport	4.65E-04	0.832718004	0.003576903	0.856431871
Community00	gene oncology	GO(BP)	GO:0033700	phospholipid efflux	4.76E-04	0.84005767	0.003659173	0.877827493
Community00	gene oncology	GO(BP)	GO:0002076	osteoblast development	4.76E-04	0.84005767	0.003659173	0.877827493
Community00	gene oncology	GO(BP)	GO:0070227	lymphocyte apoptosis	4.76E-04	0.84005767	0.003659173	0.877827493
Community00	gene oncology	GO(BP)	GO:0008211	glucocorticoid metabolic process	4.76E-04	0.84005767	0.003659173	0.877827493
Community00	gene oncology	GO(BP)	GO:0045073	regulation of chemokine biosynthetic process	4.76E-04	0.84005767	0.003659173	0.877827493
Community00	gene oncology	GO(BP)	GO:0002274	myeloid leukocyte activation	4.90E-04	0.848126394	0.003754822	0.902506285
Community00	gene oncology	GO(BP)	GO:0010810	regulation of cell-substrate adhesion	4.90E-04	0.848126394	0.003754822	0.902506285
Community00	gene oncology	GO(BP)	GO:0050795	regulation of behavior	4.90E-04	0.848126394	0.003754822	0.902506285
Community00	gene oncology	GO(BP)	GO:0021543	pallium development	4.90E-04	0.848126394	0.003754822	0.902506285
Community00	gene oncology	GO(MF)	GO:0030291	protein serine/threonine kinase inhibitor activity	4.94E-04	0.366123247	0.009076572	0.770177591
Community00	gene oncology	GO(MF)	GO:0016538	cyclin-dependent protein kinase regulator activity	4.94E-04	0.366123247	0.009076572	0.770177591
Community00	gene oncology	GO(MF)	GO:0003682	chromatin binding	4.98E-04	0.368080228	0.008959482	0.775380932
Community00	pathway	BIOCARTA	h_RacCycDPathway	Influence of Ras and Rho proteins on G1 to S Transition	5.04E-04	0.117918295	0.02069463	0.652063711
Community00	gene oncology	GO(MF)	GO:0004861	cyclin-dependent protein kinase inhibitor activity	5.05E-04	0.372366046	0.008917657	0.786831882
Community00	gene oncology	GO(BP)	GO:0007005	mitochondrion organization	5.18E-04	0.863557435	0.00395997	0.953568048
Community00	gene oncology	GO(BP)	GO:0050994	regulation of lipid catabolic process	5.19E-04	0.864404948	0.003964452	0.95653667
Community00	gene oncology	GO(BP)	GO:0044243	multicellular organismal catabolic process	5.19E-04	0.864404948	0.003964452	0.95653667
Community00	gene oncology	GO(BP)	GO:0048146	positive regulation of fibroblast proliferation	5.19E-04	0.864404948	0.003964452	0.95653667
Community00	gene oncology	GO(BP)	GO:0050708	regulation of protein secretion	5.31E-04	0.870465532	0.004046964	0.978319474
Community00	gene oncology	GO(BP)	GO:0010638	positive regulation of organelle organization	5.39E-04	0.874362981	0.004099215	0.992870181
Community00	gene oncology	GO(BP)	GO:0048565	gut development	5.45E-04	0.877331823	0.004138197	1.004258695
Community00	gene oncology	GO(BP)	GO:0031348	negative regulation of defense response	5.45E-04	0.877331823	0.004138197	1.004258695
Community00	gene oncology	GO(BP)	GO:0032675	regulation of interleukin-6 production	5.45E-04	0.877331823	0.004138197	1.004258695
Community00	gene oncology	GO(BP)	GO:0010741	negative regulation of protein kinase cascade	5.45E-04	0.877331823	0.004138197	1.004258695
Community00	gene oncology	GO(BP)	GO:0002366	leukocyte activation during immune response	5.45E-04	0.877331823	0.004138197	1.004258695
Community00	gene oncology	GO(BP)	GO:0002263	cell activation during immune response	5.45E-04	0.877331823	0.004138197	1.004258695
Community00	gene oncology	GO(BP)	GO:0043123	positive regulation of I-kappaB kinase/NF-kappaB cascade	5.79E-04	0.892287997	0.004385414	1.066155891
Community00	gene oncology	GO(BP)	GO:0016032	viral reproduction	5.87E-04	0.895360369	0.004433515	1.079926933
Community00	gene oncology	GO(BP)	GO:0051100	negative regulation of binding	6.04E-04	0.902317344	0.00455938	1.112658305
Community00	gene oncology	GO(BP)	GO:0016053	organic acid biosynthetic process	6.07E-04	0.903440762	0.004573038	1.118160492
Community00	gene oncology	GO(BP)	GO:0046394	carboxylic acid biosynthetic process	6.07E-04	0.903440762	0.004573038	1.118160492
Community00	gene oncology	GO(BP)	GO:0045987	positive regulation of smooth muscle contraction	6.17E-04	0.906763705	0.004632326	1.134816271
Community00	gene oncology	GO(BP)	GO:0002285	lymphocyte activation during immune response	6.17E-04	0.906763705	0.004632326	1.134816271
Community00	gene oncology	GO(BP)	GO:0007389	pattern specification process	6.17E-04	0.906816399	0.004624398	1.135085122
Community00	gene oncology	GO(BP)	GO:0051046	regulation of secretion	6.29E-04	0.911133119	0.004707434	1.157639965
Community00	gene oncology	GO(BP)	GO:0031589	cell-substrate adhesion	6.36E-04	0.913464811	0.004749781	1.17028095
Community00	gene oncology	GO(BP)	GO:0045348	positive regulation of MHC class II biosynthetic process	6.39E-04	0.914401129	0.004761604	1.175452738
Community00	gene oncology	GO(BP)	GO:0045747	positive regulation of Notch signaling pathway	6.39E-04	0.914401129	0.004761604	1.175452738
Community00	gene oncology	GO(BP)	GO:0048485	sympathetic nervous system development	6.39E-04	0.914401129	0.004761604	1.175452738
Community00	gene oncology	GO(BP)	GO:0045732	positive regulation of protein catabolic process	6.45E-04	0.916370046	0.004797281	1.186514309
Community00	gene oncology	GO(BP)	GO:0030595	leukocyte chemotaxis	6.49E-04	0.917757148	0.004820219	1.194463918
Community00	gene oncology	GO(BP)	GO:0043410	positive regulation of MAPKKK cascade	6.59E-04	0.920919021	0.004886253	1.213095322
Community00	gene oncology	GO(BP)	GO:0045793	positive regulation of cell size	6.59E-04	0.920919021	0.004886253	1.213095322
Community00	gene oncology	GO(CC)	GO:0005886	plasma membrane	6.64E-04	0.255970914	0.007015163	0.936717135
Community00	gene oncology	GO(BP)	GO:0010212	response to ionizing radiation	6.86E-04	0.928593189	0.005072567	1.261591032
Community00	gene oncology	GO(BP)	GO:0007612	learning	6.86E-04	0.928593189	0.005072567	1.261591032
Community00	gene oncology	GO(BP)	GO:0035107	appendage morphogenesis	6.97E-04	0.931701877	0.005147998	1.282729832
Community00	gene oncology	GO(BP)	GO:0035108	limb morphogenesis	6.97E-04	0.931701877	0.005147998	1.282729832
Community00	gene oncology	GO(MF)	GO:0050840	extracellular matrix binding	6.99E-04	0.475215601	0.01209173	1.087500502
Community00	gene oncology	GO(MF)	GO:0048037	cofactor binding	7.14E-04	0.48217895	0.012113543	1.109904986
Community00	gene oncology	GO(BP)	GO:0051897	positive regulation of protein kinase B signaling cascade	7.24E-04	0.938450156	0.005336779	1.33211965
Community00	gene oncology	GO(BP)	GO:0033081	regulation of T cell differentiation in the thymus	7.24E-04	0.938450156	0.005336779	1.33211965
Community00	gene oncology	GO(BP)	GO:0051881	regulation of mitochondrial membrane potential	7.24E-04	0.938450156	0.005336779	1.33211965
Community00	gene oncology	GO(BP)	GO:0043534	blood vessel endothelial cell migration	7.24E-04	0.938450156	0.005336779	1.33211965
Community00	gene oncology	GO(BP)	GO:0010564	regulation of cell cycle process	7.63E-04	0.946961632	0.005610142	1.402733454
Community00	gene oncology	GO(CC)	GO:0005912	adherens junction	7.63E-04	0.287852388	0.007863572	1.074714072
Community00	gene oncology	GO(CC)	GO:0031093	platelet alpha granule lumen	7.66E-04	0.289032717	0.007722952	1.079937128
Community00	gene oncology	GO(MF)	GO:0005161	platelet-derived growth factor receptor binding	7.68E-04	0.507432804	0.012792461	1.193720983
Community00	gene oncology	GO(MF)	GO:0048407	platelet-derived growth factor binding	7.68E-04	0.507432804	0.012792461	1.193720983
Community00	gene oncology	GO(BP)	GO:0007159	leukocyte adhesion	7.93E-04	0.952665074	0.005815732	1.456676636
Community00	gene oncology	GO(BP)	GO:0031341	regulation of cell killing	7.93E-04	0.952665074	0.005815732	1.456676636
Community00	gene oncology	GO(BP)	GO:0048483	autonomic nervous system development	8.09E-04	0.955529493	0.005923093	1.486261861
Community00	gene oncology	GO(BP)	GO:0051402	neuron apoptosis	8.09E-04	0.955529493	0.005923093	1.486261861
Community00	gene oncology	GO(BP)	GO:0010907	positive regulation of glucose metabolic process	8.09E-04	0.955529493	0.005923093	1.486261861
Community00	gene oncology	GO(BP)	GO:0006692	prostanoid metabolic process	8.09E-04	0.955529493	0.005923093	1.486261861
Community00	gene oncology	GO(BP)	GO:0048008	platelet-derived growth factor receptor signaling pathway	8.09E-04	0.955529493	0.005923093	1.486261861
Community00	gene oncology	GO(BP)	GO:0034103	regulation of tissue remodeling	8.09E-04	0.955529493	0.005923093	1.486261861
Community00	gene oncology	GO(BP)	GO:0006693	prostaglandin metabolic process	8.09E-04	0.955529493	0.005923093	1.486261861
Community00	gene oncology	GO(MF)	GO:0005201	extracellular matrix structural constituent	8.29E-04	0.534688754	0.013568689	1.289060184
Community00	gene oncology	GO(BP)	GO:0050778	positive regulation of immune response	8.71E-04	0.964949513	0.006362465	1.598998666
Community00	gene oncology	GO(BP)	GO:0022415	viral reproductive process	8.76E-04	0.965595337	0.006385539	1.607801162
Community00	gene oncology	GO(MF)	GO:0004857	enzyme inhibitor activity	8.87E-04	0.558645804	0.014246796	1.377507855
Community00	gene oncology	GO(BP)	GO:0060326	cell chemotaxis	9.04E-04	0.969126309	0.00657761	1.65904014
Community00	gene oncology	GO(MF)	GO:0031406	carboxylic acid binding	9.45E-04	0.581732157	0.014915801	1.467324901
Community00	gene oncology	GO(BP)	GO:0050921	positive regulation of chemotaxis	9.65E-04	0.975654817	0.007012083	1.771358885
Community00	gene oncology	GO(BP)	GO:0030856	regulation of epithelial cell differentiation	9.65E-04	0.975654817	0.007012083	1.771358885
Community00	gene oncology	GO(BP)	GO:0007178	transmembrane receptor protein serine/threonine kinase signaling pathway	9.95E-04	0.978314971	0.007216056	1.826018797
Community00	gene oncology	GO(BP)	GO:0001708	cell fate specification	9.99E-04	0.978643057	0.007231047	1.833218056
Community00	gene oncology	GO(BP)	GO:0030890	positive regulation of B cell proliferation	0.001042557	0.981917463	0.007528595	1.911777165
Community00	gene oncology	GO(BP)	GO:0030574	collagen catabolic process	0.001042557	0.981917463	0.007528595	1.911777165
Community00	gene oncology	GO(MF)	GO:0043028	caspase regulator activity	0.00104546	0.618795103	0.0162132	1.622247479
Community00	gene oncology	GO(BP)	GO:0051926	negative regulation of calcium ion transport	0.0010517	0.982543052	0.00758018	1.928388594
Community00	gene oncology	GO(BP)	GO:0048048	embryonic eye morphogenesis	0.0010517	0.982543052	0.00758018	1.928388594
Community00	gene oncology	GO(BP)	GO:0006110	regulation of glycolysis	0.0010517	0.982543052	0.00758018	1.928388594
Community00	gene oncology	GO(BP)	GO:0001958	endochondral ossification	0.0010517	0.982543052	0.00758018	1.928388594
Community00	gene oncology	GO(BP)	GO:0014068	positive regulation of phosphoinositide 3-kinase cascade	0.0010517	0.982543052	0.00758018	1.928388594
Community00	gene oncology	GO(BP)	GO:0034375	high-density lipoprotein particle remodeling	0.0010517	0.982543052	0.00758018	1.928388594
Community00	gene oncology	GO(BP)	GO:0000904	cell morphogenesis involved in differentiation	0.00105941	0.983053811	0.007621302	1.942396271
Community00	gene oncology	GO(BP)	GO:0048167	regulation of synaptic plasticity	0.001105722	0.985822013	0.007938481	2.026486891
Community00	gene oncology	GO(BP)	GO:0001764	neuron migration	0.001105722	0.985822013	0.007938481	2.026486891
Community00	gene oncology	GO(MF)	GO:0003708	retinoic acid receptor activity	0.001113998	0.642163217	0.016982122	1.727732762
Community00	gene oncology	GO(CC)	GO:0031091	platelet alpha granule	0.001114464	0.391168075	0.010966382	1.567034806
Community00	gene oncology	GO(BP)	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	0.001119831	0.986571862	0.008024459	2.052092234
Community00	gene oncology	GO(BP)	GO:0002250	adaptive immune response	0.001119831	0.986571862	0.008024459	2.052092234
Community00	gene oncology	GO(BP)	GO:0042176	regulation of protein catabolic process	0.001139564	0.987554595	0.008150195	2.087894318
Community00	gene oncology	GO(BP)	GO:0042391	regulation of membrane potential	0.00116202	0.98858572	0.008294811	2.12861985
Community00	gene oncology	GO(BP)	GO:0043467	regulation of generation of precursor metabolites and energy	0.00116554	0.988739417	0.008304447	2.135002068
Community00	gene oncology	GO(BP)	GO:0007566	embryo implantation	0.00116554	0.988739417	0.008304447	2.135002068
Community00	gene oncology	GO(BP)	GO:0032388	positive regulation of intracellular transport	0.00116554	0.988739417	0.008304447	2.135002068
Community00	gene oncology	GO(BP)	GO:0000075	cell cycle checkpoint	0.001178373	0.989282446	0.008380038	2.158266911
Community00	gene oncology	GO(BP)	GO:0050679	positive regulation of epithelial cell proliferation	0.001230829	0.99124311	0.008735537	2.25331181
Community00	gene oncology	GO(BP)	GO:0050714	positive regulation of protein secretion	0.001230829	0.99124311	0.008735537	2.25331181
Community00	gene oncology	GO(BP)	GO:0009299	mRNA transcription	0.00123871	0.991504959	0.008775085	2.267584981
Community00	gene oncology	GO(BP)	GO:0007260	tyrosine phosphorylation of STAT protein	0.00123871	0.991504959	0.008775085	2.267584981
Community00	gene oncology	GO(BP)	GO:0007089	traversing start control point of mitotic cell cycle	0.00123871	0.991504959	0.008775085	2.267584981
Community00	gene oncology	GO(BP)	GO:0033483	gas homeostasis	0.00123871	0.991504959	0.008775085	2.267584981
Community00	gene oncology	GO(CC)	GO:0030141	secretory granule	0.00128917	0.436760841	0.012401824	1.810608027
Community00	gene oncology	GO(BP)	GO:0045444	fat cell differentiation	0.00129505	0.993162169	0.009155771	2.369554255
Community00	gene oncology	GO(BP)	GO:0055123	digestive system development	0.001322832	0.99385614	0.009334252	2.419800282
Community00	gene oncology	GO(BP)	GO:0001569	patterning of blood vessels	0.001322832	0.99385614	0.009334252	2.419800282
Community00	gene oncology	GO(BP)	GO:0045933	positive regulation of muscle contraction	0.001322832	0.99385614	0.009334252	2.419800282
Community00	gene oncology	GO(BP)	GO:0000086	G2/M transition of mitotic cell cycle	0.001322832	0.99385614	0.009334252	2.419800282
Community00	gene oncology	GO(BP)	GO:0010883	regulation of lipid storage	0.001322832	0.99385614	0.009334252	2.419800282
Community00	gene oncology	GO(BP)	GO:0048546	digestive tract morphogenesis	0.001322832	0.99385614	0.009334252	2.419800282
Community00	gene oncology	GO(BP)	GO:0045884	regulation of survival gene product expression	0.001322832	0.99385614	0.009334252	2.419800282
Community00	gene oncology	GO(BP)	GO:0046849	bone remodeling	0.001322832	0.99385614	0.009334252	2.419800282
Community00	gene oncology	GO(BP)	GO:0051789	response to protein stimulus	0.001392376	0.995300039	0.009804926	2.545468858
Community00	gene oncology	GO(BP)	GO:0046456	icosanoid biosynthetic process	0.001396055	0.995366183	0.009812775	2.552112875
Community00	gene oncology	GO(BP)	GO:0050920	regulation of chemotaxis	0.001396055	0.995366183	0.009812775	2.552112875
Community00	gene oncology	GO(MF)	GO:0005164	tumor necrosis factor receptor binding	0.001416589	0.72937501	0.021198659	2.192182499
Community00	gene oncology	GO(MF)	GO:0050662	coenzyme binding	0.001426765	0.731905642	0.021008698	2.20776499
Community00	gene oncology	GO(BP)	GO:0045088	regulation of innate immune response	0.00146695	0.99647368	0.010290098	2.680057977
Community00	gene oncology	GO(BP)	GO:0002286	T cell activation during immune response	0.00147033	0.996519295	0.010294941	2.686153076
Community00	gene oncology	GO(BP)	GO:0045191	regulation of isotype switching	0.00147033	0.996519295	0.010294941	2.686153076
Community00	gene oncology	GO(BP)	GO:0044253	positive regulation of multicellular organismal metabolic process	0.00147033	0.996519295	0.010294941	2.686153076
Community00	gene oncology	GO(BP)	GO:0014066	regulation of phosphoinositide 3-kinase cascade	0.00147033	0.996519295	0.010294941	2.686153076
Community00	gene oncology	GO(BP)	GO:0050820	positive regulation of coagulation	0.00147033	0.996519295	0.010294941	2.686153076
Community00	gene oncology	GO(BP)	GO:0051043	regulation of membrane protein ectodomain proteolysis	0.00147033	0.996519295	0.010294941	2.686153076
Community00	gene oncology	GO(BP)	GO:0048384	retinoic acid receptor signaling pathway	0.00147033	0.996519295	0.010294941	2.686153076
Community00	gene oncology	GO(BP)	GO:0010595	positive regulation of endothelial cell migration	0.00147033	0.996519295	0.010294941	2.686153076
Community00	gene oncology	GO(BP)	GO:0042554	superoxide anion generation	0.00147033	0.996519295	0.010294941	2.686153076
Community00	gene oncology	GO(CC)	GO:0031982	vesicle	0.001474586	0.481427237	0.013874654	2.068498563
Community00	gene oncology	GO(BP)	GO:0000902	cell morphogenesis	0.001514064	0.997059031	0.010580519	2.764995672
Community00	gene oncology	GO(MF)	GO:0019207	kinase regulator activity	0.0015928	0.770012996	0.023059068	2.461702194
Community00	gene oncology	GO(BP)	GO:0045667	regulation of osteoblast differentiation	0.001644147	0.998218394	0.011464271	2.999151357
Community00	gene oncology	GO(BP)	GO:0045930	negative regulation of mitotic cell cycle	0.001655007	0.998291406	0.011518754	3.018674245
Community00	gene oncology	GO(BP)	GO:0051048	negative regulation of secretion	0.001656464	0.998300976	0.011508045	3.021294333
Community00	gene oncology	GO(BP)	GO:0030168	platelet activation	0.00165976	0.99832242	0.011510063	3.027219527
Community00	gene oncology	GO(BP)	GO:0045582	positive regulation of T cell differentiation	0.00165976	0.99832242	0.011510063	3.027219527
Community00	gene oncology	GO(BP)	GO:0006970	response to osmotic stress	0.00165976	0.99832242	0.011510063	3.027219527
Community00	gene oncology	GO(BP)	GO:0043583	ear development	0.001679316	0.998444188	0.01162406	3.062363926
Community00	gene oncology	GO(BP)	GO:0032869	cellular response to insulin stimulus	0.001712674	0.998631866	0.01183252	3.122288097
Community00	gene oncology	GO(CC)	GO:0012505	endomembrane system	0.001717013	0.5345393	0.015805585	2.404736745
Community00	gene oncology	GO(CC)	GO:0016323	basolateral plasma membrane	0.001768086	0.545016664	0.015942861	2.475435286
Community00	gene oncology	GO(CC)	GO:0005625	soluble fraction	0.00178372	0.548176751	0.015763716	2.497068332
Community00	gene oncology	GO(MF)	GO:0019887	protein kinase regulator activity	0.001855816	0.819613278	0.02640531	2.862700201
Community00	gene oncology	GO(BP)	GO:0010720	positive regulation of cell development	0.001899872	0.999335025	0.013095054	3.457911525
Community00	gene oncology	GO(CC)	GO:0044433	cytoplasmic vesicle part	0.001916386	0.574125239	0.016598157	2.680455159
Community00	gene oncology	GO(BP)	GO:0031175	neuron projection development	0.001923034	0.999391816	0.013230108	3.499360933
Community00	gene oncology	GO(BP)	GO:0008630	"DNA damage response, signal transduction resulting in induction of apoptosis"	0.001959633	0.999471837	0.013456407	3.564823813
Community00	gene oncology	GO(BP)	GO:0006576	biogenic amine metabolic process	0.001988312	0.999527112	0.013627886	3.616091105
Community00	gene oncology	GO(BP)	GO:0009651	response to salt stress	0.001992442	0.999534579	0.01363176	3.62347062
Community00	gene oncology	GO(BP)	GO:0030728	ovulation	0.001992442	0.999534579	0.01363176	3.62347062
Community00	gene oncology	GO(MF)	GO:0043176	amine binding	0.002009105	0.843430891	0.028123988	3.095693365
Community00	gene oncology	GO(BP)	GO:0051129	negative regulation of cellular component organization	0.002025379	0.999590073	0.013831194	3.682313134
Community00	gene oncology	GO(BP)	GO:0009410	response to xenobiotic stimulus	0.002044525	0.99961924	0.01393645	3.716503462
Community00	gene oncology	GO(BP)	GO:0001974	blood vessel remodeling	0.002044525	0.99961924	0.01393645	3.716503462
Community00	gene oncology	GO(BP)	GO:0010332	response to gamma radiation	0.002044525	0.99961924	0.01393645	3.716503462
Community00	gene oncology	GO(BP)	GO:0030195	negative regulation of blood coagulation	0.002044525	0.99961924	0.01393645	3.716503462
Community00	gene oncology	GO(BP)	GO:0051259	protein oligomerization	0.002076501	0.999663396	0.01412808	3.773576357
Community00	gene oncology	GO(BP)	GO:0048738	cardiac muscle tissue development	0.002093332	0.999684543	0.014216783	3.803606285
Community00	gene oncology	GO(BP)	GO:0034330	cell junction organization	0.002093332	0.999684543	0.014216783	3.803606285
Community00	gene oncology	GO(BP)	GO:0045821	positive regulation of glycolysis	0.002102036	0.999694953	0.014250404	3.819132213
Community00	gene oncology	GO(BP)	GO:0010873	positive regulation of cholesterol esterification	0.002102036	0.999694953	0.014250404	3.819132213
Community00	gene oncology	GO(BP)	GO:0045080	positive regulation of chemokine biosynthetic process	0.002102036	0.999694953	0.014250404	3.819132213
Community00	gene oncology	GO(BP)	GO:0048525	negative regulation of viral reproduction	0.002102036	0.999694953	0.014250404	3.819132213
Community00	gene oncology	GO(BP)	GO:0010149	senescence	0.002102036	0.999694953	0.014250404	3.819132213
Community00	gene oncology	GO(BP)	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	0.002102036	0.999694953	0.014250404	3.819132213
Community00	gene oncology	GO(BP)	GO:0034105	positive regulation of tissue remodeling	0.002102036	0.999694953	0.014250404	3.819132213
Community00	gene oncology	GO(BP)	GO:0050768	negative regulation of neurogenesis	0.002158037	0.999754187	0.014601968	3.918966019
Community00	gene oncology	GO(BP)	GO:0002526	acute inflammatory response	0.002159303	0.999755384	0.014584857	3.921222041
Community00	gene oncology	GO(CC)	GO:0070161	anchoring junction	0.002178575	0.621115263	0.018490816	3.041941392
Community00	gene oncology	GO(MF)	GO:0016504	peptidase activator activity	0.002187161	0.867181333	0.030124369	3.365675625
Community00	gene oncology	GO(CC)	GO:0030863	cortical cytoskeleton	0.002259202	0.634497569	0.018811055	3.152853749
Community00	gene oncology	GO(BP)	GO:0043933	macromolecular complex subunit organization	0.002290533	0.999852515	0.015438295	4.154779865
Community00	gene oncology	GO(BP)	GO:0022600	digestive system process	0.002298729	0.999857104	0.015466108	4.169349708
Community00	gene oncology	GO(BP)	GO:0048520	positive regulation of behavior	0.002298729	0.999857104	0.015466108	4.169349708
Community00	gene oncology	GO(BP)	GO:0006636	unsaturated fatty acid biosynthetic process	0.002298729	0.999857104	0.015466108	4.169349708
Community00	pathway	KEGG	hsa04940	Type I diabetes mellitus	0.00239646	0.298897914	0.014103669	2.818081255
Community00	gene oncology	GO(BP)	GO:0001816	cytokine production	0.002457465	0.999922521	0.016497726	4.451103303
Community00	gene oncology	GO(BP)	GO:0045089	positive regulation of innate immune response	0.002457465	0.999922521	0.016497726	4.451103303
Community00	gene oncology	GO(BP)	GO:0031343	positive regulation of cell killing	0.002496915	0.999933456	0.016731505	4.521004565
Community00	gene oncology	GO(BP)	GO:0001101	response to acid	0.002496915	0.999933456	0.016731505	4.521004565
Community00	gene oncology	GO(BP)	GO:0051180	vitamin transport	0.002496915	0.999933456	0.016731505	4.521004565
Community00	gene oncology	GO(BP)	GO:0019935	cyclic-nucleotide-mediated signaling	0.002548257	0.99994541	0.017043383	4.611906085
Community00	gene oncology	GO(BP)	GO:0007187	"G-protein signaling, coupled to cyclic nucleotide second messenger"	0.002580831	0.999951855	0.017229717	4.669534429
Community00	gene oncology	GO(BP)	GO:0001938	positive regulation of endothelial cell proliferation	0.002629953	0.999960165	0.017524823	4.756378225
Community00	gene oncology	GO(BP)	GO:0046850	regulation of bone remodeling	0.002629953	0.999960165	0.017524823	4.756378225
Community00	gene oncology	GO(BP)	GO:0045124	regulation of bone resorption	0.002629953	0.999960165	0.017524823	4.756378225
Community00	gene oncology	GO(BP)	GO:0032369	negative regulation of lipid transport	0.002629953	0.999960165	0.017524823	4.756378225
Community00	gene oncology	GO(CC)	GO:0005764	lysosome	0.002672409	0.696026213	0.021810737	3.719417164
Community00	gene oncology	GO(CC)	GO:0000323	lytic vacuole	0.002672409	0.696026213	0.021810737	3.719417164
Community00	gene oncology	GO(MF)	GO:0008009	chemokine activity	0.002678298	0.91564355	0.036233304	4.106732406
Community00	gene oncology	GO(BP)	GO:0045621	positive regulation of lymphocyte differentiation	0.002680174	0.99996718	0.017826087	4.845088968
Community00	gene oncology	GO(BP)	GO:0001657	ureteric bud development	0.002680174	0.99996718	0.017826087	4.845088968
Community00	gene oncology	GO(MF)	GO:0070325	lipoprotein receptor binding	0.002781526	0.923321959	0.037062493	4.261809226
Community00	gene oncology	GO(BP)	GO:0009791	post-embryonic development	0.002818245	0.999980733	0.018704757	5.088571561
Community00	gene oncology	GO(BP)	GO:0035113	embryonic appendage morphogenesis	0.002839925	0.999982279	0.018815073	5.126749486
Community00	gene oncology	GO(BP)	GO:0030326	embryonic limb morphogenesis	0.002839925	0.999982279	0.018815073	5.126749486
Community00	gene oncology	GO(BP)	GO:0010648	negative regulation of cell communication	0.002969325	0.999989243	0.019631409	5.354320094
Community00	gene oncology	GO(BP)	GO:0048730	epidermis morphogenesis	0.003017752	0.999991077	0.019914678	5.439354021
Community00	gene oncology	GO(BP)	GO:0045840	positive regulation of mitosis	0.003017752	0.999991077	0.019914678	5.439354021
Community00	gene oncology	GO(BP)	GO:0000186	activation of MAPKK activity	0.003017752	0.999991077	0.019914678	5.439354021
Community00	gene oncology	GO(BP)	GO:0051785	positive regulation of nuclear division	0.003017752	0.999991077	0.019914678	5.439354021
Community00	gene oncology	GO(BP)	GO:0040018	positive regulation of multicellular organism growth	0.003017752	0.999991077	0.019914678	5.439354021
Community00	gene oncology	GO(BP)	GO:0042743	hydrogen peroxide metabolic process	0.003017752	0.999991077	0.019914678	5.439354021
Community00	gene oncology	GO(BP)	GO:0001910	regulation of leukocyte mediated cytotoxicity	0.003017752	0.999991077	0.019914678	5.439354021
Community00	gene oncology	GO(BP)	GO:0019827	stem cell maintenance	0.003017752	0.999991077	0.019914678	5.439354021
Community00	gene oncology	GO(BP)	GO:0007498	mesoderm development	0.003095195	0.999993382	0.020386358	5.57518637
Community00	gene oncology	GO(BP)	GO:0055072	iron ion homeostasis	0.003107153	0.99999368	0.020429509	5.596144284
Community00	gene oncology	GO(BP)	GO:0001707	mesoderm formation	0.003107153	0.99999368	0.020429509	5.596144284
Community00	gene oncology	GO(BP)	GO:0048168	regulation of neuronal synaptic plasticity	0.003107153	0.99999368	0.020429509	5.596144284
Community00	gene oncology	GO(BP)	GO:0007422	peripheral nervous system development	0.003107153	0.99999368	0.020429509	5.596144284
Community00	gene oncology	GO(CC)	GO:0005783	endoplasmic reticulum	0.003130482	0.752228756	0.025049102	4.343897212
Community00	gene oncology	GO(BP)	GO:0051346	negative regulation of hydrolase activity	0.003151269	0.99999467	0.020681716	5.673424648
Community00	gene oncology	GO(BP)	GO:0010721	negative regulation of cell development	0.003151269	0.99999467	0.020681716	5.673424648
Community00	pathway	KEGG	hsa04610	Complement and coagulation cascades	0.003198327	0.377561826	0.018069785	3.744656102
Community00	gene oncology	GO(MF)	GO:0016597	amino acid binding	0.003199471	0.94790268	0.041917028	4.887288116
Community00	gene oncology	GO(CC)	GO:0045177	apical part of cell	0.003199661	0.759763614	0.025145101	4.437879904
Community00	gene oncology	GO(MF)	GO:0070330	aromatase activity	0.003224948	0.949115988	0.041653435	4.925290679
Community00	gene oncology	GO(BP)	GO:0045346	regulation of MHC class II biosynthetic process	0.003261528	0.999996517	0.021362342	5.866306827
Community00	gene oncology	GO(BP)	GO:0032469	endoplasmic reticulum calcium ion homeostasis	0.003261528	0.999996517	0.021362342	5.866306827
Community00	gene oncology	GO(BP)	GO:0010714	positive regulation of collagen metabolic process	0.003261528	0.999996517	0.021362342	5.866306827
Community00	gene oncology	GO(BP)	GO:0070328	triglyceride homeostasis	0.003261528	0.999996517	0.021362342	5.866306827
Community00	gene oncology	GO(BP)	GO:0010894	negative regulation of steroid biosynthetic process	0.003261528	0.999996517	0.021362342	5.866306827
Community00	gene oncology	GO(BP)	GO:0045939	negative regulation of steroid metabolic process	0.003261528	0.999996517	0.021362342	5.866306827
Community00	gene oncology	GO(BP)	GO:0007183	SMAD protein complex assembly	0.003261528	0.999996517	0.021362342	5.866306827
Community00	gene oncology	GO(BP)	GO:0010872	regulation of cholesterol esterification	0.003261528	0.999996517	0.021362342	5.866306827
Community00	gene oncology	GO(BP)	GO:0030857	negative regulation of epithelial cell differentiation	0.003261528	0.999996517	0.021362342	5.866306827
Community00	gene oncology	GO(BP)	GO:0032967	positive regulation of collagen biosynthetic process	0.003261528	0.999996517	0.021362342	5.866306827
Community00	gene oncology	GO(MF)	GO:0004860	protein kinase inhibitor activity	0.003352639	0.954784992	0.042672976	5.115552122
Community00	gene oncology	GO(MF)	GO:0016566	specific transcriptional repressor activity	0.003352639	0.954784992	0.042672976	5.115552122
Community00	gene oncology	GO(BP)	GO:0006665	sphingolipid metabolic process	0.003393158	0.999997904	0.022178617	6.09608812
Community00	gene oncology	GO(BP)	GO:0043470	regulation of carbohydrate catabolic process	0.003394466	0.999997915	0.022149513	6.098367543
Community00	gene oncology	GO(BP)	GO:0043471	regulation of cellular carbohydrate catabolic process	0.003394466	0.999997915	0.022149513	6.098367543
Community00	gene oncology	GO(BP)	GO:0043535	regulation of blood vessel endothelial cell migration	0.003394466	0.999997915	0.022149513	6.098367543
Community00	gene oncology	GO(BP)	GO:0050709	negative regulation of protein secretion	0.003394466	0.999997915	0.022149513	6.098367543
Community00	gene oncology	GO(BP)	GO:0050999	regulation of nitric-oxide synthase activity	0.003394466	0.999997915	0.022149513	6.098367543
Community00	gene oncology	GO(MF)	GO:0033613	transcription activator binding	0.003407865	0.957037085	0.042772447	5.197730251
Community00	gene oncology	GO(MF)	GO:0046965	retinoid X receptor binding	0.003407865	0.957037085	0.042772447	5.197730251
Community00	gene oncology	GO(MF)	GO:0051427	hormone receptor binding	0.003445778	0.958517929	0.042659171	5.254106741
Community00	gene oncology	GO(BP)	GO:0033043	regulation of organelle organization	0.003490197	0.999998559	0.022729622	6.265144659
Community00	gene oncology	GO(MF)	GO:0030246	carbohydrate binding	0.003518137	0.961204128	0.042961224	5.361616097
Community00	gene oncology	GO(BP)	GO:0032989	cellular component morphogenesis	0.003565476	0.999998923	0.023175847	6.396093208
Community00	gene oncology	GO(BP)	GO:0009895	negative regulation of catabolic process	0.003582896	0.999998993	0.023248742	6.426370611
Community00	gene oncology	GO(BP)	GO:0031214	biomineral formation	0.003582896	0.999998993	0.023248742	6.426370611
Community00	gene oncology	GO(BP)	GO:0048864	stem cell development	0.003612633	0.999999102	0.023400373	6.478035196
Community00	gene oncology	GO(BP)	GO:0030262	apoptotic nuclear changes	0.003612633	0.999999102	0.023400373	6.478035196
Community00	gene oncology	GO(BP)	GO:0000018	regulation of DNA recombination	0.003612633	0.999999102	0.023400373	6.478035196
Community00	gene oncology	GO(BP)	GO:0050819	negative regulation of coagulation	0.003612633	0.999999102	0.023400373	6.478035196
Community00	gene oncology	GO(BP)	GO:0000165	MAPKKK cascade	0.003637813	0.999999185	0.023522299	6.521760687
Community00	gene oncology	GO(BP)	GO:0044271	nitrogen compound biosynthetic process	0.003800393	0.999999565	0.024521399	6.803622818
Community00	gene oncology	GO(MF)	GO:0042379	chemokine receptor binding	0.003862588	0.971793475	0.046462023	5.87183544
Community00	gene oncology	GO(MF)	GO:0019210	kinase inhibitor activity	0.003863941	0.971828774	0.045880642	5.873834363
Community00	gene oncology	GO(CC)	GO:0031410	cytoplasmic vesicle	0.003899927	0.824279499	0.030045704	5.384399242
Community00	gene oncology	GO(MF)	GO:0004175	endopeptidase activity	0.003900105	0.972756148	0.04571343	5.927251765
Community00	gene oncology	GO(BP)	GO:0010769	regulation of cell morphogenesis involved in differentiation	0.004056454	0.999999838	0.026111444	7.245921113
Community00	gene oncology	GO(BP)	GO:0048706	embryonic skeletal system development	0.004056454	0.999999838	0.026111444	7.245921113
Community00	gene oncology	GO(BP)	GO:0040029	"regulation of gene expression, epigenetic"	0.004056454	0.999999838	0.026111444	7.245921113
Community00	gene oncology	GO(BP)	GO:0048332	mesoderm morphogenesis	0.004110671	0.999999869	0.026412395	7.339315417
Community00	gene oncology	GO(BP)	GO:0009968	negative regulation of signal transduction	0.004228525	0.999999917	0.027115683	7.542026737
Community00	gene oncology	GO(BP)	GO:0001952	regulation of cell-matrix adhesion	0.00428714	0.999999934	0.027441502	7.642687879
Community00	gene oncology	GO(BP)	GO:0008542	visual learning	0.00428714	0.999999934	0.027441502	7.642687879
Community00	gene oncology	GO(BP)	GO:0042307	positive regulation of protein import into nucleus	0.004297174	0.999999936	0.027459386	7.659908946
Community00	gene oncology	GO(MF)	GO:0035257	nuclear hormone receptor binding	0.004482277	0.984108146	0.051716628	6.783273156
Community00	gene oncology	GO(MF)	GO:0042974	retinoic acid receptor binding	0.004540286	0.984939434	0.05172413	6.868168945
Community00	gene oncology	GO(CC)	GO:0044420	extracellular matrix part	0.004641827	0.873867486	0.035067313	6.37768226
Community00	gene oncology	GO(BP)	GO:0042475	odontogenesis of dentine-containing tooth	0.004693768	0.999999986	0.029911702	8.338158673
Community00	gene oncology	GO(BP)	GO:0045830	positive regulation of isotype switching	0.004744624	0.999999989	0.030181735	8.424790641
Community00	gene oncology	GO(BP)	GO:0044003	modification by symbiont of host morphology or physiology	0.004744624	0.999999989	0.030181735	8.424790641
Community00	gene oncology	GO(BP)	GO:0001773	myeloid dendritic cell activation	0.004744624	0.999999989	0.030181735	8.424790641
Community00	gene oncology	GO(BP)	GO:0014037	Schwann cell differentiation	0.004744624	0.999999989	0.030181735	8.424790641
Community00	gene oncology	GO(BP)	GO:0043011	myeloid dendritic cell differentiation	0.004744624	0.999999989	0.030181735	8.424790641
Community00	gene oncology	GO(BP)	GO:0035019	somatic stem cell maintenance	0.004744624	0.999999989	0.030181735	8.424790641
Community00	gene oncology	GO(BP)	GO:0034374	low-density lipoprotein particle remodeling	0.004744624	0.999999989	0.030181735	8.424790641
Community00	gene oncology	GO(BP)	GO:0033158	"regulation of protein import into nucleus, translocation"	0.004744624	0.999999989	0.030181735	8.424790641
Community00	gene oncology	GO(BP)	GO:0030947	regulation of vascular endothelial growth factor receptor signaling pathway	0.004744624	0.999999989	0.030181735	8.424790641
Community00	gene oncology	GO(BP)	GO:0051044	positive regulation of membrane protein ectodomain proteolysis	0.004744624	0.999999989	0.030181735	8.424790641
Community00	gene oncology	GO(BP)	GO:0051023	regulation of immunoglobulin secretion	0.004744624	0.999999989	0.030181735	8.424790641
Community00	gene oncology	GO(BP)	GO:0045911	positive regulation of DNA recombination	0.004744624	0.999999989	0.030181735	8.424790641
Community00	gene oncology	GO(BP)	GO:0051000	positive regulation of nitric-oxide synthase activity	0.004744624	0.999999989	0.030181735	8.424790641
Community00	gene oncology	GO(BP)	GO:0021537	telencephalon development	0.004811444	0.999999991	0.030550848	8.538497777
Community00	gene oncology	GO(BP)	GO:0006633	fatty acid biosynthetic process	0.004816988	0.999999991	0.030535314	8.547925175
Community00	gene oncology	GO(BP)	GO:0006959	humoral immune response	0.004816988	0.999999991	0.030535314	8.547925175
Community00	gene oncology	GO(BP)	GO:0034371	chylomicron remodeling	0.004868474	0.999999993	0.030806762	8.635440785
Community00	gene oncology	GO(BP)	GO:0002248	connective tissue replacement during inflammatory response	0.004868474	0.999999993	0.030806762	8.635440785
Community00	gene oncology	GO(BP)	GO:0034393	positive regulation of smooth muscle cell apoptosis	0.004868474	0.999999993	0.030806762	8.635440785
Community00	gene oncology	GO(BP)	GO:0030219	megakaryocyte differentiation	0.004868474	0.999999993	0.030806762	8.635440785
Community00	gene oncology	GO(BP)	GO:0010661	positive regulation of muscle cell apoptosis	0.004868474	0.999999993	0.030806762	8.635440785
Community00	gene oncology	GO(BP)	GO:0042789	mRNA transcription from RNA polymerase II promoter	0.004868474	0.999999993	0.030806762	8.635440785
Community00	gene oncology	GO(BP)	GO:0006925	inflammatory cell apoptosis	0.004868474	0.999999993	0.030806762	8.635440785
Community00	gene oncology	GO(BP)	GO:0006997	nucleus organization	0.004977146	0.999999995	0.031433611	8.819897504
Community00	pathway	BIOCARTA	h_pmlPathway	Regulation of transcriptional activity by PML	0.005000465	0.712990312	0.163325273	6.301005433
Community00	gene oncology	GO(MF)	GO:0016721	"oxidoreductase activity, acting on superoxide radicals as acceptor"	0.005019149	0.990335613	0.056341885	7.566219368
Community00	gene oncology	GO(MF)	GO:0004784	superoxide dismutase activity	0.005019149	0.990335613	0.056341885	7.566219368
Community00	gene oncology	GO(MF)	GO:0070644	vitamin D response element binding	0.005019149	0.990335613	0.056341885	7.566219368
Community00	gene oncology	GO(BP)	GO:0007595	lactation	0.005046813	0.999999996	0.031815526	8.937963537
Community00	gene oncology	GO(MF)	GO:0019903	protein phosphatase binding	0.005056659	0.990665767	0.056071189	7.620690943
Community00	gene oncology	GO(CC)	GO:0005925	focal adhesion	0.005072573	0.895966237	0.037630308	6.949924997
Community00	gene oncology	GO(CC)	GO:0031090	organelle membrane	0.005090679	0.896805331	0.037144857	6.973907266
Community00	gene oncology	GO(MF)	GO:0005179	hormone activity	0.005169356	0.991591464	0.056609036	7.78416933
Community00	gene oncology	GO(BP)	GO:0042770	"DNA damage response, signal transduction"	0.005236568	0.999999998	0.03294109	9.258810629
Community00	gene oncology	GO(CC)	GO:0031988	membrane-bounded vesicle	0.005241135	0.903521823	0.037609568	7.17297128
Community00	gene oncology	GO(BP)	GO:0046883	regulation of hormone secretion	0.005284391	0.999999999	0.033183547	9.339503152
Community00	gene oncology	GO(BP)	GO:0032846	positive regulation of homeostatic process	0.005335493	0.999999999	0.033445419	9.425653512
Community00	gene oncology	GO(BP)	GO:0001704	formation of primary germ layer	0.005335493	0.999999999	0.033445419	9.425653512
Community00	gene oncology	GO(BP)	GO:0051224	negative regulation of protein transport	0.005335493	0.999999999	0.033445419	9.425653512
Community00	gene oncology	GO(BP)	GO:0046631	alpha-beta T cell activation	0.005348779	0.999999999	0.033473123	9.448039942
Community00	gene oncology	GO(BP)	GO:0002718	regulation of cytokine production during immune response	0.005348779	0.999999999	0.033473123	9.448039942
Community00	gene oncology	GO(BP)	GO:0002763	positive regulation of myeloid leukocyte differentiation	0.005348779	0.999999999	0.033473123	9.448039942
Community00	gene oncology	GO(BP)	GO:0033993	response to lipid	0.005348779	0.999999999	0.033473123	9.448039942
Community00	gene oncology	GO(BP)	GO:0019915	lipid storage	0.005348779	0.999999999	0.033473123	9.448039942
Community00	gene oncology	GO(BP)	GO:0051260	protein homooligomerization	0.00536992	0.999999999	0.033549105	9.483648877
Community00	pathway	KEGG	hsa05332	Graft-versus-host disease	0.005495063	0.557587267	0.029752563	6.353984708
Community00	gene oncology	GO(BP)	GO:0030162	regulation of proteolysis	0.005537465	0.999999999	0.034524531	9.765392033
Community00	gene oncology	GO(BP)	GO:0006643	membrane lipid metabolic process	0.005683909	1	0.035366641	10.01097224
Community00	gene oncology	GO(BP)	GO:0010522	regulation of calcium ion transport into cytosol	0.005897122	1	0.036613531	10.36738978
Community00	gene oncology	GO(BP)	GO:0008360	regulation of cell shape	0.006143712	1	0.038058435	10.77793709
Community00	gene oncology	GO(BP)	GO:0042398	cellular amino acid derivative biosynthetic process	0.006143712	1	0.038058435	10.77793709
Community00	gene oncology	GO(BP)	GO:0007276	gamete generation	0.006275723	1	0.038800379	10.99698975
Community00	gene oncology	GO(MF)	GO:0043498	cell surface binding	0.006289087	0.997023029	0.067683117	9.393798243
Community00	gene oncology	GO(BP)	GO:0021915	neural tube development	0.006335945	1	0.039103859	11.09675158
Community00	gene oncology	GO(BP)	GO:0050926	regulation of positive chemotaxis	0.006559425	1	0.040394752	11.46603333
Community00	gene oncology	GO(BP)	GO:0050927	positive regulation of positive chemotaxis	0.006559425	1	0.040394752	11.46603333
Community00	gene oncology	GO(BP)	GO:0031128	developmental induction	0.006559425	1	0.040394752	11.46603333
Community00	gene oncology	GO(BP)	GO:0045168	cell-cell signaling involved in cell fate specification	0.006559425	1	0.040394752	11.46603333
Community00	gene oncology	GO(BP)	GO:0006309	DNA fragmentation involved in apoptosis	0.006559425	1	0.040394752	11.46603333
Community00	gene oncology	GO(BP)	GO:0032755	positive regulation of interleukin-6 production	0.006559425	1	0.040394752	11.46603333
Community00	gene oncology	GO(BP)	GO:0030194	positive regulation of blood coagulation	0.006573886	1	0.040417792	11.48987915
Community00	gene oncology	GO(BP)	GO:0043129	surfactant homeostasis	0.006573886	1	0.040417792	11.48987915
Community00	gene oncology	GO(BP)	GO:0048875	chemical homeostasis within a tissue	0.006573886	1	0.040417792	11.48987915
Community00	gene oncology	GO(BP)	GO:0042523	positive regulation of tyrosine phosphorylation of Stat5 protein	0.006573886	1	0.040417792	11.48987915
Community00	gene oncology	GO(BP)	GO:0020027	hemoglobin metabolic process	0.006573886	1	0.040417792	11.48987915
Community00	gene oncology	GO(BP)	GO:0050710	negative regulation of cytokine secretion	0.006573886	1	0.040417792	11.48987915
Community00	gene oncology	GO(BP)	GO:0045123	cellular extravasation	0.006573886	1	0.040417792	11.48987915
Community00	gene oncology	GO(CC)	GO:0005924	cell-substrate adherens junction	0.006642424	0.948477655	0.046708467	9.008062724
Community00	gene oncology	GO(BP)	GO:0019882	antigen processing and presentation	0.006666616	1	0.040912802	11.64264205
Community00	gene oncology	GO(BP)	GO:0034614	cellular response to reactive oxygen species	0.006843438	1	0.041911921	11.93324754
Community00	gene oncology	GO(BP)	GO:0050707	regulation of cytokine secretion	0.006843438	1	0.041911921	11.93324754
Community00	gene oncology	GO(BP)	GO:0042990	regulation of transcription factor import into nucleus	0.006843438	1	0.041911921	11.93324754
Community00	gene oncology	GO(BP)	GO:0050729	positive regulation of inflammatory response	0.006843438	1	0.041911921	11.93324754
Community00	gene oncology	GO(MF)	GO:0070412	R-SMAD binding	0.006862317	0.99825127	0.072796054	10.20760934
Community00	gene oncology	GO(BP)	GO:0007631	feeding behavior	0.006917725	1	0.042291586	12.05506728
Community00	gene oncology	GO(MF)	GO:0002020	protease binding	0.006923632	0.998348035	0.072592514	10.2942513
Community00	gene oncology	GO(MF)	GO:0004866	endopeptidase inhibitor activity	0.007327583	0.998864754	0.07581937	10.86310835
Community00	gene oncology	GO(BP)	GO:0006631	fatty acid metabolic process	0.00733334	1	0.044713167	12.73368074
Community00	gene oncology	GO(BP)	GO:0007088	regulation of mitosis	0.007502855	1	0.045654514	13.009039
Community00	gene oncology	GO(BP)	GO:0051783	regulation of nuclear division	0.007502855	1	0.045654514	13.009039
Community00	gene oncology	GO(BP)	GO:0007369	gastrulation	0.007538972	1	0.045797833	13.06760072
Community00	gene oncology	GO(BP)	GO:0007229	integrin-mediated signaling pathway	0.007538972	1	0.045797833	13.06760072
Community00	gene oncology	GO(CC)	GO:0019867	outer membrane	0.007556875	0.965801715	0.052170487	10.18736028
Community00	gene oncology	GO(BP)	GO:0007632	visual behavior	0.007891012	1	0.047817539	13.6364646
Community00	gene oncology	GO(BP)	GO:0042446	hormone biosynthetic process	0.007891012	1	0.047817539	13.6364646
Community00	gene oncology	GO(BP)	GO:0002685	regulation of leukocyte migration	0.007938642	1	0.048024912	13.7131593
Community00	gene oncology	GO(BP)	GO:0033619	membrane protein proteolysis	0.007938642	1	0.048024912	13.7131593
Community00	gene oncology	GO(BP)	GO:0031330	negative regulation of cellular catabolic process	0.007938642	1	0.048024912	13.7131593
Community00	gene oncology	GO(BP)	GO:0007528	neuromuscular junction development	0.007938642	1	0.048024912	13.7131593
Community00	gene oncology	GO(BP)	GO:0042312	regulation of vasodilation	0.007938642	1	0.048024912	13.7131593
Community00	gene oncology	GO(BP)	GO:0006805	xenobiotic metabolic process	0.007938642	1	0.048024912	13.7131593
Community00	pathway	BIOCARTA	h_ctcfPathway	CTCF;  First Multivalent Nuclear Factor	0.008361188	0.87639797	0.229977881	10.32764878
Community00	pathway	BIOCARTA	h_cytokinePathway	Cytokine Network	0.008361188	0.87639797	0.229977881	10.32764878
Community00	gene oncology	GO(MF)	GO:0042826	histone deacetylase binding	0.008406937	0.999583641	0.085585056	12.36657038
Community00	gene oncology	GO(MF)	GO:0032813	tumor necrosis factor receptor superfamily binding	0.008406937	0.999583641	0.085585056	12.36657038
Community00	gene oncology	GO(CC)	GO:0031594	neuromuscular junction	0.00850894	0.977689094	0.057686135	11.40006176
Community00	gene oncology	GO(BP)	GO:0035148	tube lumen formation	0.008554553	1	0.051587975	14.69912447
Community00	gene oncology	GO(BP)	GO:0008593	regulation of Notch signaling pathway	0.008767431	1	0.052760441	15.03741869
Community00	gene oncology	GO(BP)	GO:0010559	regulation of glycoprotein biosynthetic process	0.008767431	1	0.052760441	15.03741869
Community00	gene oncology	GO(BP)	GO:0045736	negative regulation of cyclin-dependent protein kinase activity	0.008767431	1	0.052760441	15.03741869
Community00	gene oncology	GO(BP)	GO:0010885	regulation of cholesterol storage	0.008767431	1	0.052760441	15.03741869
Community00	gene oncology	GO(BP)	GO:0042423	catecholamine biosynthetic process	0.008767431	1	0.052760441	15.03741869
Community00	gene oncology	GO(BP)	GO:0045723	positive regulation of fatty acid biosynthetic process	0.008767431	1	0.052760441	15.03741869
Community00	gene oncology	GO(BP)	GO:0045648	positive regulation of erythrocyte differentiation	0.008767431	1	0.052760441	15.03741869
Community00	gene oncology	GO(BP)	GO:0046902	regulation of mitochondrial membrane permeability	0.008767431	1	0.052760441	15.03741869
Community00	gene oncology	GO(BP)	GO:0048070	regulation of pigmentation during development	0.008767431	1	0.052760441	15.03741869
Community00	gene oncology	GO(BP)	GO:0009913	epidermal cell differentiation	0.008906297	1	0.053493706	15.25741381
Community00	gene oncology	GO(BP)	GO:0030030	cell projection organization	0.00901361	1	0.054039392	15.42705123
Community00	gene oncology	GO(BP)	GO:0060021	palate development	0.009044948	1	0.054138954	15.47652868
Community00	gene oncology	GO(BP)	GO:0048863	stem cell differentiation	0.009044948	1	0.054138954	15.47652868
Community00	gene oncology	GO(BP)	GO:0030518	steroid hormone receptor signaling pathway	0.009072312	1	0.054215003	15.51971091
Community00	gene oncology	GO(CC)	GO:0005583	fibrillar collagen	0.009089977	0.98281188	0.060601922	12.13266714
Community00	gene oncology	GO(MF)	GO:0005072	"transforming growth factor beta receptor, cytoplasmic mediator activity"	0.009147785	0.999790978	0.091794779	13.38474408
Community00	gene oncology	GO(MF)	GO:0043027	caspase inhibitor activity	0.009147785	0.999790978	0.091794779	13.38474408
Community00	gene oncology	GO(MF)	GO:0019902	phosphatase binding	0.009192036	0.99979941	0.091232247	13.44520707
Community00	pathway	KEGG	hsa00980	Metabolism of xenobiotics by cytochrome P450	0.009337507	0.750536698	0.04837789	10.57491905
Community00	gene oncology	GO(BP)	GO:0042149	cellular response to glucose starvation	0.009473425	1	0.056466863	16.15028698
Community00	gene oncology	GO(BP)	GO:0002740	negative regulation of cytokine secretion during immune response	0.009473425	1	0.056466863	16.15028698
Community00	gene oncology	GO(BP)	GO:0034383	low-density lipoprotein particle clearance	0.009473425	1	0.056466863	16.15028698
Community00	gene oncology	GO(BP)	GO:0002739	regulation of cytokine secretion during immune response	0.009473425	1	0.056466863	16.15028698
Community00	gene oncology	GO(BP)	GO:0010523	negative regulation of calcium ion transport into cytosol	0.009473425	1	0.056466863	16.15028698
Community00	gene oncology	GO(BP)	GO:0032800	receptor biosynthetic process	0.009473425	1	0.056466863	16.15028698
Community00	gene oncology	GO(BP)	GO:0006642	triglyceride mobilization	0.009473425	1	0.056466863	16.15028698
Community00	gene oncology	GO(BP)	GO:0043619	regulation of transcription from RNA polymerase II promoter in response to oxidative stress	0.009473425	1	0.056466863	16.15028698
Community00	gene oncology	GO(BP)	GO:0032488	Cdc42 protein signal transduction	0.009473425	1	0.056466863	16.15028698
Community00	gene oncology	GO(BP)	GO:0045091	regulation of retroviral genome replication	0.009473425	1	0.056466863	16.15028698
Community00	gene oncology	GO(BP)	GO:0006927	transformed cell apoptosis	0.009473425	1	0.056466863	16.15028698
Community00	gene oncology	GO(BP)	GO:0010940	positive regulation of necrotic cell death	0.009473425	1	0.056466863	16.15028698
Community00	gene oncology	GO(BP)	GO:0002904	positive regulation of B cell apoptosis	0.009473425	1	0.056466863	16.15028698
Community00	gene oncology	GO(BP)	GO:0043589	skin morphogenesis	0.009473425	1	0.056466863	16.15028698
Community00	gene oncology	GO(BP)	GO:0042420	dopamine catabolic process	0.009473425	1	0.056466863	16.15028698
Community00	gene oncology	GO(BP)	GO:0032909	regulation of transforming growth factor-beta2 production	0.009473425	1	0.056466863	16.15028698
Community00	gene oncology	GO(BP)	GO:0001912	positive regulation of leukocyte mediated cytotoxicity	0.009495304	1	0.05650701	16.18455331
Community00	gene oncology	GO(BP)	GO:0043255	regulation of carbohydrate biosynthetic process	0.009495304	1	0.05650701	16.18455331
Community00	gene oncology	GO(CC)	GO:0005913	cell-cell adherens junction	0.009520961	0.985837053	0.062465677	12.67243514
Community00	gene oncology	GO(BP)	GO:0042440	pigment metabolic process	0.009538633	1	0.056671394	16.25237639
Community00	gene oncology	GO(CC)	GO:0030055	cell-substrate junction	0.009674589	0.9867817	0.062528994	12.86409377
Community00	gene oncology	GO(MF)	GO:0008518	reduced folate carrier activity	0.009762419	0.999882041	0.095616638	14.22104216
Community00	gene oncology	GO(CC)	GO:0016023	cytoplasmic membrane-bounded vesicle	0.010070413	0.988935915	0.064090077	13.35610474
Community00	gene oncology	GO(BP)	GO:0015914	phospholipid transport	0.010310183	1	0.061041925	17.45142346
Community00	gene oncology	GO(MF)	GO:0008201	heparin binding	0.010393004	0.999934437	0.100441837	15.0711846
Community00	gene oncology	GO(BP)	GO:0051216	cartilage development	0.010450796	1	0.061757913	17.66819125
Community00	gene oncology	GO(BP)	GO:0007623	circadian rhythm	0.010600808	1	0.062525164	17.89885245
Community00	pathway	KEGG	hsa05020	Prion diseases	0.010628342	0.794315845	0.05307132	11.95331378
Community00	gene oncology	GO(BP)	GO:0009953	dorsal/ventral pattern formation	0.010869709	1	0.063970241	18.31079182
Community00	gene oncology	GO(BP)	GO:0030902	hindbrain development	0.010869709	1	0.063970241	18.31079182
Community00	gene oncology	GO(BP)	GO:0045087	innate immune response	0.010983871	1	0.06452541	18.48508815
Community00	gene oncology	GO(CC)	GO:0043025	cell soma	0.011135069	0.993145843	0.069670023	14.66669443
Community00	gene oncology	GO(BP)	GO:0007157	heterophilic cell adhesion	0.011237592	1	0.065873882	18.87119846
Community00	gene oncology	GO(BP)	GO:0001658	branching involved in ureteric bud morphogenesis	0.011237592	1	0.065873882	18.87119846
Community00	gene oncology	GO(BP)	GO:0048538	thymus development	0.011237592	1	0.065873882	18.87119846
Community00	gene oncology	GO(BP)	GO:0046824	positive regulation of nucleocytoplasmic transport	0.011237592	1	0.065873882	18.87119846
Community00	gene oncology	GO(BP)	GO:0060675	ureteric bud morphogenesis	0.011237592	1	0.065873882	18.87119846
Community00	gene oncology	GO(MF)	GO:0030414	peptidase inhibitor activity	0.011264993	0.999970914	0.107327507	16.23379456
Community00	pathway	KEGG	hsa04622	RIG-I-like receptor signaling pathway	0.011312936	0.814343529	0.054582429	12.67641991
Community00	gene oncology	GO(BP)	GO:0045909	positive regulation of vasodilation	0.011339341	1	0.066352892	19.02555339
Community00	gene oncology	GO(BP)	GO:0014823	response to activity	0.011339341	1	0.066352892	19.02555339
Community00	gene oncology	GO(BP)	GO:0008354	germ cell migration	0.011339341	1	0.066352892	19.02555339
Community00	gene oncology	GO(BP)	GO:0006809	nitric oxide biosynthetic process	0.011339341	1	0.066352892	19.02555339
Community00	gene oncology	GO(BP)	GO:0046688	response to copper ion	0.011339341	1	0.066352892	19.02555339
Community00	gene oncology	GO(BP)	GO:0032350	regulation of hormone metabolic process	0.011339341	1	0.066352892	19.02555339
Community00	gene oncology	GO(BP)	GO:0014910	regulation of smooth muscle cell migration	0.011339341	1	0.066352892	19.02555339
Community00	gene oncology	GO(BP)	GO:0045931	positive regulation of mitotic cell cycle	0.011339341	1	0.066352892	19.02555339
Community00	gene oncology	GO(BP)	GO:0010745	negative regulation of foam cell differentiation	0.011339341	1	0.066352892	19.02555339
Community00	gene oncology	GO(BP)	GO:0010039	response to iron ion	0.011339341	1	0.066352892	19.02555339
Community00	gene oncology	GO(BP)	GO:0000768	syncytium formation by plasma membrane fusion	0.011339341	1	0.066352892	19.02555339
Community00	gene oncology	GO(BP)	GO:0001542	ovulation from ovarian follicle	0.011339341	1	0.066352892	19.02555339
Community00	gene oncology	GO(MF)	GO:0046332	SMAD binding	0.01137904	0.999973849	0.107258592	16.38474627
Community00	gene oncology	GO(CC)	GO:0034362	low-density lipoprotein particle	0.011490499	0.994159133	0.070835662	15.10010958
Community00	gene oncology	GO(BP)	GO:0034976	response to endoplasmic reticulum stress	0.011691468	1	0.06824999	19.55759001
Community00	gene oncology	GO(BP)	GO:0048638	regulation of developmental growth	0.011744166	1	0.068445396	19.63692839
Community00	gene oncology	GO(MF)	GO:0051183	vitamin transporter activity	0.011825714	0.99998276	0.110133608	16.97350887
Community00	gene oncology	GO(BP)	GO:0030100	regulation of endocytosis	0.01185932	1	0.068992834	19.81003778
Community00	gene oncology	GO(BP)	GO:0006968	cellular defense response	0.01185932	1	0.068992834	19.81003778
Community00	gene oncology	GO(BP)	GO:0010608	posttranscriptional regulation of gene expression	0.013027259	1	0.075454321	21.54595925
Community00	gene oncology	GO(BP)	GO:0048806	genitalia development	0.013172974	1	0.076156875	21.7600268
Community00	gene oncology	GO(BP)	GO:0043449	cellular alkene metabolic process	0.013172974	1	0.076156875	21.7600268
Community00	gene oncology	GO(BP)	GO:0009954	proximal/distal pattern formation	0.013172974	1	0.076156875	21.7600268
Community00	gene oncology	GO(BP)	GO:0050886	endocrine process	0.013172974	1	0.076156875	21.7600268
Community00	gene oncology	GO(BP)	GO:0006921	cell structure disassembly during apoptosis	0.013172974	1	0.076156875	21.7600268
Community00	gene oncology	GO(BP)	GO:0045776	negative regulation of blood pressure	0.013172974	1	0.076156875	21.7600268
Community00	gene oncology	GO(BP)	GO:0003073	regulation of systemic arterial blood pressure	0.01319335	1	0.076157189	21.78991595
Community00	gene oncology	GO(BP)	GO:0051047	positive regulation of secretion	0.013686795	1	0.078791857	22.51046896
Community00	gene oncology	GO(BP)	GO:0007249	I-kappaB kinase/NF-kappaB cascade	0.014031015	1	0.080585191	23.00939263
Community00	gene oncology	GO(BP)	GO:0048812	neuron projection morphogenesis	0.014147933	1	0.081113124	23.17816422
Community00	gene oncology	GO(BP)	GO:0046209	nitric oxide metabolic process	0.014300045	1	0.081833547	23.39721574
Community00	gene oncology	GO(BP)	GO:0050996	positive regulation of lipid catabolic process	0.014300045	1	0.081833547	23.39721574
Community00	gene oncology	GO(BP)	GO:0008045	motor axon guidance	0.014300045	1	0.081833547	23.39721574
Community00	gene oncology	GO(BP)	GO:0045907	positive regulation of vasoconstriction	0.014300045	1	0.081833547	23.39721574
Community00	gene oncology	GO(BP)	GO:0042100	B cell proliferation	0.014300045	1	0.081833547	23.39721574
Community00	gene oncology	GO(BP)	GO:0010744	positive regulation of foam cell differentiation	0.014300045	1	0.081833547	23.39721574
Community00	gene oncology	GO(BP)	GO:0042993	positive regulation of transcription factor import into nucleus	0.014300045	1	0.081833547	23.39721574
Community00	gene oncology	GO(BP)	GO:0034612	response to tumor necrosis factor	0.014300045	1	0.081833547	23.39721574
Community00	pathway	KEGG	hsa00150	Androgen and estrogen metabolism	0.014388673	0.8829311	0.066853724	15.85854542
Community00	gene oncology	GO(CC)	GO:0005773	vacuole	0.015042948	0.998823219	0.09062671	19.32100998
Community00	gene oncology	GO(BP)	GO:0006468	protein amino acid phosphorylation	0.015061918	1	0.085905696	24.4855011
Community00	pathway	BIOCARTA	h_cardiacegfPathway	Role of EGF Receptor Transactivation by GPCRs in Cardiac Hypertrophy	0.015274502	0.978348865	0.346789123	18.11344711
Community00	pathway	BIOCARTA	h_tob1Pathway	Role of Tob in T-cell activation	0.015274502	0.978348865	0.346789123	18.11344711
Community00	gene oncology	GO(BP)	GO:0002889	regulation of immunoglobulin mediated immune response	0.015308186	1	0.087129538	24.83413957
Community00	gene oncology	GO(BP)	GO:0002712	regulation of B cell mediated immunity	0.015308186	1	0.087129538	24.83413957
Community00	gene oncology	GO(BP)	GO:0003002	regionalization	0.015356545	1	0.087266417	24.90242084
Community00	gene oncology	GO(BP)	GO:0010623	developmental programmed cell death	0.015363204	1	0.087175147	24.91181866
Community00	gene oncology	GO(BP)	GO:0034313	diol catabolic process	0.015363204	1	0.087175147	24.91181866
Community00	gene oncology	GO(BP)	GO:0042541	hemoglobin biosynthetic process	0.015363204	1	0.087175147	24.91181866
Community00	gene oncology	GO(BP)	GO:0045136	development of secondary sexual characteristics	0.015363204	1	0.087175147	24.91181866
Community00	gene oncology	GO(BP)	GO:0042424	catecholamine catabolic process	0.015363204	1	0.087175147	24.91181866
Community00	gene oncology	GO(BP)	GO:0002360	T cell lineage commitment	0.015363204	1	0.087175147	24.91181866
Community00	gene oncology	GO(BP)	GO:0043618	regulation of transcription from RNA polymerase II promoter in response to stress	0.015363204	1	0.087175147	24.91181866
Community00	gene oncology	GO(BP)	GO:0010901	regulation of very-low-density lipoprotein particle remodeling	0.015363204	1	0.087175147	24.91181866
Community00	gene oncology	GO(BP)	GO:0010560	positive regulation of glycoprotein biosynthetic process	0.015363204	1	0.087175147	24.91181866
Community00	gene oncology	GO(BP)	GO:0007442	hindgut morphogenesis	0.015363204	1	0.087175147	24.91181866
Community00	gene oncology	GO(BP)	GO:0046852	positive regulation of bone remodeling	0.015363204	1	0.087175147	24.91181866
Community00	gene oncology	GO(BP)	GO:0002326	B cell lineage commitment	0.015363204	1	0.087175147	24.91181866
Community00	gene oncology	GO(BP)	GO:0032364	oxygen homeostasis	0.015363204	1	0.087175147	24.91181866
Community00	gene oncology	GO(BP)	GO:0010871	negative regulation of receptor biosynthetic process	0.015363204	1	0.087175147	24.91181866
Community00	gene oncology	GO(BP)	GO:0019614	catechol catabolic process	0.015363204	1	0.087175147	24.91181866
Community00	gene oncology	GO(BP)	GO:0043620	regulation of transcription in response to stress	0.015363204	1	0.087175147	24.91181866
Community00	gene oncology	GO(BP)	GO:0001783	B cell apoptosis	0.015363204	1	0.087175147	24.91181866
Community00	gene oncology	GO(BP)	GO:0034391	regulation of smooth muscle cell apoptosis	0.015363204	1	0.087175147	24.91181866
Community00	gene oncology	GO(BP)	GO:0034382	chylomicron remnant clearance	0.015363204	1	0.087175147	24.91181866
Community00	gene oncology	GO(BP)	GO:0002347	response to tumor cell	0.015363204	1	0.087175147	24.91181866
Community00	gene oncology	GO(BP)	GO:0051024	positive regulation of immunoglobulin secretion	0.015363204	1	0.087175147	24.91181866
Community00	gene oncology	GO(BP)	GO:0022614	membrane to membrane docking	0.015363204	1	0.087175147	24.91181866
Community00	gene oncology	GO(BP)	GO:0045780	positive regulation of bone resorption	0.015363204	1	0.087175147	24.91181866
Community00	gene oncology	GO(BP)	GO:0010939	regulation of necrotic cell death	0.015363204	1	0.087175147	24.91181866
Community00	gene oncology	GO(BP)	GO:0030224	monocyte differentiation	0.015363204	1	0.087175147	24.91181866
Community00	gene oncology	GO(BP)	GO:0060056	mammary gland involution	0.015363204	1	0.087175147	24.91181866
Community00	gene oncology	GO(BP)	GO:0070230	positive regulation of lymphocyte apoptosis	0.015363204	1	0.087175147	24.91181866
Community00	gene oncology	GO(BP)	GO:0002251	organ or tissue specific immune response	0.015363204	1	0.087175147	24.91181866
Community00	gene oncology	GO(BP)	GO:0032331	negative regulation of chondrocyte differentiation	0.015363204	1	0.087175147	24.91181866
Community00	gene oncology	GO(BP)	GO:0046486	glycerolipid metabolic process	0.015591353	1	0.088291456	25.23313309
Community00	gene oncology	GO(BP)	GO:0070271	protein complex biogenesis	0.015730457	1	0.088919291	25.42840127
Community00	gene oncology	GO(BP)	GO:0006461	protein complex assembly	0.015730457	1	0.088919291	25.42840127
Community00	gene oncology	GO(MF)	GO:0050661	NADP or NADPH binding	0.015749327	0.99999956	0.142786107	21.98104375
Community00	gene oncology	GO(MF)	GO:0008517	folic acid transporter activity	0.015825113	0.99999959	0.142044001	22.07492175
Community00	gene oncology	GO(MF)	GO:0060228	phosphatidylcholine-sterol O-acyltransferase activator activity	0.015825113	0.99999959	0.142044001	22.07492175
Community00	gene oncology	GO(BP)	GO:0042157	lipoprotein metabolic process	0.016274822	1	0.091741355	26.18793098
Community00	gene oncology	GO(BP)	GO:0042742	defense response to bacterium	0.016315784	1	0.091829778	26.24478642
Community00	gene oncology	GO(BP)	GO:0060627	regulation of vesicle-mediated transport	0.016547634	1	0.092947745	26.56581526
Community00	gene oncology	GO(BP)	GO:0019722	calcium-mediated signaling	0.016575978	1	0.092966076	26.60496998
Community00	gene oncology	GO(CC)	GO:0031968	organelle outer membrane	0.016602088	0.999418526	0.098298231	21.11122184
Community00	gene oncology	GO(MF)	GO:0032403	protein complex binding	0.016680388	0.999999816	0.147759819	23.12707802
Community00	gene oncology	GO(BP)	GO:0014031	mesenchymal cell development	0.017188492	1	0.096120395	27.44631047
Community00	gene oncology	GO(BP)	GO:0048762	mesenchymal cell differentiation	0.017188492	1	0.096120395	27.44631047
Community00	gene oncology	GO(BP)	GO:0009309	amine biosynthetic process	0.01743547	1	0.097303561	27.78296902
Community00	gene oncology	GO(BP)	GO:0045862	positive regulation of proteolysis	0.017649221	1	0.098304717	28.0731412
Community00	gene oncology	GO(BP)	GO:0043331	response to dsRNA	0.017649221	1	0.098304717	28.0731412
Community00	gene oncology	GO(BP)	GO:0046632	alpha-beta T cell differentiation	0.017656664	1	0.098203618	28.08322506
Community00	gene oncology	GO(BP)	GO:0006949	syncytium formation	0.017656664	1	0.098203618	28.08322506
Community00	gene oncology	GO(BP)	GO:0030279	negative regulation of ossification	0.017656664	1	0.098203618	28.08322506
Community00	gene oncology	GO(BP)	GO:0046716	muscle maintenance	0.017656664	1	0.098203618	28.08322506
Community00	gene oncology	GO(BP)	GO:0007519	skeletal muscle tissue development	0.017800608	1	0.098828654	28.27798415
Community00	gene oncology	GO(BP)	GO:0060538	skeletal muscle organ development	0.017800608	1	0.098828654	28.27798415
Community00	gene oncology	GO(BP)	GO:0032990	cell part morphogenesis	0.01782324	1	0.098807764	28.30856047
Community00	gene oncology	GO(MF)	GO:0005542	folic acid binding	0.01839683	0.999999963	0.160284589	25.19864043
Community00	gene oncology	GO(BP)	GO:0042552	myelination	0.018464661	1	0.102061739	29.17002223
Community00	gene oncology	GO(MF)	GO:0005520	insulin-like growth factor binding	0.0185744	0.999999969	0.160217671	25.40993964
Community00	gene oncology	GO(BP)	GO:0060485	mesenchyme development	0.018781276	1	0.103586371	29.59163444
Community00	gene oncology	GO(BP)	GO:0006790	sulfur metabolic process	0.019301752	1	0.106174958	30.27955745
Community00	gene oncology	GO(CC)	GO:0005741	mitochondrial outer membrane	0.020105221	0.99988119	0.116450562	24.99972956
Community00	pathway	KEGG	hsa04350	TGF-beta signaling pathway	0.020160718	0.950918559	0.089895701	21.54520245
Community00	gene oncology	GO(BP)	GO:0045766	positive regulation of angiogenesis	0.020201328	1	0.110730178	31.45357741
Community00	gene oncology	GO(BP)	GO:0042311	vasodilation	0.020201328	1	0.110730178	31.45357741
Community00	gene oncology	GO(BP)	GO:0035137	hindlimb morphogenesis	0.020201328	1	0.110730178	31.45357741
Community00	gene oncology	GO(BP)	GO:0000737	"DNA catabolic process, endonucleolytic"	0.020201328	1	0.110730178	31.45357741
Community00	gene oncology	GO(BP)	GO:0006687	glycosphingolipid metabolic process	0.020201328	1	0.110730178	31.45357741
Community00	pathway	BIOCARTA	h_nuclearRsPathway	Nuclear Receptors in Lipid Metabolism and Toxicity	0.020215545	0.993812636	0.398617803	23.29036118
Community00	pathway	BIOCARTA	h_extrinsicPathway	Extrinsic Prothrombin Activation Pathway	0.020331139	0.993991768	0.371843464	23.40777415
Community00	gene oncology	GO(BP)	GO:0045664	regulation of neuron differentiation	0.020414406	1	0.111684434	31.72890912
Community00	gene oncology	GO(BP)	GO:0022411	cellular component disassembly	0.020471975	1	0.111826951	31.8031175
Community00	gene oncology	GO(BP)	GO:0051147	regulation of muscle cell differentiation	0.020489792	1	0.111762695	31.82606848
Community00	gene oncology	GO(BP)	GO:0031646	positive regulation of neurological system process	0.020489792	1	0.111762695	31.82606848
Community00	gene oncology	GO(BP)	GO:0014075	response to amine stimulus	0.020489792	1	0.111762695	31.82606848
Community00	gene oncology	GO(BP)	GO:0017015	regulation of transforming growth factor beta receptor signaling pathway	0.020489792	1	0.111762695	31.82606848
Community00	gene oncology	GO(BP)	GO:0033555	multicellular organismal response to stress	0.020489792	1	0.111762695	31.82606848
Community00	gene oncology	GO(BP)	GO:0007613	memory	0.020489792	1	0.111762695	31.82606848
Community00	gene oncology	GO(MF)	GO:0004713	protein tyrosine kinase activity	0.020941441	0.999999997	0.177272672	28.17376017
Community00	gene oncology	GO(BP)	GO:0045806	negative regulation of endocytosis	0.021413342	1	0.116383738	33.00580622
Community00	gene oncology	GO(BP)	GO:0010165	response to X-ray	0.021413342	1	0.116383738	33.00580622
Community00	gene oncology	GO(BP)	GO:0045453	bone resorption	0.021413342	1	0.116383738	33.00580622
Community00	gene oncology	GO(BP)	GO:0042402	biogenic amine catabolic process	0.021413342	1	0.116383738	33.00580622
Community00	pathway	KEGG	hsa04672	Intestinal immune network for IgA production	0.021588998	0.960449091	0.09324577	22.89690592
Community00	pathway	BIOCARTA	h_il6Pathway	IL 6 signaling pathway	0.022069069	0.996138665	0.370646304	25.15317196
Community00	pathway	BIOCARTA	h_stemPathway	Regulation of hematopoiesis by cytokines	0.02212386	0.996192161	0.34852411	25.2075965
Community00	pathway	BIOCARTA	h_hifPathway	Hypoxia-Inducible Factor in the Cardiovascular System	0.02212386	0.996192161	0.34852411	25.2075965
Community00	gene oncology	GO(BP)	GO:0019953	sexual reproduction	0.022228696	1	0.12041621	34.03125904
Community00	gene oncology	GO(BP)	GO:0019228	regulation of action potential in neuron	0.022263008	1	0.120424934	34.07408532
Community00	gene oncology	GO(BP)	GO:0007281	germ cell development	0.022324624	1	0.120573416	34.1509247
Community00	gene oncology	GO(BP)	GO:0052509	positive regulation by symbiont of host defense response	0.02242545	1	0.120921832	34.27647937
Community00	gene oncology	GO(BP)	GO:0060395	SMAD protein signal transduction	0.02242545	1	0.120921832	34.27647937
Community00	gene oncology	GO(BP)	GO:0010896	regulation of triglyceride catabolic process	0.02242545	1	0.120921832	34.27647937
Community00	gene oncology	GO(BP)	GO:0060136	embryonic process involved in female pregnancy	0.02242545	1	0.120921832	34.27647937
Community00	gene oncology	GO(BP)	GO:0042532	negative regulation of tyrosine phosphorylation of STAT protein	0.02242545	1	0.120921832	34.27647937
Community00	gene oncology	GO(BP)	GO:0007406	negative regulation of neuroblast proliferation	0.02242545	1	0.120921832	34.27647937
Community00	gene oncology	GO(BP)	GO:0034384	high-density lipoprotein particle clearance	0.02242545	1	0.120921832	34.27647937
Community00	gene oncology	GO(BP)	GO:0000083	regulation of transcription of G1/S-phase of mitotic cell cycle	0.02242545	1	0.120921832	34.27647937
Community00	gene oncology	GO(BP)	GO:0052510	positive regulation by organism of defense response of other organism during symbiotic interaction	0.02242545	1	0.120921832	34.27647937
Community00	gene oncology	GO(BP)	GO:0048304	positive regulation of isotype switching to IgG isotypes	0.02242545	1	0.120921832	34.27647937
Community00	gene oncology	GO(BP)	GO:0050901	leukocyte tethering or rolling	0.02242545	1	0.120921832	34.27647937
Community00	gene oncology	GO(BP)	GO:0030277	maintenance of gastrointestinal epithelium	0.02242545	1	0.120921832	34.27647937
Community00	gene oncology	GO(BP)	GO:0030316	osteoclast differentiation	0.02242545	1	0.120921832	34.27647937
Community00	gene oncology	GO(BP)	GO:0045922	negative regulation of fatty acid metabolic process	0.02242545	1	0.120921832	34.27647937
Community00	gene oncology	GO(BP)	GO:0042159	lipoprotein catabolic process	0.02242545	1	0.120921832	34.27647937
Community00	gene oncology	GO(BP)	GO:0031641	regulation of myelination	0.02242545	1	0.120921832	34.27647937
Community00	gene oncology	GO(BP)	GO:0052255	modulation by organism of defense response of other organism during symbiotic interaction	0.02242545	1	0.120921832	34.27647937
Community00	gene oncology	GO(BP)	GO:0010669	epithelial structure maintenance	0.02242545	1	0.120921832	34.27647937
Community00	gene oncology	GO(BP)	GO:0034379	very-low-density lipoprotein particle assembly	0.02242545	1	0.120921832	34.27647937
Community00	gene oncology	GO(BP)	GO:0052031	modulation by symbiont of host defense response	0.02242545	1	0.120921832	34.27647937
Community00	gene oncology	GO(BP)	GO:0045071	negative regulation of viral genome replication	0.02242545	1	0.120921832	34.27647937
Community00	gene oncology	GO(BP)	GO:0060443	mammary gland morphogenesis	0.02242545	1	0.120921832	34.27647937
Community00	gene oncology	GO(BP)	GO:0050796	regulation of insulin secretion	0.022654692	1	0.121923962	34.56110142
Community00	gene oncology	GO(BP)	GO:0065003	macromolecular complex assembly	0.022932774	1	0.123170636	34.90479886
Community00	gene oncology	GO(BP)	GO:0033077	T cell differentiation in the thymus	0.022969013	1	0.123185134	34.9494627
Community00	gene oncology	GO(BP)	GO:0006284	base-excision repair	0.022969013	1	0.123185134	34.9494627
Community00	gene oncology	GO(BP)	GO:0042098	T cell proliferation	0.022969013	1	0.123185134	34.9494627
Community00	gene oncology	GO(BP)	GO:0003044	regulation of systemic arterial blood pressure mediated by a chemical signal	0.022969013	1	0.123185134	34.9494627
Community00	gene oncology	GO(MF)	GO:0030197	"extracellular matrix constituent, lubricant activity"	0.023089904	1	0.19204804	30.59909063
Community00	gene oncology	GO(MF)	GO:0043425	bHLH transcription factor binding	0.023089904	1	0.19204804	30.59909063
Community00	gene oncology	GO(MF)	GO:0031994	insulin-like growth factor I binding	0.023089904	1	0.19204804	30.59909063
Community00	gene oncology	GO(CC)	GO:0030139	endocytic vesicle	0.02323566	0.999971394	0.131837944	28.3230663
Community00	gene oncology	GO(CC)	GO:0005819	spindle	0.023314511	0.999972403	0.130616428	28.40498134
Community00	gene oncology	GO(BP)	GO:0006281	DNA repair	0.024029462	1	0.128379411	36.24368067
Community00	gene oncology	GO(BP)	GO:0006606	protein import into nucleus	0.024141723	1	0.128769283	36.3792535
Community00	gene oncology	GO(BP)	GO:0048667	cell morphogenesis involved in neuron differentiation	0.024760042	1	0.131698782	37.12109996
Community00	gene oncology	GO(BP)	GO:0034329	cell junction assembly	0.024962406	1	0.132532564	37.36210877
Community00	gene oncology	GO(BP)	GO:0080135	regulation of cellular response to stress	0.024997274	1	0.132526733	37.40354693
Community00	gene oncology	GO(BP)	GO:0030282	bone mineralization	0.025571544	1	0.135208908	38.08231104
Community00	gene oncology	GO(BP)	GO:0050764	regulation of phagocytosis	0.025571544	1	0.135208908	38.08231104
Community00	gene oncology	GO(BP)	GO:0060191	regulation of lipase activity	0.025673249	1	0.135531452	38.20179401
Community00	gene oncology	GO(BP)	GO:0048741	skeletal muscle fiber development	0.025956047	1	0.136750785	38.53287901
Community00	gene oncology	GO(BP)	GO:0003014	renal system process	0.025956047	1	0.136750785	38.53287901
Community00	pathway	BIOCARTA	h_vobesityPathway	Visceral Fat Deposits and the Metabolic Syndrome	0.02632808	0.998697587	0.377827766	29.27644422
Community00	gene oncology	GO(BP)	GO:0007409	axonogenesis	0.027183617	1	0.142624748	39.9507041
Community00	gene oncology	GO(BP)	GO:0051170	nuclear import	0.027271251	1	0.142864139	40.05072789
Community00	pathway	BIOCARTA	h_p53hypoxiaPathway	Hypoxia and p53 in the Cardiovascular system	0.027359106	0.998999588	0.369025343	30.24257352
Community00	pathway	BIOCARTA	h_nthiPathway	NFkB activation by Nontypeable Hemophilus influenzae	0.027359106	0.998999588	0.369025343	30.24257352
Community00	gene oncology	GO(BP)	GO:0007272	ensheathment of neurons	0.027415699	1	0.143381436	40.21525487
Community00	gene oncology	GO(BP)	GO:0030307	positive regulation of cell growth	0.027415699	1	0.143381436	40.21525487
Community00	gene oncology	GO(BP)	GO:0008366	axon ensheathment	0.027415699	1	0.143381436	40.21525487
Community00	gene oncology	GO(CC)	GO:0005604	basement membrane	0.027463677	0.99999585	0.150456824	32.59465574
Community00	pathway	BIOCARTA	h_il2rbPathway	IL-2 Receptor Beta Chain in T cell Activation	0.027943808	0.999138706	0.356650513	30.78504416
Community00	gene oncology	GO(CC)	GO:0016324	apical plasma membrane	0.028896187	0.999997846	0.155877581	33.98741433
Community00	gene oncology	GO(BP)	GO:0031344	regulation of cell projection organization	0.028936951	1	0.150613634	41.92222119
Community00	gene oncology	GO(MF)	GO:0034061	DNA polymerase activity	0.029047836	1	0.233912355	36.9298817
Community00	gene oncology	GO(BP)	GO:0030199	collagen fibril organization	0.029165474	1	0.151522826	42.17462413
Community00	pathway	BIOCARTA	h_atmPathway	ATM Signaling Pathway	0.029450236	0.999414625	0.354570111	32.16477973
Community00	pathway	BIOCARTA	h_th1th2Pathway	Th1/Th2 Differentiation	0.029450236	0.999414625	0.354570111	32.16477973
Community00	gene oncology	GO(BP)	GO:0001838	embryonic epithelial tube formation	0.030017052	1	0.155440229	43.10607984
Community00	gene oncology	GO(BP)	GO:0019058	viral infectious cycle	0.030017052	1	0.155440229	43.10607984
Community00	gene oncology	GO(BP)	GO:0043200	response to amino acid stimulus	0.030130338	1	0.155780881	43.22891712
Community00	gene oncology	GO(BP)	GO:0006297	"nucleotide-excision repair, DNA gap filling"	0.030130338	1	0.155780881	43.22891712
Community00	gene oncology	GO(BP)	GO:0042310	vasoconstriction	0.030130338	1	0.155780881	43.22891712
Community00	gene oncology	GO(BP)	GO:0060070	Wnt receptor signaling pathway through beta-catenin	0.030130338	1	0.155780881	43.22891712
Community00	gene oncology	GO(BP)	GO:0043409	negative regulation of MAPKKK cascade	0.030130338	1	0.155780881	43.22891712
Community00	gene oncology	GO(BP)	GO:0048547	gut morphogenesis	0.030130338	1	0.155780881	43.22891712
Community00	gene oncology	GO(BP)	GO:0048873	homeostasis of number of cells within a tissue	0.030130338	1	0.155780881	43.22891712
Community00	gene oncology	GO(BP)	GO:0031575	G1/S transition checkpoint	0.030130338	1	0.155780881	43.22891712
Community00	pathway	BIOCARTA	h_asbcellPathway	Antigen Dependent B Cell Activation	0.030401535	0.999541449	0.347588586	33.02294867
Community00	gene oncology	GO(BP)	GO:0016331	morphogenesis of embryonic epithelium	0.030474426	1	0.157230008	43.60047953
Community00	gene oncology	GO(BP)	GO:0032722	positive regulation of chemokine production	0.030554816	1	0.157408858	43.68695558
Community00	gene oncology	GO(BP)	GO:0032816	positive regulation of natural killer cell activation	0.030554816	1	0.157408858	43.68695558
Community00	gene oncology	GO(BP)	GO:0010718	positive regulation of epithelial to mesenchymal transition	0.030554816	1	0.157408858	43.68695558
Community00	gene oncology	GO(BP)	GO:0010770	positive regulation of cell morphogenesis involved in differentiation	0.030554816	1	0.157408858	43.68695558
Community00	gene oncology	GO(BP)	GO:0019430	removal of superoxide radicals	0.030554816	1	0.157408858	43.68695558
Community00	gene oncology	GO(BP)	GO:0006699	bile acid biosynthetic process	0.030554816	1	0.157408858	43.68695558
Community00	gene oncology	GO(BP)	GO:0046426	negative regulation of JAK-STAT cascade	0.030554816	1	0.157408858	43.68695558
Community00	gene oncology	GO(BP)	GO:0051095	regulation of helicase activity	0.030554816	1	0.157408858	43.68695558
Community00	gene oncology	GO(BP)	GO:0014065	phosphoinositide 3-kinase cascade	0.030554816	1	0.157408858	43.68695558
Community00	gene oncology	GO(BP)	GO:0032814	regulation of natural killer cell activation	0.030554816	1	0.157408858	43.68695558
Community00	gene oncology	GO(BP)	GO:0035112	genitalia morphogenesis	0.030554816	1	0.157408858	43.68695558
Community00	gene oncology	GO(BP)	GO:0031057	negative regulation of histone modification	0.030554816	1	0.157408858	43.68695558
Community00	gene oncology	GO(BP)	GO:0050665	hydrogen peroxide biosynthetic process	0.030554816	1	0.157408858	43.68695558
Community00	gene oncology	GO(BP)	GO:0015884	folic acid transport	0.030554816	1	0.157408858	43.68695558
Community00	gene oncology	GO(BP)	GO:0060216	definitive hemopoiesis	0.030554816	1	0.157408858	43.68695558
Community00	gene oncology	GO(BP)	GO:0010889	regulation of sequestering of triglyceride	0.030554816	1	0.157408858	43.68695558
Community00	gene oncology	GO(BP)	GO:0032375	negative regulation of cholesterol transport	0.030554816	1	0.157408858	43.68695558
Community00	gene oncology	GO(BP)	GO:0070229	negative regulation of lymphocyte apoptosis	0.030554816	1	0.157408858	43.68695558
Community00	gene oncology	GO(BP)	GO:0032372	negative regulation of sterol transport	0.030554816	1	0.157408858	43.68695558
Community00	gene oncology	GO(BP)	GO:0008634	negative regulation of survival gene product expression	0.030554816	1	0.157408858	43.68695558
Community00	gene oncology	GO(BP)	GO:0043353	enucleate erythrocyte differentiation	0.030554816	1	0.157408858	43.68695558
Community00	gene oncology	GO(BP)	GO:0046668	regulation of retinal cell programmed cell death	0.030554816	1	0.157408858	43.68695558
Community00	gene oncology	GO(MF)	GO:0015238	drug transporter activity	0.031350021	1	0.248076998	39.22801646
Community00	pathway	KEGG	hsa04810	Regulation of actin cytoskeleton	0.032533601	0.992516379	0.134087765	32.56783937
Community00	gene oncology	GO(BP)	GO:0032649	regulation of interferon-gamma production	0.032599634	1	0.166953221	45.84488645
Community00	gene oncology	GO(BP)	GO:0033044	regulation of chromosome organization	0.032599634	1	0.166953221	45.84488645
Community00	gene oncology	GO(BP)	GO:0060606	tube closure	0.032599634	1	0.166953221	45.84488645
Community00	gene oncology	GO(BP)	GO:0042401	biogenic amine biosynthetic process	0.032599634	1	0.166953221	45.84488645
Community00	gene oncology	GO(BP)	GO:0001843	neural tube closure	0.032599634	1	0.166953221	45.84488645
Community00	pathway	KEGG	hsa05014	Amyotrophic lateral sclerosis (ALS)	0.033129861	0.993168975	0.132782232	33.0613102
Community00	gene oncology	GO(BP)	GO:0060193	positive regulation of lipase activity	0.033266696	1	0.169892782	46.53175942
Community00	gene oncology	GO(BP)	GO:0006766	vitamin metabolic process	0.033266696	1	0.169892782	46.53175942
Community00	gene oncology	GO(BP)	GO:0051301	cell division	0.033853463	1	0.172437867	47.12913137
Community00	gene oncology	GO(BP)	GO:0048610	reproductive cellular process	0.033964392	1	0.172735844	47.24135356
Community00	gene oncology	GO(CC)	GO:0030669	clathrin-coated endocytic vesicle membrane	0.034169662	0.999999809	0.179917822	38.88740441
Community00	gene oncology	GO(CC)	GO:0034366	spherical high-density lipoprotein particle	0.034169662	0.999999809	0.179917822	38.88740441
Community00	gene oncology	GO(MF)	GO:0008013	beta-catenin binding	0.034226064	1	0.265629341	41.98891041
Community00	gene oncology	GO(BP)	GO:0016337	cell-cell adhesion	0.034371719	1	0.174422577	47.65149836
Community00	gene oncology	GO(CC)	GO:0005730	nucleolus	0.034615128	0.999999845	0.179989885	39.28544025
Community00	gene oncology	GO(BP)	GO:0007492	endoderm development	0.03508665	1	0.177537698	48.36409244
Community00	gene oncology	GO(BP)	GO:0001837	epithelial to mesenchymal transition	0.03508665	1	0.177537698	48.36409244
Community00	gene oncology	GO(BP)	GO:0002062	chondrocyte differentiation	0.03508665	1	0.177537698	48.36409244
Community00	gene oncology	GO(BP)	GO:0009743	response to carbohydrate stimulus	0.035235496	1	0.178002568	48.51129334
Community00	gene oncology	GO(BP)	GO:0046879	hormone secretion	0.035672407	1	0.179803809	48.94108607
Community00	gene oncology	GO(BP)	GO:0030808	regulation of nucleotide biosynthetic process	0.036132195	1	0.181702768	49.38971672
Community00	gene oncology	GO(BP)	GO:0030802	regulation of cyclic nucleotide biosynthetic process	0.036132195	1	0.181702768	49.38971672
Community00	gene oncology	GO(BP)	GO:0043900	regulation of multi-organism process	0.03626017	1	0.182061817	49.51392187
Community00	gene oncology	GO(BP)	GO:0006664	glycolipid metabolic process	0.03626017	1	0.182061817	49.51392187
Community00	gene oncology	GO(BP)	GO:0006879	cellular iron ion homeostasis	0.03626017	1	0.182061817	49.51392187
Community00	gene oncology	GO(BP)	GO:0032680	regulation of tumor necrosis factor production	0.03626017	1	0.182061817	49.51392187
Community00	gene oncology	GO(CC)	GO:0044448	cell cortex part	0.036852392	0.999999945	0.188494476	41.2483135
Community00	gene oncology	GO(BP)	GO:0046700	heterocycle catabolic process	0.03763315	1	0.188143042	50.82843582
Community00	gene oncology	GO(BP)	GO:0050808	synapse organization	0.037785624	1	0.188602224	50.97240237
Community00	gene oncology	GO(BP)	GO:0034504	protein localization in nucleus	0.038320476	1	0.190804829	51.47426694
Community00	gene oncology	GO(BP)	GO:0030111	regulation of Wnt receptor signaling pathway	0.038729919	1	0.192426743	51.85516917
Community00	gene oncology	GO(BP)	GO:0002791	regulation of peptide secretion	0.038729919	1	0.192426743	51.85516917
Community00	gene oncology	GO(BP)	GO:0019433	triglyceride catabolic process	0.039652579	1	0.196364842	52.70317144
Community00	gene oncology	GO(BP)	GO:0048340	paraxial mesoderm morphogenesis	0.039652579	1	0.196364842	52.70317144
Community00	gene oncology	GO(BP)	GO:0048147	negative regulation of fibroblast proliferation	0.039652579	1	0.196364842	52.70317144
Community00	gene oncology	GO(BP)	GO:0048302	regulation of isotype switching to IgG isotypes	0.039652579	1	0.196364842	52.70317144
Community00	gene oncology	GO(BP)	GO:0055093	response to hyperoxia	0.039652579	1	0.196364842	52.70317144
Community00	gene oncology	GO(BP)	GO:0032332	positive regulation of chondrocyte differentiation	0.039652579	1	0.196364842	52.70317144
Community00	gene oncology	GO(BP)	GO:0043249	erythrocyte maturation	0.039652579	1	0.196364842	52.70317144
Community00	gene oncology	GO(BP)	GO:0006111	regulation of gluconeogenesis	0.039652579	1	0.196364842	52.70317144
Community00	gene oncology	GO(BP)	GO:0046885	regulation of hormone biosynthetic process	0.039652579	1	0.196364842	52.70317144
Community00	gene oncology	GO(BP)	GO:0046321	positive regulation of fatty acid oxidation	0.039652579	1	0.196364842	52.70317144
Community00	gene oncology	GO(BP)	GO:0045737	positive regulation of cyclin-dependent protein kinase activity	0.039652579	1	0.196364842	52.70317144
Community00	gene oncology	GO(BP)	GO:0014002	astrocyte development	0.039652579	1	0.196364842	52.70317144
Community00	gene oncology	GO(BP)	GO:0010288	response to lead ion	0.039652579	1	0.196364842	52.70317144
Community00	gene oncology	GO(BP)	GO:0010660	regulation of muscle cell apoptosis	0.039652579	1	0.196364842	52.70317144
Community00	gene oncology	GO(BP)	GO:0060343	trabecula formation	0.039652579	1	0.196364842	52.70317144
Community00	gene oncology	GO(BP)	GO:0060396	growth hormone receptor signaling pathway	0.039652579	1	0.196364842	52.70317144
Community00	gene oncology	GO(BP)	GO:0001935	endothelial cell proliferation	0.039652579	1	0.196364842	52.70317144
Community00	gene oncology	GO(BP)	GO:0010543	regulation of platelet activation	0.039652579	1	0.196364842	52.70317144
Community00	gene oncology	GO(BP)	GO:0048596	embryonic camera-type eye morphogenesis	0.039652579	1	0.196364842	52.70317144
Community00	gene oncology	GO(MF)	GO:0008047	enzyme activator activity	0.03972473	1	0.299484299	46.94362788
Community00	gene oncology	GO(BP)	GO:0008624	induction of apoptosis by extracellular signals	0.039852778	1	0.197022179	52.88529661
Community00	gene oncology	GO(BP)	GO:0021761	limbic system development	0.040148059	1	0.198105413	53.15270921
Community00	gene oncology	GO(BP)	GO:0042246	tissue regeneration	0.040148059	1	0.198105413	53.15270921
Community00	pathway	KEGG	hsa05217	Basal cell carcinoma	0.040234656	0.997706866	0.15534648	38.69217496
Community00	pathway	KEGG	hsa04623	Cytosolic DNA-sensing pathway	0.040234656	0.997706866	0.15534648	38.69217496
Community00	gene oncology	GO(BP)	GO:0043450	alkene biosynthetic process	0.040435504	1	0.19914938	53.41164537
Community00	gene oncology	GO(BP)	GO:0045076	regulation of interleukin-2 biosynthetic process	0.040435504	1	0.19914938	53.41164537
Community00	gene oncology	GO(BP)	GO:0019370	leukotriene biosynthetic process	0.040435504	1	0.19914938	53.41164537
Community00	gene oncology	GO(BP)	GO:0007224	smoothened signaling pathway	0.040435504	1	0.19914938	53.41164537
Community00	gene oncology	GO(BP)	GO:0048536	spleen development	0.040435504	1	0.19914938	53.41164537
Community00	gene oncology	GO(BP)	GO:0045445	myoblast differentiation	0.040435504	1	0.19914938	53.41164537
Community00	gene oncology	GO(BP)	GO:0008206	bile acid metabolic process	0.040435504	1	0.19914938	53.41164537
Community00	gene oncology	GO(BP)	GO:0007530	sex determination	0.040435504	1	0.19914938	53.41164537
Community00	gene oncology	GO(BP)	GO:0051966	"regulation of synaptic transmission, glutamatergic"	0.040435504	1	0.19914938	53.41164537
Community00	gene oncology	GO(BP)	GO:0042219	cellular amino acid derivative catabolic process	0.040435504	1	0.19914938	53.41164537
Community00	gene oncology	GO(MF)	GO:0005021	vascular endothelial growth factor receptor activity	0.040793251	1	0.303901829	47.85926074
Community00	pathway	BIOCARTA	h_41bbPathway	The 4-1BB-dependent immune response	0.041384851	0.99997312	0.42529687	42.23136814
Community00	pathway	BIOCARTA	h_plateletAppPathway	Platelet Amyloid Precursor Protein Pathway	0.041548842	0.999974241	0.410415132	42.35953965
Community00	gene oncology	GO(CC)	GO:0005581	collagen	0.041559375	0.999999994	0.208004946	45.18696995
Community00	gene oncology	GO(BP)	GO:0030799	regulation of cyclic nucleotide metabolic process	0.041807042	1	0.205033924	54.62862194
Community00	gene oncology	GO(BP)	GO:0034284	response to monosaccharide stimulus	0.041942509	1	0.205382504	54.74717724
Community00	gene oncology	GO(BP)	GO:0009746	response to hexose stimulus	0.041942509	1	0.205382504	54.74717724
Community00	gene oncology	GO(BP)	GO:0048839	inner ear development	0.04236028	1	0.206983402	55.11095131
Community00	pathway	KEGG	hsa05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	0.042996262	0.998503014	0.161207505	40.76117096
Community00	pathway	BIOCARTA	h_amiPathway	Acute Myocardial Infarction	0.043122035	0.999982889	0.407056348	43.57583843
Community00	pathway	BIOCARTA	h_ranklPathway	Bone Remodelling	0.043122035	0.999982889	0.407056348	43.57583843
Community00	pathway	BIOCARTA	h_arfPathway	Tumor Suppressor Arf Inhibits Ribosomal Biogenesis	0.043122035	0.999982889	0.407056348	43.57583843
Community00	pathway	KEGG	hsa04660	T cell receptor signaling pathway	0.043418825	0.998597733	0.15876642	41.07205106
Community00	gene oncology	GO(CC)	GO:0005694	chromosome	0.043630261	0.999999998	0.21501806	46.84085035
Community00	gene oncology	GO(MF)	GO:0019842	vitamin binding	0.04409639	1	0.321996724	50.59711424
Community00	pathway	KEGG	hsa00590	Arachidonic acid metabolism	0.044140751	0.998745981	0.157446395	41.59971734
Community00	gene oncology	GO(BP)	GO:0046324	regulation of glucose import	0.044263629	1	0.215127093	56.73356187
Community00	gene oncology	GO(BP)	GO:0014020	primary neural tube formation	0.044263629	1	0.215127093	56.73356187
Community00	gene oncology	GO(BP)	GO:0021987	cerebral cortex development	0.044263629	1	0.215127093	56.73356187
Community00	gene oncology	GO(BP)	GO:0048858	cell projection morphogenesis	0.044430523	1	0.215595265	56.87316246
Community00	gene oncology	GO(CC)	GO:0030425	dendrite	0.044559459	0.999999998	0.216817411	47.56776081
Community00	pathway	KEGG	hsa04210	Apoptosis	0.044714162	0.998852549	0.155706674	42.01574314
Community00	gene oncology	GO(MF)	GO:0005319	lipid transporter activity	0.046009519	1	0.33109149	52.12068412
Community00	gene oncology	GO(BP)	GO:0051607	defense response to virus	0.046170245	1	0.222923398	58.30322348
Community00	gene oncology	GO(BP)	GO:0001990	regulation of systemic arterial blood pressure by hormone	0.046170245	1	0.222923398	58.30322348
Community00	gene oncology	GO(BP)	GO:0045685	regulation of glial cell differentiation	0.046170245	1	0.222923398	58.30322348
Community00	gene oncology	GO(BP)	GO:0042036	negative regulation of cytokine biosynthetic process	0.046170245	1	0.222923398	58.30322348
Community00	gene oncology	GO(BP)	GO:0042417	dopamine metabolic process	0.046170245	1	0.222923398	58.30322348
Community00	gene oncology	GO(BP)	GO:0019048	virus-host interaction	0.046170245	1	0.222923398	58.30322348
Community00	gene oncology	GO(BP)	GO:0032651	regulation of interleukin-1 beta production	0.046170245	1	0.222923398	58.30322348
Community00	gene oncology	GO(BP)	GO:0006140	regulation of nucleotide metabolic process	0.04805414	1	0.230797627	59.80115906
Community00	gene oncology	GO(CC)	GO:0001533	cornified envelope	0.048208859	1	0.230299301	50.33422551
Community00	gene oncology	GO(BP)	GO:0009712	catechol metabolic process	0.048606583	1	0.232891492	60.23067634
Community00	gene oncology	GO(BP)	GO:0006584	catecholamine metabolic process	0.048606583	1	0.232891492	60.23067634
Community00	gene oncology	GO(BP)	GO:0034311	diol metabolic process	0.048606583	1	0.232891492	60.23067634
Community00	gene oncology	GO(BP)	GO:0010827	regulation of glucose transport	0.048606583	1	0.232891492	60.23067634
Community00	gene oncology	GO(BP)	GO:0050806	positive regulation of synaptic transmission	0.048606583	1	0.232891492	60.23067634
Community00	gene oncology	GO(BP)	GO:0042439	ethanolamine and derivative metabolic process	0.048606583	1	0.232891492	60.23067634
Community00	gene oncology	GO(BP)	GO:0009914	hormone transport	0.048836749	1	0.233596474	60.40834266
Community00	gene oncology	GO(BP)	GO:0046328	regulation of JNK cascade	0.04914558	1	0.23463515	60.64555194
Community00	gene oncology	GO(BP)	GO:0043536	positive regulation of blood vessel endothelial cell migration	0.04962628	1	0.236402008	61.01209829
Community00	gene oncology	GO(BP)	GO:0050732	negative regulation of peptidyl-tyrosine phosphorylation	0.04962628	1	0.236402008	61.01209829
Community00	gene oncology	GO(BP)	GO:0044269	glycerol ether catabolic process	0.04962628	1	0.236402008	61.01209829
Community00	gene oncology	GO(BP)	GO:0008635	activation of caspase activity by cytochrome c	0.04962628	1	0.236402008	61.01209829
Community00	gene oncology	GO(BP)	GO:0043537	negative regulation of blood vessel endothelial cell migration	0.04962628	1	0.236402008	61.01209829
Community00	gene oncology	GO(BP)	GO:0046461	neutral lipid catabolic process	0.04962628	1	0.236402008	61.01209829
Community00	gene oncology	GO(BP)	GO:0010574	regulation of vascular endothelial growth factor production	0.04962628	1	0.236402008	61.01209829
Community00	gene oncology	GO(BP)	GO:0060325	face morphogenesis	0.04962628	1	0.236402008	61.01209829
Community00	gene oncology	GO(BP)	GO:0001976	neurological system process involved in regulation of systemic arterial blood pressure	0.04962628	1	0.236402008	61.01209829
Community00	gene oncology	GO(BP)	GO:0032673	regulation of interleukin-4 production	0.04962628	1	0.236402008	61.01209829
Community00	gene oncology	GO(BP)	GO:0060416	response to growth hormone stimulus	0.04962628	1	0.236402008	61.01209829
Community00	gene oncology	GO(BP)	GO:0021936	regulation of granule cell precursor proliferation	0.04962628	1	0.236402008	61.01209829
Community00	gene oncology	GO(BP)	GO:0010869	regulation of receptor biosynthetic process	0.04962628	1	0.236402008	61.01209829
Community00	gene oncology	GO(BP)	GO:0010717	regulation of epithelial to mesenchymal transition	0.04962628	1	0.236402008	61.01209829
Community00	gene oncology	GO(BP)	GO:0010884	positive regulation of lipid storage	0.04962628	1	0.236402008	61.01209829
Community00	gene oncology	GO(BP)	GO:0046464	acylglycerol catabolic process	0.04962628	1	0.236402008	61.01209829
Community00	gene oncology	GO(BP)	GO:0021940	positive regulation of granule cell precursor proliferation	0.04962628	1	0.236402008	61.01209829
Community00	gene oncology	GO(BP)	GO:0031076	embryonic camera-type eye development	0.04962628	1	0.236402008	61.01209829
Community00	gene oncology	GO(BP)	GO:0045540	regulation of cholesterol biosynthetic process	0.04962628	1	0.236402008	61.01209829
Community00	gene oncology	GO(BP)	GO:0033574	response to testosterone stimulus	0.04962628	1	0.236402008	61.01209829
Community00	gene oncology	GO(BP)	GO:0019934	cGMP-mediated signaling	0.04962628	1	0.236402008	61.01209829